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ABSTRACT 
 
The HaloacidDehalogenase Enzyme Superfamily (HADSF) is a ubiquitous family of 
enzymes.Presently, more than 45, 000 deposited gene sequences encode proteins of the 
HADSF, and only a fraction of these have defined structure and/or function. The work 
described in this thesis focuses on function determination in several members of the 
HADSF. An integrated bioinformatic-protein structure-enzyme mechanism approach was 
used to differentiate and track D-glycero-D-manno-heptose-1,7-bisphosphate 
phosphatase (GHMB) and histidinol phosphatephosphatase (HisB)orthologues;2-keto-3-
deoxynononic acid 9-phosphatephosphatase (KDN9PP) and 2-keto-3-deoxy-D-manno-
octulosonic acid 8-phosphatephosphatase (KDO8PP)orthologues; inorganic 
pyrophosphatase and β-phosphoglucomutase (β-PGM) orthologues. In addition, a 
structure-function/bioinformatic analysis was carried-out on thebifunctional 1,3-
diposphoglycerate acyltransferase/Cys-S-glyceryl-3-phosphate phosphatase (FKBH). 
vii 
 
Each study began with the examination of the genome context of the encoding gene of 
the target HADSF member. Based on this analysis possible catalytic functions were 
posited. In vitro activity assays were then applied to test possible substrates. Having 
identified a potential physiological substrate the X-ray structure of the enzyme-substrate 
(or substrate analog) complex was determined. From this structure the substrate 
recognition residues were identified. These residues were replaced by site directed 
mutagenesis and the impact on substrate binding and catalysis was determined by 
measuring the steady-state kinetic constants kcatand kcat/Km for each of the mutant 
enzymes. Residues shown to be important were used as sequence markers to identify 
among the sequence homologues identified in BLAST searches the most confidently 
defined orthologues. The final step used in the function annotation procedure was to 
examine the genome context of the encoding gene of each putative orthologue. These 
data were then used to formulate the proposal for in vivo function.  
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CHAPTER ONE 
 
HALOACID DEHALOGENASE ENZYME SUPERFAMILY FUNCTION 
DISCOVERY 
 
1.1 Introduction to the Haloacid Dehalogenase Enzyme Superfamily 
The Haloacid Dehalogenase Enzyme Superfamily (HADSF) is a ubiquitous 
family of enzymes [1]. Presently, >45, 000 deposited gene sequences encode proteins of 
the HADSF, and only a fraction of these have defined structure and/or function. 
Numerous proteins from the HADSF are found in each organism (29 in E. coli and 185 in 
humans, for example.)  
The HADSF was named after the first family member characterized: 2-
haloalkanoate dehalogenase. Despite the name, the dehalogenases, which catalyze carbon 
group transfer, represent a minute fraction of the family [2-4]. The known reactions 
catalyzed by the HADSF are depicted in Figure 1.1. Most of these are phosphoryl 
transfer reactions of which the phosphohydrolase activities of the ATPases and the 
phosphatases are the most prevalent. Diversification of the HADSF catalytic scaffold to 
include phosphonate (P-C bond) hydrolysis (phosphonatases) and the transfer of 
phosphoryl groups between hexose hydroxyl substituents (phosphomutases) has occurred 
less frequently. phosphotransferases, having evolved to perform a multitude of different 
biochemical functions essential to cell growth and adaptation. Nature uses the phosphoryl 
group to enhance metabolite solubility, link monomers, facilitate protein-substrate 
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binding, couple catabolism to biosynthesis and movement, and as the on-off switch for 
signal transduction. Phosphotransferases therefore rank high among Nature's protein 
catalysts and a significant fraction of these phosphotransferases are found in the HADSF. 
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Figure 1.1: Known reactions catalyzed by the members of the HADSF. 
           
  All members of the HADSF possess an Alpha, Beta-core catalytic domain 
consisting of a central parallel Beta-sheet flanked by Alpha-helices on both sides [5,6]. 
The core catalytic domain of the HAD superfamily contains a three layered Alpha/Beta 
sandwich comprised of repeating Beta-Alpha units which adopt the topology typical of 
the Rossmannoid class of Alpha/Beta-folds. The central sheet is parallel and typically 
comprised of at least five strands (S1–S5) in a 54123 strand order (Figure 1.2). The HAD 
fold is distinguished from other Rossmannoid folds by two key structural motifs: First, 
immediately downstream of strand S1 is a unique, six residue structural motif that 
assumes a nearly complete single helical turn, termed the “squiggle”. Second, 
downstream of the squiggle there is a Beta-hairpin turn formed by two strands projecting 
from the core of the domain. This structural motif constitutes the “flap”. The squiggle, 
being close to a helical conformation, can be alternatively tightly or loosely wound, 
inducing a movement in the flap immediately juxtaposed to the active site and 
alternatively results in the closed and open states.  Since the simplest structures (type C1) 
add the cap domain to the flap motif itself (Figure 1.3A), conformational changes in the 
squiggle allow the active site to be completely sealed in the closed state. Although the C2 
caps have a different insertion site and thus likely lack mobility comparable to the C1 
caps, together, the movement of the “squiggle-flap” and C2 cap allow dynamic ligand 
induced fit. 
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Figure 1.2: Topology diagram of the classic HADSF Rossmann core domain. Core 
strands conserved across all members are in blue; non-conserved elements that may have 
been absent from the ancestral state are in gray. The HAD C0/C1 cap insertion point is a 
bright green and the C2 cap insertion point is an orange line. The magenta loop 
represents  
the conserved squiggle. Residues conserved across all members are labeled on their 
corresponding loops. 
The concave surface of one face of the catalytic domain is the location of the 
active site (Figure 1.3B) where the substrate binds with its phosphoryl group pointed at 
the bottom and its leaving group projected upwards towards solvent. The core domain 
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catalyzes the transfer of the phosphoryl group from a specific phosphate ester or 
anhydride to an acceptor, which is most commonly a water molecule.  The catalytic 
scaffold, or "active-site template" is formed by 4-loops that station the conserved 
catalytic residues" (Figure 1.3B). These include the two Asp residues of loop 1, the loop 
2 Ser/Thr, the loop 3 Lys/Arg and the loop 4 Asp/Glu.  
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Figure 1.3: A) The HADSF subfamilies-C1 and C2 are distinguished by the insertion 
points of the cap (gold) in the Rossmann fold (blue) (C1 after b-strand 1, C2 after b-
strand 1, C0 has a minimal insert in either site. B) liganded Beta-PGM with catalytic 
segments colored as in C) with cap residue in black. 
              The HADSF phosphotransferase reaction occurs in two steps (Figure 1.4). The 
first step involves phosphoryl transfer to one of the two loop 1 Asp residues (the Asp 
nucleophile) aided by proton transfer from the other loop 1 Asp residue (the Asp 
acid/base residue). The second step involves phosphoryl transfer from the 
aspartylphosphate to the acceptor (a water molecule in the case of the phosphohydrolases 
or hexose in the case of the phosphomutases) activated by the Asp acid/base residue.  
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Figure 1.4: The two-step reaction pathways catalyzed. 
              The Mg2+ cofactor is coordinated by the carboxylate group of the loop 1 Asp 
nucleophile, the backbone amide C=O of the loop 1 Asp acid/base and by the carboxylate 
of  an Asp (or Glu) located on loop 4 (Figure 1.5). 
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Figure 1.5: The Mg2+ (cyan sphere) binding site in a HADF phosphatase. 
              The Mg2+ functions to prevent charge repulsion between the Asp nucleophile 
and the transferring phosphoryl group and at the same time orient the Asp nucleophile, 
transferring phosphoryl group and the Asp acid/base for the reaction (Figure 1.6). 
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Figure 1.6: A depiction of the charge shielding and orientation functions of the HADF 
Mg2+ cofactor. 
              The transferring phosphoryl group is also activated for nucleophilic attack 
through hydrogen bond formation with the loop 2 Thr/Ser side chain, the loop 3 Lys and 
several backbone amide NHs of the catalytic scaffold (Figure 1.7).  
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Figure 1.7: Activation of the transferring phosphoryl group (represented by the grey and 
red vanadate) by hydrogen bonds to the side chains Thr (green and red) and Lys (blue) 
and backbone amide NHs (BB). Hydrogen bonds are shown as black dashed lines. 
            The catalytic scaffold common to all HADSF phosphotransferases acts binds the  
tetrahedral phosphoryl group of the substrate weakly and through increased noncovalent 
bonding interactions stabilizes the trigonal bipyramidal phosphorane at the transition 
states. Crystallographic snap-shots of various liganded HADSF phosphotransferases 
indicate that the catalytic scaffold acts as an electrostatic mold for transition state 
stabilization (Figure 1.8).  
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Figure 1.8: Crystallographic snapshots of (A) the hexose phosphate phosphatase BT4131 
bound with Mg2+ and tungstate, (B) Beta-phosphoglucomutase bound with Mg2+ and 
Beta-glucose-1,6-bisphosphate and (C) KDN-9-phosphate phosphatase bound with Mg2+, 
vanadate and neuramic acid. 
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1.2 The Structural Determinants of HADSF Phosphatases Substrate Recognition  
 The expansion of the HADSF can be attributed to phosphatases whose 
biochemical functions can be divided into four main categories: 1) metabolism, 2) 
regulation of metabolic pools, 3) cell housekeeping, and 4) nutrient uptake. Earlier work 
on the HADSF phosphatases showed that the physiological substrates run the full gamut 
in size and shape from phosphoproteins, nucleic acids, and phospholipids to 
phosphorylated disaccharides, sialic acids and terpenes to the smallest of the 
organophosphate metabolites, phosphoglycolate [7]. It is through the acquisition of 
structural accessories to the catalytic domain that the HADSF has succeeded in covering 
this vast range of substrate structure.  
            Whereas the catalytic scaffold binds the substrate phosphoryl group weakly at the 
ground state and tightly at the transition state it does not bind the leaving group (Figure 
1.9). Therefore, the substrate must derive additional binding energy through favorable 
binding interactions with residues outside of the catalytic scaffold. This added binding 
energy augments the binding energy derived from binding the tetrahedral phosphoryl 
group such that under physiological conditions the HADSF phosphotransferase is able to 
target its physiological substrate. 
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Figure 1.9: Snap-shots of C0 HADSF phosphatases illustrating the placement of the 
leaving group into the solvent. 
           The C0 phosphatases either form tetramers wherein the active site is formed at the 
subunit-subunit interface: one subunit contributes the catalytic residues and the other 
subunit contributes the leaving group binding residues (Figure 1.10).  
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Figure 1.10: KDN-9-phosphate phosphatase bound with neuramic acid (black stick). 
Each subunit is shown in a different color.  
            Other C0 HADSF phosphotransferases do not rely on an interfaced subunit to 
bind the substrate leaving group. Those that act on large substrates such as a 
phosphorylated protein or a nucleic acid use the surface surrounding the catalytic site to 
dock with the substrate. Those that act on metabolites possess extended loops that bind 
the substrate-leaving group (Figure 1.11).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: The C0 HADSF phosphatase GMHB bound with Mg2+ (cyan sphere) and  
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substrate (glycerol-manno-heptose 1,7-bisphosphate) (stick). The residues that bind the  
substrate leaving group are located on the extended loops colored blue, green or magenta.  
            The majority of the HADSF phosphatases, do however possess a cap domain. In 
the caped phosphatases the catalytic scaffold of the Rossmann-like domain alone binds 
the transferring phosphoryl group, whereas the cap domain alone binds the leaving group 
(Figure 1.12). Thus, HADSF phosphatase catalytic residues positioned by the catalytic 
scaffold are physically separated from the substrate recognition residues positioned on 
the cap domain.  
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Figure 1.12: The C1 HADSF phosphotransferase b-phosphoglucomutatase bound with 
Mg2+ (cyan sphere) and Beta-glucose-1,6-bisphosphate (black stick). The cap domain is 
shown in magenta and the catalytic domain in gray. 
            The cap domain provides a large surface, which can accommodate numerous 
substrate recognition residues. Typically, however, only one or two cap residues 
participate in binding the physiological substrate. The cap domain serves as a “pegboard” 
(see Figure 1.13) for the placement/replacement of substrate recognition residues.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Structure of a-phosphomannose mutase showing the cap residues (yellow) 
that are potentially available to bind a substrate-leaving group. 
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            Notably, the cap domain carries the potential to recognize more than one 
substrate, and this ability fosters promiscuity among the HADSF phosphatases. 
Promiscuity might directly support a general housekeeping role in the cell or 
alternatively, facilitate specialization through replacements that enhance the binding of 
the physiological substrate and suppress the binding of others. In addition, the cap 
residues can be tailored to specifically target two structurally distinct physiological 
substrates. Such tailoring would provide the HADSF phosphatase with two biochemical 
functions. For example, the housekeeper NagD [8] protects the cell from toxic 
glucoseamine 6-phosphate build-up during cell wall recycling, and siphons excess UMP 
from imbalanced ribonucleotide pools.  
 
1.3 HADSF Phosphatase Function Determination 
             A challenge of this decade to the life sciences community is the accurate function 
annotation to the rapidly growing numbers of enzyme sequences and structures that are 
accumulating in the public databases. The classification of enzymes into enzyme families 
constitutes the first step in function assignment because members of a given family share 
a common chemical trait the knowledge of which facilitates function determination. An 
enzyme family grows by evolving new members of unique function via gene duplication 
and random mutation against a selection pressure. The inherited family chemical trait 
(exemplified in the phosphotransferase branch of the HADSF as the ability to stabilize 
trigonal bipyramidal phosphorane-like transition states) is the result of an inherited  
17 
 
backbone fold, which in turn supports the catalytic scaffold. Located on the catalytic 
scaffold are the residues that are inherited in the duplicated family member and which 
can be conserved and replaced as needed to adapt the inherited chemical trait to a novel 
biochemical context. It is through developing an understanding of the structural 
determinants of enzyme function that genomic enzymologists hope to expedite the 
process of function annotation.  
            Function assignment to a HADSF phosphatase entails identification of its 
physiological substrate, and in order for this function assignment to facilitate future 
assignments, the structural basis for substrate recognition must be determined. Moreover, 
knowledge of the key substrate recognition residues also allows the tracking orthologs 
found in the gene data banks thus expanding function well beyond that of the single 
enzyme that was subjected to the structure-function analysis. This is exemplified by my 
work on the HADSF phosphatase BT2127 reported in Chapter 2. 
            Organophosphates comprise a big piece (viz.  ~35%) of the metabolome. Because 
of their predominance the HADSF phosphatases play a major role in regulating and 
recycling the organophosphate metabolite pool as well functioning in metabolic 
pathways.  By discovering new functions among the HADSF phosphatases novel 
biochemical pathways can be revealed. This is exemplified by my work on the HADSF 
phosphatase FKBH reported in Chapter 3.  
       In addition to my investigation of BT2127 and FKBH, I have participated in the 
structure-function analysis of HADSF phosphatases GMHB, KDO-8-phosphate 
phosphatase and KDN-9-phosphate phosphatase. This work is reported in the Appendix 
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 of this thesis.  
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CHAPTER TWO 
DIVERGENCE OF STRUCTURE AND FUNCTION IN THE HALOACID 
DEHALOGENASE (HAD) ENZYME SUPERFAMILY: BACTERIODES 
THETAIOTAMICRON BT2127 IS AN INORGANIC PYROPHOSPHATASE 
 
2.1 Introduction 
  Function annotation to the rapidly growing numbers of enzyme sequences and 
structures that are accumulating in the public databases is a challenge that should be met 
quickly so that the scientific community can effectively mine these databases. Ultimately, 
enzyme function annotation must be done by computer because experimental-based 
function determinations are far too time consuming. The Enzyme Function Initiative 
(http://enzymefunction.org/) was instituted in 2010 for the ultimate purpose of evolving 
current experimental strategies into computational-based function prediction. The work 
reported in this chapter is an early product of this initiative as it outlines enzyme function 
determination in a member of the Haloalkonate Dehalogenase enzyme superfamily 
(HADSF) that is based on an integrated bioinformatic-protein structure-enzyme 
mechanism approach which provides reliable tracking of orthologs. 
            The HADSF was selected to explore methods of function assignment because of 
its large size, its presence in all organisms represented in the NCBI genome bank and 
because of the diversity in the types of chemical reactions that its members catalyze. The 
initial focus is on the HADSF phosphatase subfamily. HADSF phosphatases can number 
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up to 30 in bacterial cells and up 200 - 300 in eukaryotic cells. A central question to be 
addressed is “how many unique in vivo functions are there to be discovered within this 
subfamily?”. Bacterial (as opposed to eukaryotic) HADSF phosphatases were chosen for 
study, so to avoid splice variants and the complicating issues of protein partners and 
subcellular localizations as modulators of in vivo function. Function assignment to the 
bacterial HADSF phosphatase thus entails identification of its physiological substrate 
among the pool of organophosphate metabolites that exist in the cell, followed by 
defining the biological context of the catalyzed reaction. 
            Earlier work that involved the screening of 23 cytoplasmic E. coli HADSF 
phosphatases with an 80-compound library of known metabolites made clear the 
challenge of identifying the physiological substrate [1]. Specifically, most of the 
phosphatases displayed activities towards multiple substrates, which in numerous 
instances were structurally dissimilar. In addition, there also existed some degree of 
overlap in the substrate ranges between paired phosphatases.  Nevertheless, the 
physiological substrates of several of the 23 E. coli HADSF phosphatases have been 
convincingly identified and their in vivo functions as phosphoserine phosphatase (SerB)  
[1,2],histidinol phosphate phosphatase (HisB) [3], trehalose-6-phosphate phosphatase 
(OtsB) [4], 3-deoxy-D-manno-octulosonate-8-phosphate phosphatase (YrbI) [5] , 
glycerol-manno-heptose 1,7-bisphosphate phosphatase (YaeD) [6] assigned. Notably, 
each of these phosphatases function in biosynthetic pathways. The in vivo function 
assignment was facilitated by gene context as well as by a narrow substrate range 
coupled and a high kcat/Km value for the physiological substrate. In addition, gene 
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knockout experiments have been used to show that the promiscuous phosphatases YniC 
[1] and YjjG [7] can function in vivo to remove toxic 2-deoxy-glucose-6-phosphate and 
toxic nonconical nucleoside-5’-monophosphates.  Genetic experiments have also shown 
that YjjG performs in the thymidine salvage pathway as a dUMP nucleotidase [8].  
            With the objective in mind of gaining insight into how many of the HADSF 
phosphatases contained in two different species of bacteria share common function and 
how many do not, a side-by-side comparison of the HADSF phosphatases from E. coli 
and Bacteroides thetaiotaomicron was initiated. Whereas these two species derive from 
different phyla they share a common habitat: the human gut. B. thetaiotaomicron 
possesses 19 HADSF phosphatases. Two of these have been experimentally 
characterized. One is 3-deoxy-D-manno-octulosonate-8-phosphate phosphatase 
(BT1677) [9], ortholog to the E. coli YrbI of the 3-deoxy-D-manno-octulosonate pathway 
and the other one is 2-keto-3-deoxy-D-glycero-D-galactonate-9-phosphate phosphatase 
(BT1713) of the 2-keto-3-deoxy-D-glycero-D-galactonate pathway [10], which notably is 
not found in E. coli.  
            In collaboration with structural biologists in the Steve Almo lab at Einstein 
Medical School and the Karen Allen’s lab at Boston University, I have carried out the 
structure-function analysis of the unknown HADSF member BT2127 (ExPASy accession 
# Q8A5V9) from B. thetaiotaomicron. In this chapter I report the BT2127 function, X-
ray structure and biological range and contrast these with those of its closest homologue 
Beta-phosphoglucomutase (Beta-PGM) and with those of a HADSF Archeal inorganic 
pyrophosphatase.   
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2.2 Materials and Methods 
 
2.2.1 General Method 
All chemicals and buffers were purchased from Sigma-Aldrich. The sources of 
the gene cloning materials are as follows: primers, T4 DNA ligase, restriction enzymes 
(Invitrogen); E. coli BL21 (DE3) competent cells and Pfu, Turbo polymerases 
(Strategene); pET14b, pET23a and pET28a vector kits (Novagen); Qiaprep Spin 
Miniprep Kit (Qiagen). DEAE Sepharose was from Amersham Biosciences. Butyl and 
Phenyl-Sepharose resins were purchased from Sigma-Aldrich, whereas the Ni-NTA resin 
was from Qiangen. Snakeskin pleated dialysis tubing was purchased from Thermo 
Scientific. SDS-PAGE analysis was performed with a 12% acrylamide running gel and a 
4% stacking gel (37.5:1 acrylmide:biacryamide ratio) (BioRad, Hercules, CA). Protein 
solutions were concentrated using a 10K Amicon Ultra Centrifugal filter (Millipore). The 
nucleotide sequence of each cloned gene or mutant gene was determined by the Center 
for Genetics in Medicine, University of New Mexico. Electro-spray mass-spectrometry 
(ES-MS) determinations were carried out by the University of the New Mexico Mass 
Spectrometry Facility. Protein concentrations were determined using the Bradford assay 
kit from Sigma-Aldrich. 
 
2.2.2 Preparation of Recombinant Wild-type and Mutant BT2127  
The DNA encoding the gene NP_811040 from B. thetaiotaomicron was amplified 
by PCR using the genomic DNA B. thetaiotaomicron (ATCC 29148D), Pfu Turbo DNA 
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polymerase and oligonucleotide primers (5’-GATTCCATCTAACCCACATATG AGAA 
AGAAAC) and (5’-CTTTTGCATAGTAGGATCCGTATTT ATAGGT) containing 
restriction endonuclease cleavage sites NdeI and BamHI. The pET-28A vector, cut by 
restriction enzymes NdeI and BamHI, was ligated to the PCR product that had been 
purified and then digested with the same restriction enzymes. The ligation product was 
used to transform E. coli BL21 (DE3) competent cells which were then grown on a 
Kanamycin-containing agar plate. The selected colony was checked for BT2127 
production and the isolated plasmid was sequenced to verify the correct gene sequence. 
For BT2127 preparation, the transformed cells (9 L) were grown at 25 °C with agitation 
at 200 rpm in Luria broth containing 40 µg/mL Kanamycin to an OD600 of 0.6-0.7, and 
then induced for 12 h at 20 °C with 0.4 mM isopropyl Alpha-D-thiogalactopyranoside. 
The cells were harvested by centrifugation (6500 rpm for 15 min at 4 °C) to yield 2.2 g/L 
of culture medium. The cell pellet was suspended (1 g wet cells/10 mL) in ice-cold buffer 
A (50 mM Tris (pH 7.6), 5 mM MgCl2 and 1 mM DTT). The cell suspension was passed 
through a French press at 1,200 PSIG before centrifugation at 20,000 rpm and 4°C for 45 
min. The supernatant was loaded onto a 40 × 5 cm DEAE-Sepharose 50-120 column, 
which was eluted with a 2 L linear gradient of NaCl (from 0 to 0.5 M) in buffer A. The 
column fractions were analyzed by SDS-PAGE. The desired fractions were combined 
and loaded onto 10 mL Ni-NTA Agarose column at 4 oC. After washing the column with  
100 mL of buffer B (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole (pH 8.0)), the 
enzyme was eluted with 200 mL elution buffer C (50 mM NaH2PO4, 300 mM NaCl, 250 
mM imidazole (pH 8.0)). The column fractions were analyzed by SDS-PAGE, and the  
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desired fractions were combined and concentrated with an Amicon Ultrafiltration 
apparatus (PM10) before dialysis at 4 oC against buffer A. Yield: 11 mg BT2127/g wet 
cells. 
The site directed mutagenesis was carried out using a PCR-based strategy, the 
BT2127-pET-28A clone as template and commercial primers. The mutant proteins were 
purified in the same manner as described for the wild-type BT2127.  
 
2.2.3 BT2127 Molecular Weight Determination 
The theoretical subunit molecular mass of recombinant BT2127 was calculated by 
using the amino acid composition, derived from the gene sequence, and the ExPASy 
Molecular Biology Server program Compute pI/MW. The subunit size of recombinant 
BT2127 was determined by SDS-PAGE analysis, which included the molecular weight 
standards from New England Biolabs Inc. The subunit mass was determined by MS-ES 
mass spectrometry. The molecular weight of native BT2127 was estimated by FPLC gel 
filtration column chromatography against protein standards (13.7-220 kDa from GE 
Healthcare). The 1.6 cm x 60 cm Sephacryl S-200HR column (GE Healthcare) was 
eluted at 4 oC with buffer D (50 mM HEPES, 100 mM NaCl (pH 7.5)) at a flow rate of 1 
mL/min. The BT2127 molecular weight was derived from the measured elution volume 
by extrapolation of the plot of the elution volume of the molecular weight standard versus  
log molecular weight. BT2127 native mass was also analyzed at the HHMI 
Biopolymer/Keck Foundation Biotechnology Resource Laboratory at Yale University by 
size exclusion chromatography coupled with on-line laser scattering, refractive index, 
26 
 
and ultraviolet detection. 
 
2.2.4 Kinetic Assay for Beta-Phosphoglucomutase Activity 
Reaction solutions initially contained 7 M wild-type BT2127, 200 µM Beta-
glucose-1-phosphate, 10 M Beta-glucose-1,6-bisphosphate, 2 mM MgCl2, 0.4 mM 
NADP and 5.4 units/ml glucose-6-phosphate dehydrogenase in 50 mM K+-HEPES (pH 
7.5). The formation of NADPH from reduction of glucose-6-phosphate was monitored at 
340 nm (ε = 6.2 mM-1cm-1). 
 
2.2.5 Steady-State Kinetic Constant Determinations 
Initial velocities for BT2127 catalyzed hydrolysis of phosphate esters and 
anhydrides were measured at 25 oC using assay solutions that contained 1 mM MgCl2, 
1.0 unit/ml purine nucleoside phosphorylase, and 0.2 mM MESG in 50 mM Tris (pH 
7.5). The reactions were monitored at 360 nm (ε= 9.8 mM-1 cm-1). The steady-state 
kinetic parameters (Km and kcat) were determined by fitting the initial velocity data 
measured at varying substrate concentrations (ranging from 0.5Km to 5Km) to equation 1 
using KinetAsyst I. 
V0=Vmax [S]/ ([S] + Km)                             (Equation.1) 
 
V0 is the initial velocity, Vmax the maximum velocity, [S] the substrate concentration, and 
Km the Michaelis constant for the substrate. The kcat value was calculated from Vmax and 
[E] according to the equation kcat=Vmax/[E], where [E] is the enzyme concentration.  
The steady-state competitive inhibition constant Ki was determined for 
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imidodiphosphate by fitting the initial velocity data, measured as a function of 
pyrophosphate (3, 5, 8, 10, 15, 20µM) and imidodiphosphate (0, 10, 35, 50µM) 
concentration to Equation 2 using KinetAsyst I. 
V0=Vmax [S]/ (Km(1+(1/Ki))+[S] )                         (Equation.2) 
Where [I] is the inhibitor concentration and Ki is the inhibition constant. 
 
2.2.6 pH Rate Profile Determination 
The steady-state kinetic constants kcat and Km for BT2127-catalyzed hydrolysis of 
pyrophosphate were measured at 25 oC as a function of reaction solution pH. Reaction 
solutions initially contained pyrophosphate (0.5Km to 10Km), 1 mM MgCl2, 1.0 unit/ml 
purine nucleoside phosphorylase, 0.2 mM MESG in 50 mM buffer (MES, pH 5.0-6.0; 
HEPES, pH 6.5-7.5; Tris, pH 8.0-8.5). The kcat/Km data were fitted with Equation 2 and 
the kcat data were fitted with Equation 3.  
LogY = Log[C/(1 + [H]/Kb)]                                                              (2) 
LogY = Log[C/(1 + [H]/Ka + Kb/[H])]                                               (3) 
where Y is the kcat or   kcat/Km, [H] is the hydrogen ion concentration of the reaction 
solution, Ka and Kb are the apparent ionization constants, and C is the constant value of 
Y. 
 
2.2.7 BT2127 Crystallization and Structure Determination 
            This work was carried out by X-ray crystallographers Patskovsky Yury and 
Rafael Toro. I prepared the wild-type and mutant proteins. The proteins were crystallized 
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by the sitting drop vapor diffusion method. In brief, the protein solution (usually 0.3 or 1 
mL) was mixed with an equal volume of a precipitant solution and equilibrated at room 
temperature (294 oK) against the same precipitant solution in the clear tape-sealed 96-
well INTELLI-plates (Art Robbins Instruments, Sunnyvale, CA, USA). Crystallization was 
performed using either a TECAN crystallization robot (TECAN US, Research Triangle 
Park, NC, USA) or a PHOENIX crystallization robot (Art Robbins Instruments) and 
three types of commercial crystallization screens: the WIZARD screen (Emerald 
BioSystems, Bainbridge Island, WA, USA), the INDEX and the CRYSTAL SCREEN I 
and II (both from Hampton Research, Aliso Viejo, CA, USA).   A number of 
crystallization conditions produced diffraction-quality protein crystals starting within 24-
72 h of incubation. The crystals were collected using Hampton Research cryogenic loops, 
quickly transferred in liquid nitrogen, and stored frozen in liquid nitrogen until X-ray 
analysis and/or data collection. Only in one case (PDB code 3QU2) was the 
cryoprotectant glycerol employed. Where necessary, the crystallization conditions were 
optimized manually using 24-well Cryschem sitting drop plates (Hampton Research).  
The crystallization conditions for each crystal structure are listed in the Table SI1 
(Supporting Information) 
            The X-ray diffraction data from majority of frozen crystals were collected at 100 
oK on the Beamline X29A (NSLS, Brookhaven National Laboratory) using the 
wavelength of the radiation of either 0.93 or 1.08 Angstroms. The X-ray diffraction data 
from the crystal of the D13A mutant were collected at 100 oK using an RU-200 rotating-
anode X-ray generator ( =1.5418Å) coupled to a Rigaku R-AXIS IV area detector.  All 
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diffraction data were processed and scaled using the HKL2000 software package 
(Otwinowski and Minor, 1997). The first out of 13 crystal structures (PDB 3QU2) reporte
d here was solved by molecular replacement using coordinates for the PDB structure 
3DV9 as a search model and the program MOLREP (the CCP4 program package suit, 
www.ccp4.ac.uk).  The other 12 structures were solved using coordinates for the structure 
3QU2 as a search model.  Each structure was refined using REFMAC 5.03 (CCP4 suit, 
Murshudov et al, 1997) and the resulting model was fixed manually using COOT 
visualization and refinement software (Emsley et al, 2010). The data collection and 
refinement statistics for these structures are shown in the Tables SI2-SI5 of Supporting 
Information. 
 
2.2.8 Bioinformatic Analysis 
Putative orthologues to BT2127 and the pyrophosphatase from Themococcus 
onnurineus TON0002 were identified by carrying out BLAST searches of the NCBI 
microbial genome bank (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) and 
selecting those sequences in which the key marker residues are conserved. The multiple 
sequence alignments were made in Cobalt (http://www.ncbi.nlm.nih.gov/tools/cobalt/) 
and displayed in ESPript (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi).  
            In order to compare biological ranges of BT2127 and Beta-PGM a more 
automated approach was employed. BLAST searches were performed for BT2127, Beta-
PGM, maltose phosphorylase, and trehalose phosphorylase using a locally installed copy 
of BLAST against the NCBI non-redundant protein database (ftp://ftp.ncbi.nih. 
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gov/blast/db/) with default parameters. The resulting hits were filtered for query coverage 
>90% and >30% sequence identity. A reciprocal BLAST search, using an e-value 
threshold of 1e-10, was performed for each filtered hit.  A hit was considered successful 
if the reciprocal BLAST search identified the initial query sequence. For each successful 
hit, taxonomic information was downloaded from NCBI taxonomy website 
(http://www.ncbi. Nlm.nih.gov/Taxonomy/taxonomyhome.html/). For the selection of β-
PGM orthologues, only species with a maltose or trehalose phosphorylase gene were 
considered. A phylogenetic tree for the orthologues was generated using iTOL - 
interactive Tree Of Life (http://itol.embl.de/) and visualized using FigTree 
(http://tree.bio.ed.ac.uk/software/fig tree/). 
 
2.3 Results and Discussion 
2.3.1 BT2127 Substrate Specificity Profile  
 Because the closest characterized structural homolog of BT2127 is Beta-
phosphoglucomutase (Beta-PGM), the ability of purified recombinant BT2127 (see SDS-
PAGE gel in Figure 2.1) to catalyze the conversion of Beta-glucose-1-phosphate to 
glucose-6-phosphate in the presence of the cofactor Beta-glucose-1, 6-bisphosphate was 
tested. No activity was observed above the detection limit of one catalytic turnover per 
hour.  
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Figure 2.14: Commassie blue stained SDS-PAGE gel of purified BT2127 (Q8A5V9). 
            Next, the BT2127 phosphatase activity was tested using a structurally diverse 
chemical library of 21 organophosphate metabolites as the substrate screen (Table 2.1). 
The most active substrates identified by this screen were further analyzed to determine 
kcat and kcat/Km values (Table 2.2) at the pH optimum of 7.5 (pH rate profile is shown in 
Figure 2.2).  
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Table 2.1: The apparent first order rate constants for BT2127 catalyzed hydrolysis of 
phosphate esters and anhydrides at pH 7.5 and 25 oC. Reaction solutions initially 
contained 0.3 mM substrate, 8.4 μM BT2127, 1 mM MgCl2, 1.0 unit/mL purine 
nucleoside phosphorylase and 0.2 mM MESG in 50 mM Tris (pH 7.5). The kobs value 
was calculated by dividing the initial velocity of the reaction by the enzyme 
concentration. 
 
Substrate kobs (min-1) Substrate kobs (min-1) 
Pyrophosphate 19 -fucose-1-P 0.10 
Imidodiphosphate 0.06 GMP 0.38 
Glyceraldehyde 3-P 0.17 UDP 0.17 
Glycerate-3-P 0.31 ATP 0.20 
D-erythrose-4-P 0.20 dATP 0.18 
Dihydroxyacetone phosphate 0.30 Farnesylpyrophosphate 0.059 
Glycerol-2-P 0.49 PLP NAa 
Glucose-1-P 0.12 CTP NAa 
Glucose-6-P 0.19 Serine-3-P NAa 
Fructose-6-P 0.32 Threonine P NAa 
ß-fucose-6-P 0.21   
a NA represents no detectable activity. 
 
 
33 
 
Table 2.2: Steady-state kinetic constants for BT2127-catalyzed hydrolysis of 
pyrophosphate and selected phosphate monoesters at 25 oC and pH 7.5. See Materials 
and Methods for Details. 
Substrate kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
pyrophosphate 0.32 ± 0.01 0.0036 ± 0.0004 9 x 104 
glycerol-1-phosphate 0.35 ± 0.02 4.8 ± 0.3 7 x 101 
D-ribose-5-phosphate 0.20 ± 0.02 3.8 ± 0.3 6 x 101 
fructose-6-phosphate 0.066 ± 0.002 6.4 ± 0.2 1 x 101 
uridine-5-phosphate 0.15 ± 0.01 2.6 ± 0.4 6 x 101 
p-nitrophenylphosphate 0.0019 ± 0.0004 0.05 ± 0.01 4 x 101 
 
 
Figure 2.15: The pH rate profiles measured for BT2127 catalyzed hydrolysis of 
pyrophosphate. (See the Materials and Methods section for details). 
            The kcat value is governed by the rate-limiting step of the two-step reaction: 
phosphoryl transfer from the bound substrate to the Asp nucleophile followed by 
hydrolysis of the aspartyl-phosphate intermediate (Figure 2.3). Variation in the kcat value 
with substrate structure indicates that the first step is rate-limiting (or at least partially 
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rate-limiting) and that some substrates bind more productively than others. The largest 
kcat value was measured for the substrate inorganic pyrophosphate (0.3 s-1). Inorganic 
pyrophosphate exists in the cell as the magnesium complex, and it undergoes 
spontaneous hydrolysis to two molecules of orthophosphate at the reported rate of 2.8 x 
10-10 s-1 (at 25 oC, pH 8.5) [11]. BT2127 thus increases the hydrolysis rate ~1 x 109-fold. 
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Figure 2.16: The HADSF phosphatase chemical pathway. 
            The kcat/Km value (also known as the substrate specificity constant) is determined 
by the substrate binding affinity as well as by the efficiency that the bound substrate is 
converted to product. Because the concentration of the substrate in the cell is likely to be 
sub-saturating, the kcat/Km value is most useful for identifying substrates that have 
physiologically relevant activities. HADSF phosphatases that target a single  
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physiological substrate typically display a kcat/Km value in the range of 1 x 105 to 1 x 107 
M-1 s-1, whereas those that function as regulators of the level and composition of 
organophosphate metabolite pools typically have Km values in the mini-molar range and 
kcat/Km values in the 1 x 103 to 1 x 104 M-1 s-1 range. The kcat/Km value of ~1 x 105 M-1 s-1 
measured for inorganic pyrophosphate qualifies it as a candidate for physiological 
substrate. Furthermore, the fact that the screen did not identify other substrates with 
physiologically relevant activities suggests that BT2127 might indeed function in vivo as  
an inorganic pyrophosphatase.  
 
2.3.2 BT2127 Structure Determination 
            The structure of BT2127 was examined in order that we might identify the 
structural determinants of substrate recognition. A total of 13 X-ray structure 
determinations were carried out with wild-type enzyme and the D11N, D13A, D13N and 
E47A, E47D, and E47N mutants. The crystallization conditions (Table 2.3) and the 
crystallographic and refinement statistics are reported in Supporting Information (Tables 
2.4-2.7). The different crystallization conditions led to different crystal packing and to 
different ligands in the active site. All crystallizations were carried-out in the presence of 
5 mM MgCl2, however only six of the structures (PDB codes 3QU2, 3QU4, 3QU9, 
3QUQ, 3QUT and 3QX7) contained Mg2+ within the active site. In two of the structures 
(PDB codes 3QU7 and 3QYP) Ca2+ derived from the crystallization solution, replaced 
the Mg2+.  Co-crystallization of each enzyme was attempted with pyrophosphate as well 
as with its analog imidodiphosphate (a competitive inhibitor with a Ki = 13 ± 1 µM  
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(Figure 2.4), but without success.  Crystal soaking with these two ligands also failed to  
place the intended ligand in the active site. Three structures derived from the 
pyrophosphate-soaked crystals (PDB codes 3QYP, QX7 and 3QU7) contained the 
hydrolysis product phosphate.   
 
Figure 2.17: Inhibition plot for BT2127 with Imidodiphosphate under different fixed 
concentrations of pyrophosphate. 
            The structures of the BT2127 mutants showed that the wild-type native 
conformation, including the active site residue side chains, was retained. Therefore, the 
reduction in catalytic activity in the mutants (vide infra) is attributed to a loss of side 
chain function and not to an alteration of the native conformation. 
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           Table 2.3: A list of the crystallization conditions used for wild-type and mutant BT2127. 
 
BT2127 PDB code Crystallization conditions 
WT 3QU2 
0.1 M sodium citrate, pH 5.6, 30% PEG4000, 0.2 M ammonium  
acetate, 5 mM, MgCl2, 294 oK 
WT 3QXG 5 mM MgCl2, 294 
oK 
WT 3QUQ 0.1 M Bis-Tris, pH 6.5, 25% PEG3350, 0.2 M MgCl2, 294 oK 
WT 3QX7 0.056 M sodium phosphate monobasic, pH 8.2, 1.34 M 
potassium phosphate dibasic, 5 mM MgCl2, 294 oK 
D11N 3QU5 0.1 M Bis-Tris, pH 6.5, 25% PEG3350, 0.2 M MgCl2, 294 oK 
D13A 3QU4 
0.1M MES, pH 6.0, 20% PEG8000, 0.2 M calcium acetate,5 mM 
MgCl2, 291 oK 
D13N 3QU9 
0.1 M potassium sodium tartrate, pH 8.0, 0.1 M imidazole, 0.2 M 
NaCl, 5 mM MgCl2, 294 oK 
D13N 3QU7 
0.1 M sodium acetate, pH 4.5, 30% PEG400, 0.2 M calcium  
acetate,5 mM MgCl2, 294 oK 
D13N 3QUT 0.15 M Malic acid, pH 7, 20% PEG3350, 5 mM MgCl2, 294 oK 
E47D 3R9K 
0.1 M Tris-HCl, pH 8.5, 30% PEG4000, 0.2 M LiSO4, 5 mM  
MgCl2, 294 oK 
E47N 3QYP 
0.2M MES, pH 6.0, 20% PEG8000, 0.2 M calcium acetate,5 mM 
MgCl2, 294 oK 
E47N 3QUC 
0.1 M Tris-HCl, pH 8.5, 30% PEG4000, 0.2 M LiSO4, 5 mM  
MgCl2, 294 oK 
E47A 3QUB 
0.1 M Tris-HCl, pH 8.5, 30% PEG4000, 0.2 M LiSO4, 5 mM  
MgCl2, 294 oK 
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Table 2.4: Data collection and refinement statistics for the wild-type BT2127 crystals. 
PDB ID 3QUQ 3QU2 3QX7 3QXG 
Cap orientation Opened Closed Closed Closed 
Space group P212121 C2 P3121 C2 
Unit cell dimensions (Å) - - - - 
-a 45.20 137.60 84.58 114.07 
-b 65.34 71.76 84.58 70.59 
-c 75.62 114.53 79.27 76.32 
Cell angles (degrees) - - - - 
-alpha 90.00 90.00 90.00 90.00 
-beta 90.00 105.80 90.00 119.77 
-gamma 90.00 90.00 120.00 90.00 
Molecules per asymmetric 
unit 1 4 1 2 
Solvent content 38.42 51.25 61.05 50.18 
Matthew’s Coefficient 2.00 2.52 3.16 2.47 
X-ray source NSLS X29A 
NSLS 
X29A 
NSLS 
X29A 
NSLS 
X29A 
Wavelength 1.0750 1.0809 0.9791 0.9791 
Resolution 49.45-1.65 40.00-1.94 20.00-2.00 50.00-1.24 
Reflections 28,023 79,445 22,599 147,352 
Completeness (%) 99.2 (92.1) 99.3 (93.1) 95.00 99.0 (86.0) 
I/sigma (I) 6.10 (3.00) 3.40 (1.20) 7.40 (1.00) 7.40 (0.90) 
Rsym (Rmerge) 0.092 (0.530) 
0.124 
(0.800) 
0.078 
(0.900) 0.056 (?) 
Rwork (Rfree) 16.4 (17.8) 23.4 (27.5) 19.1 (24.3) 15.2  (18.2) 
Rfree reflections (%) 683 (3.2%) 2349 (3%) 683 (3.2%) 4418 (3.0%) 
Average B factor (overall) 23.69 20.31 58.11 22.23 
-amino acid residues 22.54 19.78 58.15 20.26 
 33.12 25.21 56.95 35.98 
Root-mean square deviation - - - - 
-bond lengths 0.011 0.010 0.011 0.012 
-bond angles 1.293 1.273 1.293 1.411 
Ramachandran 
  
99.1 (0.9) 99.1 (0.9) 98.7 (1.3) 98.8 (1.2) 
Number of solvent molecules 98 649 98 525 
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Table 2.5: Data collection and refinement statistics for the BT2127 D11N crystals. 
PDB ID 3QU5 
Mutation D11N 
Cap orientation Closed 
Space group P21 
Unit cell dimensions (Å) - 
-a 42.80 
-b 77.21 
-c 70.76 
Cell angles (degrees) - 
-alpha 90.00 
-beta 90.41 
-gamma 90.00 
Molecules per asymmetric unit 2 
Solvent content 45.44 
Matthew’s Coefficient 2.25 
Wavelength 0.9786 
Resolution 40.00-1.24 
Reflections 129,987 
Completeness (%) 96.3 (68.4) 
I/sigma (I) 8.00 (1.40) 
Rsym (Rmerge) 0.043 (0.550) 
Rwork (Rfree) 13.0 (16.0) 
Rfree reflections (%) 3775 (3%) 
Average B factor (overall) 22.35 
-amino acid residues 19.62 
-waters 35.36 
Root-mean square deviation - 
-bond lengths 0.011 
-bond angles 1.407 
Ramachandran favored/allowed (%) 99.4 (0.6) 
Number of solvent molecules 764 
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Table 2.6: Data collection and refinement statistics for the BT2127 D13 mutant crystals.  
PDB ID 3QU4 3QUT 3QU7 3QU9 
Mutation D13A D13N D13N D13N 
Cap orientation Closed Opened Closed Closed 
Space group P1 P212121 C2221 P3121 
Unit cell dimensions (Å) - - - - 
-a 69.94 45.47 72.55 84.17 
-b 76.22 65.40 136.87 84.17 
-c 95.59 76.17 114.83 79.36 
Cell angles (degrees) - - - - 
-alpha 89.97 90.00 90.00 90.00 
-beta 89.97 90.00 90.00 90.00 
-gamma 90.00 90.00 90.00 120.00 
Molecules per asymmetric 
 
8 1 2 1 
Solvent content 47.95 38.42 53.48 59.60 
Matthew’s Coefficient 2.36 2.00 2.64 3.04 
X-ray source NSLS 
 
NSLS 
 
NSLS 
 
NSLS 
 
Wavelength 1.5418 0.9791 0.9792 1.0750 
Resolution 50.00-2.00 50.00-1.50 50.00-1.90 40.00-1.87 
Reflections 133,986 37,187 45,325 27,292 
Completeness (%) 93.2 (83.9) 100.0 
(100.0) 
99.8 (99.5) 99.1 (92.8) 
I/sigma (I) 4.50 (0.60) 7.40 (3.00) 7.70 (2.00) 8.10 (1.00) 
Rsym (Rmerge) 0.101 
(0.730) 
0.067 
(0.600) 
0.053 
(0.680) 
0.069 
(0.820) 
Rwork (Rfree) 21.8 (28.6) 14.5 (17.2) 19.0 (22.6) 20.9 (25.2) 
Rfree reflections (%) 3211 (3) 1152 (3.1) 1408 (3.1) 826 (3.2) 
Average B factor (overall) 36.17 25.13 47.74 51.00 
-amino acid residues 36.24 23.78 47.63 50.92 
-waters 35.32 35.55 49.74 52.02 
Root-mean square deviation - - - - 
-bond lengths 0.009 0.011 0.009 0.011 
-bond angles 1.177 1.387 1.202 1.352 
Ramachandran 
Favored/allowed(%) 
98.3 (1.7) 98.7 (1.3) 98.7 (1.3) 97.0 (3.0) 
 982 243 275 110 
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Table 2.7: Data collection and refinement statistics for BT2127 E47 mutant crystals. 
PDB ID 3QUB 3R9K 3QUC 3QYP 
Mutation E47A E47D E47N E47N 
Cap orientation Closed Closed Closed Closed 
Space group P3121 P3121 P3121 P21 
Unit cell dimensions (Å) - - - - 
-a 85.38 84.60 84.72 42.94 
-b 85.38 84.60 84.72 77.18 
-c 78.92 79.24 79.21 70.80 
Cell angles (degrees) - - - - 
-alpha 90.00 90.00 90.00 90.00 
-beta 90.00 90.00 90.00 90.21 
-gamma 120.00 120.00 120.00 90.00 
Molecules per asymmetric unit 1 1 1 2 
Solvent content 59.60 59.60 59.60 43.50 
Matthew’s Coefficient 3.04 3.04 3.04 2.17 
X-ray source NSLS 
X29A 
NSLS 
X29A 
NSLS 
X29A 
NSLS 
X29A 
Wavelength 1.0750 1.0750 1.0750 0.9792 
Resolution 40.00-1.90 50.00-1.80 50.00-1.87 50.00-1.60 
Reflections 27,369 30,588 27,575 61,148 
Completeness (%) 99.1 (99.6) 99.7 
 
97.2 (95.3) 95.3 (69.0) 
I/sigma (I) 4.60 (1.00) 8.50 (1.20) 4.30 (1.20) 9.50 (1.00) 
Rwork (Rfree) 19.8 (24.3) 19.0 (22.7) 21.6 (28.3) 18.5 (21.7) 
Rfree reflections (%) 846 (3.2%) 966 (3.2%) 703 
 
1776 
 
Average B factor (overall) 43.06 44.14 57.09 29.12 
-amino acid residues 42.58 43.57 57.04 28.16 
-waters 47.80 49.74 58.06 36.31 
Root-mean square deviation -  - - 
-bond lengths 0.010 0.011 0.010 0.012 
-bond angles 1.253 1.225 1.256 1.343 
Ramachandran favored/allowed 
 
99.1 (0.9) 98.3 (1.7) 98.7 (1.3) 99.6 (0.4) 
 191 192 127 467 
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Quaternary Structure. The theoretical mass of BT2127 minus its N-terminal Met is 
26,983 Da compared to 26,970 Da determined by mass spectrometry. The SDS-PAGE 
analysis (Figure 2.1) gave an estimated subunit mass of 27 kDa. The native mass was 
determined by using molecular size gel filtration chromatography to be 27-28 kDa. Thus, 
BT2127 is a monomer. Seven of the structure determinations revealed only a single 
protein molecule in the asymmetric cell (PDB codes 3QU9, 3QUB, 3QUC, 3QUQ, 
3QUT, 3QX7 and 3R9K).  
 
Tertiary Structure. BT2127 possess the conserved HADSF Alpha/Beta Rossmann-like 
catalytic domain comprised of a six-stranded parallel Beta sheet (Beta1, and Beta4-
Beta8) surrounded by six helices (Alpha1-Alpha3, and Alpha5-Alpha7) and the type C1A 
tetra-Alpha-helical cap domain inserted between Beta1 and Alpha1.  Well-characterized 
members of the C1A class include Lactobacillus lactis Beta-PGM (Z-score 10.2) [12] 
and Bacillus cereus phosphonatase (Z-score 7.8) [13]. The superposition of the structure 
of BT2127 with that of Beta-PGM is shown in Figure 2.5. The C1A type cap domains of 
BT2127 and Beta-PGM superimpose with a RMSD of 2.4 Å (13.4% identity), whereas 
the two catalytic domains superimpose with a RMSD of 1.9 Å (26.7% identity). The 
closest homolog (Z-score 14.7) is the HADSF member PDB code 3DV9 from 
Bacteroides vulgatis, which is annotated “putative Beta-PGM”. As detailed below I posit 
that this protein is not Beta-PGM but rather a pyrophosphatase, orthologue to BT2127.  
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Figure 2.18: Superposition of BT2127 (PDB code 3QX7) (gray) and L. lactis Beta-PGM 
(PDB code 1O08) (cyan). 
 
Cap Domain-Catalytic Domain Association. CA1 cap motion has been most thoroughly 
studied with L. lactis Beta-PGM for which crystallographic snapshots of the enzyme in 
the cap-open and cap-closed conformations have been obtained (see superposition in 
Figure 2.6) [14,15], The snapshots of BT2127 reveal a cap-closed conformation that is 
similar to that of Beta-PGM (Figure 2.5) and a cap-open conformation that is not as open 
as that observed for Beta-PGM (Figure 2.6).  
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Figure 2.19: (Left) Superposition of the cap-open (royal blue) and cap-closed (cyan) 
conformations of L. lactis Beta-PGM (PDB codes 1ZOL and 1O08). (Right) 
Superposition of the cap-open (black) and cap-closed (gray) conformations of BT2127 
(PDB codes 3QUQ and 3QX7).  
 In the case of Beta-PGM the cap and catalytic domains associate for catalysis and 
dissociate to allow ligand exchange. An earlier crystallographic based analysis of the 
“clam-like” domain movement in Beta-PGM using DynDom (Hayward 1997 ) indicated  
That the cap and catalytic domain move as rigid spheres and that the movement is 
primarily the result of changes in backbone conformations (psi and phi angles) at 
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domain-domain linker 1 hinge residues Thr114-Asp15-Thr16-Ala17 [16]. The more 
modest domain movement observed in BT2127 is attributed to changes in phi and psi 
angles at linker 1 hinge residues Ser19-Met20-Pro21 and linker 2 hinge residues Pro87-
Glu88-Ala89-Glu90-Arg91. The rotation angle between the cap and catalytic domains in 
BT2127 is 16.3 degrees, with a translation of -0.6 Å and a closure percentage of 99.6%. 
As seen with Beta-PGM, the BT2127 cap and core domains must dissociate in order for 
pyrophosphate to bind to the active site and phosphate to depart from it because only in 
the cap-open conformation is there solvent access to the active site. 
 Crystallographer Jeremiah Farelli used the program Voidoo (http://xray.bmc.uu 
.se/usf/voidoo.html) was to calculate the volume of the active sites of BT2127 (189.8 Å3) 
and Beta-PGM (285.1 Å3) in their cap-closed conformations. Next, the volumes of 
pyrophosphate (99.4 Å3) and Beta-glucose-1,6-bisphosphate (242.5 Å3) were calculated 
using the molinspiration server (http://www.molinspiration.com/). Whereas 
pyrophosphate is small enough to fit in the active site of BT2127, Beta-glucose-1,6-
bisphosphate is not. Models of the BT2127 bound with pyrophosphate and Beta-glucose-
1,6-bisphosphate were generated to show the fit of the ligand in the 3-dimensional space 
available within the active site cavity (Figure 2.7). Whereas the pyrophosphate can be 
easily docked in a productive binding mode without steric clash, the larger Beta-glucose-
1,6-bisphosphate ligand cannot fit without the cap dissociating to some extent from the 
core domain.  
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Figure 2.20: The active site of BT2127 in the cap-closed conformation (PDB code 
3QX7) showing the unfilled area (mesh) calculated in Voidoo and the pyrophosphate and 
Beta-glucose-1,6-bisphosphate ligands modeled in Coot. Oxygen atoms are colored red, 
carbon atoms cyan and phosphorus atoms orange. 
  I posit that the cap-open and cap-closed conformations observed in the BT2127 
crystal structures are not artifacts of crystal packing because the different crystallization 
conditions led to different crystal packing and different ligands in the active site. 
Substrate binding and product release would occur with the cap-open conformer whereas  
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catalysis would occur with the cap-closed conformer.  The low level activity that is 
observed with the larger substrates (Table 2.1 and 2.2) might be rationalized by catalytic 
turnover in a conformer in which the cap domain is partially dissociated to enlarge the 
active site cavity.  
Active Site. The active site scaffold of the HADSF phosphotransferase catalytic domain 
consists of a 4-loop platform on which the conserved catalytic residues are located: the 
Asp nucleophile and Asp acid/base on loop 1; the Thr/Ser and Lys hydrogen bond donors 
to the transferring phosphoryl group on loop 2 and 3, respectively; the Asp/Glu Mg2+ 
ligand on loop 4 [17]. Figure 2.8 shows the residues surrounding the Mg2+ cofactor in the 
BT2127-Mg complex and the interacting residues in the BT2127 E47N-Ca-phosphate 
complex. As observed with other HADSF phosphotransferases, the Mg2+ is coordinated 
to the loop 1 Asp nucleophile (Asp11) carboxylate group and Asp acid/base (Asp13) 
backbone amide C=O (2.2 Å). However, the BT2127 loop 4 Asp171 is not positioned to 
coordinate the Mg2+ but instead is positioned to form a hydrogen bond (2.7 Å) to one of 
the two Mg2+ water ligands. It is the loop 4 Asn172 that forms a coordination bond with 
the Mg2+ (2.3 Å).  A second deviation from the classical HADSF Mg2+ binding site [18, 
19] is the identity of the sixth ligand, Glu47 (2.0 Å), which is located on the specificity 
loop of the cap domain (Thr50-Arg49-Gly48-Glu47).  
 From the structure of BT2127 E47N bound with phosphate and Ca2+ at the 
catalytic site we observe that an oxygen atom of the phosphate ligand replaces a water 
ligand (Figure 2.8). The phosphate ligand also is engaged in numerous hydrogen bond 
interactions with the active site residues: loop 2 Thr113 and loop 3 Lys147 side chains,  
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and loop 1 Asp13, loop 2 Gly114 & Ser115 backbone amide NHs.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.21: (Left) The Mg2+ binding site observed structure of wild-type BT2127 bound 
with Mg2+ (PDB code 3QUQ). (Right) The phosphate binding site observed in the 
structure of the BT2127 E47N mutant bound with phosphate and Ca2+ (PDB code 
3QYP). Oxygen atoms are colored red, nitrogen atoms blue and phosphorus atoms  
orange. The Mg2+ is shown as a magenta sphere, the Ca2+ as a green sphere and the water 
molecules are represented as red spheres. Coordination bonds are shown as dashed purple 
lines and hydrogen bonds as dashed black lines.  
 In order to best illustrate the key interactions in the context of the pyrophosphate 
substrate, a model of the BT2127 active site (cap-closed conformer) with pyrophosphate 
bound in an orientation that superimposes the transferring phosphoryl group on the 
phosphate ligand of the BT2127 E74N-Ca-phosphate structure was made (by Jeremiah 
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Farelli) (Figure 2.9). Only one P-O-P rotomer conformation placed the phosphate-
leaving group within the vacant space defined by the Voidoo analysis (vide supra). Here  
it can engage in hydrogen bond formation with a water molecule that is bound to cap 
domain Trp27 and with the backbone amide NH of cap domain residue Gly48 and 
catalytic domain Ser115. Moreover, the Asp13 acid/base is positioned to donate a 
hydrogen bond to a non-bridging oxygen atom, and possibly to the bridging oxygen 
atom, of the phosphate-leaving group.  
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Figure 2.22: The BT2127 active site with pyrophosphate (manually docked). The Mg2+ 
is shown as a magenta sphere and the water molecules are represented as red spheres. 
Oxygen atoms are colored red, nitrogen atoms blue and phosphorus atoms orange. 
Coordination bonds are shown as dashed purple lines and hydrogen bonds as dashed 
black lines. 
 It is noteworthy that at pH 7.5 the pyrophosphate is monoprotonated (pKa = 9.3) 
and if it were to bind with the protonated phosphate group in the leaving-group position,  
then there would be no need of acid catalysis.  On the other hand, it has been suggested 
that the Asp acid/base of the HADSF phosphotransferases is protonated by the substrate 
phosphate ester, which binds to the active site in the monoprotonated form and upon 
coordination with the Mg2+ loses its proton [16].  Thus, in order for the Asp13 to be 
protonated the pyrophosphate would have to be fully ionized. 
 Interestingly, by replacing the pyrophosphate bridging oxygen atom with an “NH” 
as in imidodiphosphate tight binding to BT2127 is retained (Ki = 13 ± 1µM) but catalytic 
turnover is greatly diminished (Table 2.1). We infer from this observation that the Asp13 
is not able to protonate the bridging nitrogen atom most likely owing to steric 
restrictions. In contrast, several of the 23 E. coli HADSF phosphatases examined by 
Kuznetsova et al [1] showed significant hydrolase activity with imidodiphosphate but 
curiously, not with pyrophosphate.  
 The transferring phosphate group of the modeled pyrophosphate is positioned to 
coordinate with the Mg2+ and to form hydrogen bonds with the side chains of loop 2 
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Thr113 and loop 3 Lys147 and with the backbone amide NHs of loop 1 Asp13 and loop 2 
Gly114 (Figure 2.10).  
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Figure 2.23: (Top) Superposition of BT2127 (gray) bound with phosphate and Mg2+ 
(PDB code 3QX7) and β-PGM (cyan) bound with Mg2+ and β-glucose-1,6-bis-phosphate 
(PDB code 1O08). (Bottom) Zoom in on the active site.  
 An interesting side note is the position that phosphate ligand assumes in the 
structure of wild-type BT2127-Mg-phosphate complex (PDB code 3QX7). Superposition 
of this structure with the structure of L. lactis Beta-PGM bound with Beta-glucose-1,6-
bisphosphate places the phosphate ligand at the same position that the non-transferring 
phosphoryl group is found  (i.e., C6-phosphate) (Figure 2.10).  It is tempting to speculate 
that once formed the phosphate product in the BT2127 active site it might diffuse into 
this vacant space to make room for the water nucleophile, which will undergo in-line 
attack at the phosphorus atom of the aspartylphosphate intermediate in the second step of 
the reaction (Figure 2.3). Alternatively, the movement of the phosphate into the cap 
domain might trigger cap dissociation.  
 
2.3.3 Site Directed Mutagenesis of BT2127 Active Site and Domain-Domain 
Interface Residues 
 The individual contributions that the active site residues make to catalysis were 
evaluated by site-directed mutagenesis coupled with steady-state kinetic analysis of the 
mutant enzymes in catalysis of pyrophosphate hydrolysis. The mutants that did not 
display activity above background are listed in Table 2.8 as not active (“NA”). The 
mutants that displayed detectable yet very low activity were evaluated by measuring the 
initial velocity of the reaction using a concentration of pyrophosphate (300µM) that we 
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assume to be saturating. The ratio of the initial velocity and the enzyme concentration 
gives an approximate kcat value (i.e, turnover rate). For the mutants that displayed higher 
activity, kcat and Km values were measured.    
 
Table 2.8: Steady-state kinetic constants for wild-type and mutant BT2127-catalyzed 
hydrolysis of pyrophosphate at 25 oC and pH 7.5. See Materials and Methods for Details. 
 
 
a NA represents no activity detected above the detection limit kcat < 0.001 min-1. 
BT2127 kcat (min-1) Km (M) kcat/Km (M-1s-1) 
Wild-type 1.9 (± 0.06) x 101 3.6 ± 0.4 8.9 x 104 
D11N NAa ------ ------ 
D13A NAa ------- ------ 
D13N NAa ------- ------ 
K147A ~2 x10-3 b ------- ------ 
N172A 7.4 (± 1.8) x 10-1 4.5 ± 0.3 3 x 103 
T113A 4.0 (± 0.03) x 10-1 5.9 ± 0.2 1 x 103 
S115A 8.4 (± 0.12) x10-2 3.6 ± 0.4 4 x 102 
T50A 4.1 (± 0.18) x 10-1 2.7 ± 0.7 3 x 103 
R49A ~3 x 10-2 b ------- ------- 
K79A ~2 x 10-2 b ------- ------- 
H23A 3.3 (± 0.06) x 10-1 1.2 (± 0.08) x 101 5 x 102 
M20A ~5.1 x 10-2 b ------- ------- 
M20K 2.4 (± 0.04) x 10-1 2.5 (±0.3) x 101 2 x102 
M20L 5.8 (± 0.04) x 10-2 3.5 ± 0.1 3 x 102 
E47A ~3 x 10-3 ------- ------- 
E47Q 4.8 (± 0.4) x 10-1 6 ± 1 1 x 103 
E47N ~3 x 10-3 b ------- ------- 
E47D ~3 x10-3 b ------- ------- 
S80A 1.7 (± 0.04) x 10-1 7.1 ± 0.9 4.1 x 102 
Q117A ~3 x 10-2 b ------- ------- 
Y76F ~2 x 10-2 b ------- ------- 
S19A ~2 x1 0-2 b ------- ------- 
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b The rate was determined by measuring the initial velocity of orthophosphate formation 
(µM/min) and dividing that value by the enzyme concentration. Reaction solutions 
initially contained 10 µM enzyme, 300µM pyrophosphate, 1 mM MgCl2, 1.0 unit/ml 
purine nucleoside phosphorylase, and 0.2 mM MESG in 50 mM Tris (pH 7.5). 
 
Table 2.9: The apparent first order rate  (kobs (min-1)) constants for BT2127 catalyzed 
hydrolysis of phosphate esters and anhydrides at pH 7.5 and 25 oC. Reaction solutions 
initially contained 300 µM substrate, 8.4 µM mutant BT2127, 1 mM MgCl2, 1.0 unit/mL 
purine nucleoside phosphorylase and 0.2 mM MESG in 50 mM Tris (pH 7.5). The kobs 
value was calculated by dividing the initial velocity of the reaction by the enzyme 
concentration. 
Substrate wild-type E47A E47N M20A M20L M20K 
Ppi 1.9 x 101 4.7 x 10-4 5.5 x 10-4 8.4 x 10-4 3.1 x 10-3 6.5 x 10-3 
D-ribose5P 2.0 x10-1 2.5 x 10-4 7.3 x 10-4 1.3 x10-3 2.1 x 10-3 2.3 x 10-4 
glycerol1p 3.5 x 10-1 4.4 x 10-4 4.6 x 10-4 4.8 x 10-3 4.2 x 10-3 4.0 x 10-3 
PNPP 5.8 x 10-3 4.2 x 10-4 3.8 x 10-4 2.1 x 10-5 2.6 x 10-3 4.6 x 10-3 
fructose6p 5.3 x 10-3 2.5 x 10-4 9.5 x 10-5 4.4 x 10-4 1.6 x 10-3 3.6 x 10-4 
UMP 1.5 x 10-1 2.16 x 10-
 
2.6 x10-4 3.16x10-4 1.6 x 10-3 3.7 x 10-3 
imidodip 1.03 x 10-
 
6.2 x 10-5 2.2 x 10-4 6.0 x 10-3 3.1 x 10-3 4.4 x 10-3 
glucose1p 2.0 x 10-3 1.1 x 10-4 9.5 x 10-5 8.4 x 10-4 1.3 x 10-3 2.9 x 10-3 
glucose6p 3.2 x10-3 1.9 x 10-4 2.9 x 10-4 2.8 x 10-4 6.2 x 10-4 3.7 x 10-3 
ßG1,6p 4.1 x 10-3 3.0 x 10-5 2.8 x 10-5 6.3 x 10-4 6.7 x 10-4 1.5 x 10-4 
ß-fucose1p 3.5 x 10-3 2.3 x 10-4 9.2 x 10-4 2.5 x 10-4 2.1 x 10-3 1.6 x 10-3 
a-fucose1p 1.7 x10-3 5.5 x 10-4 3.2 x 10-4 2.3 x 10-4 1.9 x 10-3 9.1 x 10-4 
glycerol2p 8.16 x 10-
 
2.1 x 10-4 2.7 x 10-4 1.6 x 10-4 1.6 x 10-3 3.7 x 10-3 
serine3p 3.3 x 10-6 1.4 x 10-4 4.1 x 10-4 3.5 x 10-4 1.0 x 10-3 3.5 x 10-3 
 
 Firstly, we tested the impact of Ala and/or Asn replacement of the key catalytic 
residues Asp11 and Asp13, both of which are stringently conserved (see multiple 
sequence alignment of putative BT2127 orthologues in Figure 2.11). Not surprisingly, 
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given that the Asp nucleophile and Asp acid/base are known to be essential to HADSF 
phosphatase catalysis, Ala and/or Asn replacement of BT2127 Asp11 or Asp13 removed 
all detectable activity (Table 2.8). However, the observation of a phosphate ligand in the 
active sites of pyrophosphate-soaked crystals of BT2127 D13N indicates that a single 
turnover reaction had occurred during the 15 min soaking time or within the frozencrystal 
during data collection.  
 Ala replacement of the residues that contribute to the positioning of the Asp13 
acid-base: Ser19, His23, Ser115 and Met20 (each of which is stringently conserved) 
reduced the turnover rate 950, 60, 230 and 370-fold, respectively. The Met20 was also 
replaced by Leu and by Lys. The M20L and M20K mutants were found to be 330 and 80-
fold lower in turnover rate compared to that of the wild-type BT2127. Because the Met20 
side chain restricts both the volume and the polarity of the region available to 
accommodate the substrate leaving-group we tested the activities of M20A, M20L and 
M20K towards the same panel of phosphate esters that were used to screen the wild-type 
enzyme. The objective was to determine if creating additional space (Ala for Met with 
Leu as the control) at the binding site might facilitate catalyzed hydrolysis of a larger 
substrate. 
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Figure 2.24: Multiple alignment of the amino acid sequences of BT2127 orthologues. 
            Likewise, we wished to determine if the placement of positively charged side 
chain (Lys for Met with Leu as the control) that might favorably interact with the 
phosphate-leaving group might enhance activity towards pyrophosphate. The results 
(reported in Table 2. 9) indicate that the substrate specificity of the mutants was not  
significantly different than that of wild-type BT2127. 
 The coordination of the Mg2+ by the loop 1 Asp nucleophile and by the backbone  
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amide C=O of the Asp acid-base is observed in all structurally characterized HADSF 
phosphatases and an Asp or Glu residue located on loop 4 adds a third ligand. In some 
cases an Asp or Glu also located on loop 4 forms a hydrogen bond with a water ligand 
bound to the Mg2+ cofactor. To my knowledge the collaboration between a loop 4 amide 
(Asn172) and cap domain specificity loop carboxylate (Glu47) to augment the Mg2+ 
binding by the two loop 1 Asp residues has not previously been reported. The Ala 
replacement of the stringently conserved Asn172 resulted in only a 26-fold reduction in 
turnover rate. In contrast, Ala replacement of the stringently conserved Glu47 resulted in 
~6000-fold decrease in turnover rate and the same reduction is observed with the E47D 
and E47N mutants. The E47 might be required for Mg2+ binding and/or for productive 
binding of the cap and catalytic domains (E47 remains coordinated to the Mg2+ in the 
cap-open conformation). Notably, the structures of the three E47 mutants (PDB codes 
3QUB, 3R9K, 3QUC, 3QYP) crystallized in the presence of Mg2+ conserve the positions 
of the Asp11 and Asn172 side chain and the Asp13 backbone amide C=O yet the Mg2+ is 
absent, and the enzyme is in the cap-closed conformation.   In contrast, the E47N mutant 
crystallized in the presence of Ca2+ (PDB code 3QYP) contains Ca2+ and it is coordinated 
to the loop 1 and 4 ligands as well as to the Asn47. The larger coordination sphere of 
Ca2+ apparently compensates for the shortened reach of the Asn side chain (see Figure 
2.8). The replacement of Glu47 with Gln would allow Mg2+ coordination and this is 
reflected in the comparatively higher activity of this mutant which has a turnover rate that  
is decreased only 40-fold from that of the wild-type enzyme (Table 2.8). These findings 
suggest that E47 rather than the loop 4 Asn172 plays the key role in Mg2+ binding. The 
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E47-Mg2+ coordination is the likely reason why the cap domain does not dissociate from 
the catalytic domain to the extent observed with ß-PGM.   
 The Thr113 and Lys147 activate the transferring phosphoryl group via hydrogen 
bond formation (Figures 2.8 and 2.9). Both are stringently conserved, and we found that 
the turnover rate was reduced 42-fold in the case of the T113A mutant and 9,500-fold in 
the case of the K147A mutant.   
 The stringently conserved cap domain residue Lys49 is not close enough to the 
catalytic site for direct interaction with pyrophosphate. It does however, form a hydrogen 
bond with stringently conserved cap domain His23, which in turn forms a hydrogen bond 
with the catalytic domain Asp13 acid/base (Figure 2.9). Whereas the turnover rate of the 
K49A mutant was found to be 950-fold slower than that of the wild-type BT2127, that of 
the H23A mutant was reduced only 60-fold. Thus, Lys49 appears to contributing to 
catalysis in some way beyond simply serving as a hydrogen bond partner to His23 (vide 
infra).  
Additional mutants were examined to evaluate the contributions made by residues 
located at the domain-domain interface, which appear from the structures to stabilize the 
cap-closed conformation through hydrogen bond formation with a partner located on the 
opposing domain (Figure 2.12).   
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Figure 2.25: Interactions at the BT2127 cap domain (yellow)-catalytic domain (gray) 
interface. 
Firstly, the stringently conserved Gln117 of the catalytic domain forms a 
hydrogen bond with cap domain residue Ser80 (replaced with Thr, Ala or Arg in 8 out of 
33 sequences). Ala replacement of Gln117 reduced the turnover rate 630-fold whereas 
Ala replacement of Ser80 reduced the turnover rate 110-fold. Secondly, the stringently 
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conserved Tyr76 located on the inter-domain linker 2 is almost close enough (3.7 Å) for 
hydrogen bond formation with the backbone amide NH of catalytic domain Gln117 and 
Gly116 (highly conserved; replaced with Ala in 1 out of 33 sequences). The conservative 
replacement of Tyr76 with Phe reduced the turnover rate 950-fold.  Thirdly, the highly 
conserved (31 out of 33 sequences) Arg49 and Thr50 (32 out of 33 sequences) are 
located on the cap domain specificity loop (Thr50-Arg49-Gly48-Glu47). The Arg49 side 
chain projects into solvent where the nonpolar hydrocarbon region of the side chain 
packs against the side chains of the catalytic domain Pro148 (stringently conserved) and 
Leu175 (conservatively replaced by Met in 5 out of 33 sequences), an interaction that 
might facilitate the proper positioning of Glu47 within the active and/or influence the 
association of the cap and core domains. Ala replacement of Arg49 reduced the turnover 
rate 630-fold.  Thr50 is seen in the crystal structures to be a bit too far away (4.3 Å) from 
the stringently conserved catalytic domain Gly114 amide C=O for hydrogen bond 
formation. Nevertheless, Ala replacement of Thr50 reduced catalytic turnover 50-fold, 
suggesting that the solution conformation might allow hydrogen bond formation or 
alternatively, that the Thr50 contributes to the conformation of the cap domain substrate  
specificity loop.  
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2.3.4 BT2127 Biological Range and In Vivo Function 
 Based on the structure-function analysis described in the previous sections we 
selected the catalytic residues Asp11, Asp13, Thr113 and Lys147 as well the metal 
binding residues Asp171, Asn172 and Glu47 to curate the list of BT2127 homologues 
identified by BLAST searches. An alignment of 33 putative homologues was generated 
(see Figure 2.11) that conserved 46 residues (including the 7 marker residues) out of 244 
residues total (19% conservation). The lowest pair-wise sequence identity between 
BT2127 and a putative sequence homolog is 47%. Many of these sequences have N-
terminal extensions (~20 amino acids) when compared to the BT2127 sequence. One of 
these is the orthologue from Bacteroides vulgatis (ExPASy accession code A6L7P8). The 
supposition of its X-ray structure (PDB code 3DV9) with that of BT2127 (not shown) 
reveals that N-terminal extension forms an a-helix at the surface of the catalytic domain 
located at the edge of the ß-sheet, distant from the active site.  
 Although the marker residues used in the curation of the BT2127 homologues are 
by definition stringently conserved, 14 sequences could be identified that replaced a 
marker residue, Asn172 with Asp (multiple sequence alignment shown in Figure 2.13). 
These sequences are more divergent (28-30% pair-wise sequence identity with BT2127) 
and all but one of them also possesses the conservative replacement of the Met12 of the 
Asp11-Met12-Asp13 loop 1 catalytic motif with Leu.  
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Figure 2.26: Alignment of the BT2127 sequence with the sequences of more distantly 
related homologues, which do not conserve the marker residue Asn172.  
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            Although the residue that separates the Asp nucleophile and Asp acid/base on 
loop 1 is not known to have a direct catalytic role, it has been our observation that it is 
typically conserved within function families that have clear sequence boundaries. 
Moreover, highly or stringently conserved supporting residues identified in the previous 
section such as Tyr76, Thr50, Gln117, Ser19, Met20 and K49 are not conserved.  
Nevertheless, the 14 sequences might in fact be pyrophosphatases, but such annotation 
should be first supported by an in vitro activity assay of a representative member. For 
now we will refer to them as “BT2127-like” homologues. 
 The biological range of the putative BT2127 orthologues is restricted to the phylum 
Bacteroidetes/Chlorobi (Figure 2.14). BT2127 orthologues are found in all Bacteroides 
species/strains represented in the gene databanks (with the exception of B. pectinophilus 
that instead possesses at BT2127-like homologue) as well in the Parabacteroides 
species/strains and Prevotella species/strains. Bacteroides, Parabacteroides and 
Prevotella colonize the human cavity from mouth to colon, yet occupy different regions 
along this environmentally stratified track. The BT2127-like homologues are also 
contained in the Bacteroidetes/Chlorobi phylum where they are found in select species 
that occupy a diverse range of habitats: Capnocytophaga ochracea (human mouth); 
Chlorobium luteolum and Pelodictyon phaeoclathratiforme (sulfide rich equatic 
environments), Croceibacter atlanticus and Flavobacteria bacterium BAL38, BBFL7, 
ALC-1 (sea water); Listeria innocua, Listeria marthii, Listeria monocytogenes and 
Listeria seeligeri (ubiquitous in the environment), Paenibacillus sp. Y412MC10 and 
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Paenibacillus vortex (heterogeneous and complex environments such as  soil and 
rhizosphere).  
 
Figure 2.27: A phylogenic representation of the biological range of the putative 
orthologues of BT2127 (blue), Beta-PGM (brown) and the archeal pyrophosphatase 
TON0002 (purple). This tree was created by Chetanya Pandya.  
 
 The substrate specificity profile and the active site structure strongly indicate that 
inorganic pyrophosphate is the physiological substrate for BT2127. Independent  
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supportive evidence for the in vivo function of BT2127 as inorganic pyrophosphatase 
derives from gene context analysis. Pyrophosphate is derived from nucleoside 5’-
triphosphates as they undergo nucleotidyl transfer reactions catalyzed by ligases, 
synthases, nucleotidyl transferases and DNA and RNA polymerases. The hydrolysis of 
the pyrophosphate product drives these reactions forward and at the same time 
replenishes the orthophosphate pool.  
 The gene neighborhoods of BT2127 and the 33 putative orthologues were 
examined for the bacterial genomes that have been mapped. The BT2127 gene overlaps 
the fkp gene that encodes the bifunctional L-fucose kinase/L-fucose-1-phosphate 
guanyltransferase. The products of the kinase-catalyzed reaction are Beta-L-fucose-1-
phosphate (a poor substrate for BT2127, kcat ~0.1 min-1) and ADP whereas the products 
of the transferase-catalyzed reaction are pyrophosphate and  Beta –L-fucose-GDP. The 
Beta –L-fucose-GDP is in turn used as a precursor for the decoration of surface capsular 
polysaccharides and glycoproteins with L-fucose for colonizing the mammalian intestine 
[19]. Thus, we posit that the biochemical function of BT2127 is inorganic pyrophosphate 
hydrolysis, which supports the biological function of host colonization. Intriguingly, 
several genes upstream and on the same DNA strand as BT2127 is the lysyl-tRNA 
synthase gene lysS (BT2122). Thus, BT2127 might also assist protein synthesis by 
removal of the synthase pyrophosphate product.   
 In Bacteriodes fragilis the putative pyrophosphatase orthologue encoding gene 
(BF3814) is next to the gene (BF3815) that encodes a putative Asparagines synthase. 
Located a few genes upstream and on the same DNA strand is the lysyl-tRNA synthase 
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gene (BF3610). This same gene context is observed for Bacteroides helcogenes (viz. 
Bache 3336 = lysyl-tRNA synthase gene, Bache 3341 = pyrophosphatase gene, Bache 
3343 =Asparagines synthase). In Parabacteroides distasonis (BDI 0146 = lysyl-tRNA 
synthase gene, BDI 0150 = pyrophosphatase gene) and Prevotella denticola (1697 = 
pyrophosphatase gene, 1699 = lysyl-tRNA synthase gene). Finally, we note that the 
Paludibacter propionicigenes genome encodes two BT2127 homologs, one having 56% 
sequence identity (Paplr 3043) and the other 28% sequence identity (Paplr 2273) with 
BT2127. The Palpr 3043 gene is located on a different DNA strand, opposite of the gene 
encoding DNA polymerase (Palpr 3030). Curiously, it is the more distant homolog (Paplr 
2273) that is co-located on the same strand with cysteinyl-tRNA synthase.  
 
2.3.5 Structural Determinants in the Divergence of Function in BT2127 and ß-PGM 
 Beta–PGM and maltose phosphorylase or trehalose phosphorylase collaborate in 
the utilization of maltose or trehalose as a carbon and energy source. Beta -PGM and 
BT2127 share 30% sequence identity and a common cap domain fold (tetra-a-helical) in 
addition to the highly conserved catalytic domain fold. Most significantly, they share the 
cap His20-Lys76 hydrogen bond diad motif that in Beta-PGM is the responsible for the 
discrimination between Beta-glucose-1-phosphate and solvent as reactants with the 
aspartyl phosphate intermediate (Figure 2.15) [16].  
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Figure 2.28: Left: The hydrogen bond network (black dashed line) of L. lactis Beta-
PGM. Mg2+ cyan sphere and Beta-glucose-1,6-bisphosphate stick (oxygen red, carbon 
yellow, phosphorus orange, nitrogen blue). Center: The placement of Asp10 in the cap-
open conformation (arrows indicate the direct direction of movement of the Thr16 hinge 
backbone and Asp10 side chain in going to the cap-closed conformation. Right: The 
placement of Asp10 in the cap-closed conformation. 
            Briefly, in the cap domain open conformation the Beta–PGM Asp acid/base side 
chain assumes a rotomer conformation, stabilized by hydrogen bond formation with the  
backbone amide NH and side chain of the linker hinge residue Thr117, which places it 
outside of the active site [14]. Upon substrate induced cap closure the His20-Lys76 diad 
and the Beta-glucose 1,6-bisphosphate P-O-C oxygen atom engage the Asp acid/base in 
hydrogen bond formation, placing it into position for catalysis (see Figure 2.15) [15].  
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 As described above, BT2127 conserves the His23-Lys79 diad, and in both the cap 
domain-open and closed conformations the Asp13 side is in the same conformation, 
engaged in hydrogen bond formation with linker residue Ser15. In the cap-closed 
conformation the His23-Lys79 diad is close enough to the Asp13 carboxylate for 
hydrogen bond formation with the His23, however in the cap-open conformation it is too 
far away. The cap domain His-Lys diad appears to be a vestige of the common ancestry 
between BT2127 and Beta-PGM.  
 Having determined the biological range of the BT2127 orthologues we next 
examined the biological range of Beta-PGM using the same approach applied to BT2127. 
The specifics will be published separately, but here we present the final result that the 
putative Beta-PGM orthologues are primarily found in the phylum Firmicutes and 
especially in the genera Bacilli (as represented in Figure 2.14), however they can also be 
found in certain species of the phyla Proteobacteria, Actinobacteria and 
Bactoidetes/Chlorobi (not represented in Figure 2.14). Notably, a bacterial species that 
contain orthologues of both BT2127 and Beta-PGM were not found.  
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2.3.6 Evolution of Pyrophosphatases Within the HADSF and Other Superfamilies 
 Inorganic pyrophosphatases are essential to cellular function. The large (660-770 
amino acid) membrane-bound pyrophosphatases are limited in range to plants and certain 
bacteria, wherein they function as proton pumps.  The soluble pyrophosphatases are 
ubiquitous and they are found into two distinct fold families (type I and type II). The type 
I pyrophosphatases are widely distributed in all three kingdoms of life. This is an ancient 
family with high sequence divergence. The more recently characterized family is the type 
II family. Inorganic pyrophosphatases of the type II family are restricted in range to 
select lineages of bacteria [20].  
 The type I pyrophosphatases are single domain, Beta-barrel proteins whereas the 
type II pyrophosphatases are two-domain Alpha/Beta-proteins in which the active site is 
located at the domain-domain interface. Type I and II pyrophosphatases employ three or 
four Mg2+ cofactors to activate the transferring phosphoryl group and water nucleophile 
and to stabilize the phosphate-leaving group [20,21];  
 Most recently, a novel pyrophosphatase (TON0002) from Thermococcus 
onnurineus was discovered [22]. This Archeal pyrophosphatase is a member of the 
HADSF, which prompted us to take a closer look at its structure and biological range. 
Like BT2127, TON0002 possesses a C1 tetra-alpha-helical cap domain, yet this enzyme 
has evolved some unique structural features as inferred from the structure of its close 
sequence homolog (60% identity) from Pyrococcus horikoshii (PDB code 2OM6).  The 
superposition of the structures of BT2127 and the P. horikoshii enzyme is shown in 
Figure 2.16. 
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Figure 2.29: Superposition of the structures of BT2127 (gray) (PDB code 3QX7) and the 
putative pyrophosphatase from P. horikoshii (teal) (PDB code 2OM6).  
 The two sets of alpha-helices that form the TON0002 cap domain are splayed apart 
thereby expanding the area above the catalytic site. The active site would be open to 
solvent on two sides of the protein if it were not for: (1) the insertion of a hydrophobic 
loop (viz. loop 2) from the catalytic domain between the paired a-helices which seals one 
of the two openings and fills part of the void and (2) the long side chains of Arg48, Lys52  
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and Arg55 from the cap Alpha-helix 2 that partially occlude the opening on the opposite 
side.  
 A model was made (by Jeremiah Farelli) of the active site with Mg2+ and 
pyrophosphate bound by using the positions of the Mg2+ and the phosphate (to define the 
cofactor and transferring phosphoryl group) in BT2127 structure and the position of the 
sulfate ligand in the P. horikoshii enzyme structure to define the position of the 
phosphate leaving group (Figure 2.17). Remarkably, the loop 1 Asp acid/ base and loop 
2 Thr/Ser are not conserved and instead Trp12 and Gly122, respectively are observed at 
these positions. The loop 1 Asp nucleophile is Asp10 and the loop 3 Lys is Lys158.  The 
counterparts to the BT2127 loop 4 Glu171 and Asn172 are Gly182 and Asp183, 
respectively. In the model, the phosphoryl leaving group is positioned for favorable 
interaction with Arg48, Lys52 and Arg55 of the cap domain  a-helix 2 whereas the 
transferring phosphoryl group is positioned to coordinate the Mg2+ and to favorably 
interact with catalytic domain residues Asn123 (loop 2) and Lys158 (loop 3).  
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Figure 2.30: The active site of the putative pyrophosphatase from T. onnurineus , 
BT2127 modeled with pyrophosphate (manually docked) and Mg2+ (derived from the 
superposition of BT2127 PDB code 3QUQ). The Mg2+ is shown as a magenta sphere and 
the water molecules are represented as red spheres. Oxygen atoms are colored red, 
nitrogen atoms blue and phosphorus atoms orange. Coordination bonds are shown as 
dashed purple lines and hydrogen bonds as dashed black lines. 
  Because the sequence identity is high (60%) and because the key active site 
residues identified in the P. horikoshii enzyme structure are conserved in the T. 
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onnurineus pyrophosphatase we assume that the P. horikoshii enzyme is also a 
pyrophosphatase. The active site model suggests that the backbone amide NH of Asn123 
substitutes for the conserved loop 2 Thr/Ser in activating the transferring leaving group 
and that cap domain residues Arg48, Lys52 and Arg55 stabilize the phosphate leaving 
group. In the second partial reaction (Figure 2.3), the loop 1 Asp acid/base activates the 
water nucleophile for attack on the aspartylphosphate. If it were to assume a slightly 
altered side chain rotomer conformation from that observed in the structure, the Asn123 
could orient (but not deprotonate) the water nucleophile.  
 The biological range of the Archeal pyrophosphatase orthologues was tracked so 
that we might compare it to the BT2127 orthologues. A BLAST search carried out using 
the T. onnurineus pyrophosphatase identified three orders of Archea that produce 
homologues: Thermococcales (53-80% sequence identity), Desulfurococcales (31-41% 
sequence identity) and Thermoproteales (29-33% sequence identity). A sequence 
alignment was made (all sequences conserved Trp12) and those sequences that did not 
conserve the marker residues Arg48, Lys52, Arg55 and Asn123 were omitted. The 
alignment of suggested orthologues (orders Thermococcales and Thermoproteales) is 
shown in Figure 2.18 whereas the biological range is contrasted with those of the 
BT2127 orthologues in Figure 2.14. Inspection of the gene contexts associated with 
these putative orthologues revealed that in some of the thermophiles a gene encoding 
DNA polymerase was found either on the same DNA strand next to pyrophosphates 
gene, or across from it on the opposite strand. This suggests a possible biochemical 
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context for the pyrophosphatase, i.e. aiding the polymerase by removing its product, 
pyrophosphate. On the other hand, the TON0002 kcat/Km ~ 4 x 102 M-1 s-1 is so low.  
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Figure 2.31: Multiple alignment of the amino acid sequences of TON0002 orthologues.  
One might question its physiologically relevance especially given that the T. onnurineus 
genome encodes a type A inorganic pyrophosphatase.  
 
2.3.7 Conclusion 
 A BLAST search of the B. thetaiotaomicron genome using the E. coli type I 
inorganic pyrophosphatase and the Bacillus subtilus type II inorganic pyrophosphatase 
sequences as query failed to identify a homologue. Thus, the C1-type HADSF member 
BT2127 appears to be the only known soluble inorganic pyrophosphatase in B. 
thetaiotaomicron. The C1-type class appears to be the most prevalent and functionally 
versatile of the three HADSF classes (C0, C1, C2) [23]. Aside from the many 
phosphatases that have evolved within this class, dehalogenase, phosphonatase, Beta-
PGM and the newly identified pyrophosphatase activites have evolved as well. By 
comparing these structures we gain insight into the key structural changes that might be 
responsible for the change in function. In the case of the inorganic pyrophosphatase 
BT2127 and its closest relative Beta-PGM the key structural changes are seemingly 
directed at the how large the leaving group can be (phosphate vs glucose-phosphate) and 
the position of the Asp acid/base in the cap-open vs cap-closed conformation. The 
BT2127 pyrophosphatase active site volume precludes binding the Beta-glucose-1, 6-
bisphosphate. The two key residues in space restriction are the cap domain residues 
Tyr76 and Glu47. The Beta-PGM activity requires the movement of the Asp acid/base 
out of the active site when the cap opens to allow the association of the Beta-Glucose-1-
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Phosphate for reaction with the aspartylphosphate. In both BT2127 and Beta-PGM the 
Asp acid/base forms a hydrogen bond with the linker hinge residue. In Beta-PGM this 
hydrogen bond only occurs in the cap-open conformation and it holds the Asp acid/base 
outside of the active site. In the BT2127 pyrophosphatase the hydrogen bond is present in 
both the cap-open and cap-closed conformations and the Asp acid/base remains in the 
active site.  
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CHAPTER THREE 
STRUCTURE, CATALYSIS AND FUNCTION OF FKBH 
 
3.1 Introduction 
FKBH is comprised of three sequential structural domains. The center domain is a 
capless HADSF domain whose closest characterized homologue is the mammalian 
phosphatase MDP (ExPASY accession # Q86V88, 176 amino acids). The physiological 
substrate of MDP is not known although it has been speculated to be a protein 
phosphorylated at a tyrosine residue [1]. FKBH catalyzes the three-step reaction shown 
in Figure 3.1, the product of which is a glyceryl-holo acyl carrier protein/domain or 
glyceryl-CoA. The C-terminal domain catalyzes the autoacylation of its Cys residue 
using the metabolite 1,3-diphosphoglycerate as substrate [2] (see Figure 3.1). The C(3) 
phosphoryl group is then removed by the HAD domain. The glyceryl unit is transferred 
to the pantetheine thiol of a charged acyl carrier protein. The biological function of 
FKBH varies according to the biosynthetic context of the synthase that acts on the 
glyceryl-holo acyl carrier protein or domain. The glycerated ACP can either modified to 
serve as a starter unit for some polyketides biosynthesis (Figure 3.1A)[3-5], or it can be 
oxidized into a glycolate unit which can act as an extender unit in some other polyketide 
products (Figure 3.1B)[6-11], or the glycerate unit can be transferred to pantetheine arm 
of CoA to produce a glycerate CoA, which can be applied to construct other large 
molecules (Figure 3.1C)[12]. 
84 
 
The Bacteriodes fragilisstrain YCH46 genome encodes two putative FKBH 
homologues: BF0824 (529 amino acids) and BF1531 (575 amino acids). Curiously, the 
encoding genes are not located within polyketide biosynthetic gene clusters. Instead they 
are found within two respective capsular polysaccaharide loci (BF0803-BF0823 and 
BF1529-BF1554). B. fragilis  lives closely associated with mucosal surface of the human  
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Figure 3.32 Pathway for FKBH generation of the glyceryl unit and pathways for its 
incorporation into natural products. 
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colon where it us under constant scrutiny by the host’s immune system. Variation in the 
polysaccharide makeup of the B. fragilis outer capsule is important for evasion as well as 
for opportunistic pathogenesis. Three different strains of B. fragilis (638R, NCTC 9343, 
YCH46) have been sequenced to show that the genomes of all three contain ten distinct 
capsular polysaccaharide loci. Remarkably, when the ten polysaccharide loci of strain 
NCTC were compared with those of 638R, it was discovered that none are shared. Strain 
YCH46 shares one locus with strain NCTC 9343 and a second, different locus with strain 
638R.  Thus, in total there are 28 unique polysaccharide loci represented among these 
three strains.  
The fact that the BF0824 and BF1531 genes are located within capsular 
polysaccaharide loci (Figure 3.2 and 3.3) suggests that the FKBH protein products are 
not functioning in the context of a polyketide synthase or a nonribosomal peptide 
synthase. Indeed, a BLAST search of the deposited B. fragilis genomes using polyketide 
synthase I and II sequences and a nonribosomal peptide synthase sequence as query 
failed to retrieve homologues. The glyceryl unit produced by BF0824 and BF1531 might 
be used in the biosynthesis of a novel capsular polysaccharide sugar moiety. 
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Figure 3.33 The capsular polysaccharide loci that contains the FKBH homolog BF1531 gene. The 
gene annotations are based on the identity of the closest sequence homolog of known  Function 
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Figure 3.34 The capsular polysaccharide loci that contains the FKBH homolog BF1531 
gene. The gene annotations are based on the identity of the closest sequence homolog of 
known function. 
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The work reported in this Chapter focuses on the structures and functions of BF0824 and 
BF1531. The X-ray structure determination of BF1531 was carried out in Professor Steve 
Almo’s laboratory at Albert Einstein School of Medicine. The (attempted) X-ray 
structure determination of BF0824 was carried out in Professor Karen Allen’s laboratory 
at Boston University. The SAXS (small angle X-ray diffraction) determinations were 
carried out in collaboration with Professors Karen Allen and Hiro Tsuruta. 
 
3.2 Materials and Methods 
3.2.1 General Methods 
All chemicals and buffers were purchased from Sigma-Aldrich. The sources of 
the gene cloning materials are as follows: primers, T4 DNA ligase, restriction enzymes 
(Invitrogen); E. coli BL21 (DE3) competent cells and Pfu, Turbo polymerases 
(Strategene); pET14b, pET23a and pET28a vector kits (Novagen); Qiaprep Spin 
Miniprep Kit (Qiagen). Genomic DNA (strain YCH46) from B. fragilis strain YCH46 
was gift from Dr. Masahira Hattori of the University of Tokushima. DEAE Sepharose 
was from Amersham Biosciences. Butyl and Phenyl-Sepharose resins were purchased 
from Sigma-Aldrich, whereas the Ni-NTA resin was from Qiangen. Snakeskin pleated 
dialysis tubing was purchased from Thermo Scientific. SDS-PAGE analysis was 
performed with a 12% acrylamide running gel and a 4% stacking gel (37.5:1 
acrylmide:biacryamide ratio) (BioRad, Hercules, CA). Protein solutions were 
concentrated using a 10K Amicon Ultra Centrifugal filter (Millipore). The nucleotide 
sequence of each cloned gene or mutant gene was determined by the Center for Genetics 
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in Medicine, University of New Mexico. Electro-spray mass-spectrometry (ES-MS) 
determinations were carried out by the University of the New Mexico Mass Spectrometry 
Facility. Protein concentrations weredetermined using the Bradford assay kit from 
Sigma-Aldrich. 
 
3.2.2 Preparation of Wild-Type Recombinant BF0824 (ExPasY #Q64Y51) 
To prepare the N-terminal His6-tagged protein the BF0824 gene was amplified by 
PCR using the genomic DNA (strain YCH46 from B. fragilis) and Pfu DNA polymerase. 
Oligonucleotide primers, which contain restriction endonuclease cleavage sites- BamhI 
(GGCGCAACTTGGATCCACATTCTCCAACTC) and NheI (GAGTCTTAATACT 
GCT AGC ATGAAGTATTTTAT) were used in the PCR reactions. The purified PCR 
product was digested with restriction enzymes BamhI and NheI and the digested product 
was ligated into vector pET28a that had been digested with the same enzymes. The 
ligation product wasused to transform E. coli BL21(DE3) competent cells. The confirmed 
colony of E. coli (BL21) cells was used to inoculate 10 mL of LB medium containing 30 
µg/mL karamycin at 37 oC and 250 RPM. The 10 mL culture was then used to inoculate 
10 L of fresh LB medium containing 30 µg/mL karamycin and the culture was grown at 
25 °C with shaking at 200 RPM. After 6 h (O.D ~0.6 at 600nm)IPTG was added to a 
final concentration of 1 mM. The mixture was incubated at 20 °C and 200 RPM for 14 h  
before harvesting the cells by centrifugation at 6500 x g for 15 min. The 10 g of wet cells 
were suspended in 100 mL of lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole; pH 8.0). Thecell suspension was passed through a French press at 1,200 PSIG 
and then centrifuged at 20000 x g at 4°C for 45 min. The supernatant was loaded onto a 
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Ni-NTA Agarose column (25 mL, 4°C) that had been pre-equilibrated with the lysis 
buffer. The column was eluted with 300 mL of wash buffer (pH 8.0;50 mM 
NaH2PO4,300 mM NaCl, 20 mM imidazole) and then eluted with 400 mL elution buffer 
(pH=8.0;50 mM NaH2PO4, 300 mM NaCl, 250 mMimidazole). The protein was dialyzed 
for 3 h against three changes of 2.5 L buffer A (pH 7.6; 50 mM Tris, 5 mM Mg2+, 1 mM 
DTT). The protein purity was verified by SDS-PAGE analysis, the desired fractions were 
combined and concentrated by using a Centricon (10kDa, Pall Filtron) at 4 oC, The 
concentration of protein was measured by using the Bradford method (12). Yield: 25mg 
protein/gm wet cell. 
A similar procedure was used to prepare C-terminal His6-tagged BF0824.The 
oligonucleotide primers used are: GAGTCTTAATACTGCT AGC ATGAAGTATTT 
TAT(NheI site) and ATTTTCTCTTCCCTCGAGGTTCATATTTATTTTAT(XhoI site). 
Following digestion, the gene was ligated into the pET 23a vector. Ampicilin was used in 
the growth media in place of the karamycin. All other steps were the same as described 
above. Yield: 15 mg protein/gm wet cell. 
Two different cloning strategies were tried in the cloning of the native  (i.e., no    
His6 tag) BT0824. Firstly, the oligonucleotide primers that contain NheI and BamH I 
restriction sites (vide supra) were used in the PCR reaction and the digested product was 
ligated to the linear pET 23a vector, which was used to transform the E. coli (BL21) cells 
as previously described.  Following cell lysis, the supernatant was loaded onto a 40 cm × 
5 cm DEAE Sepharose column at 4 oC, which was eluted with a 2 L linear gradient of 
KCl (0 to 0.5 M) in buffer A. The column fractions were analyzed by SDS-PAGE. The 
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desired protein fractions were combined, adjusted to 20% (NH4)2SO4 (W/V), and loaded 
onto a 18 cm × 3 cm Butyl-Sepharose column that had been pre-equilibrated with buffer 
A containing 20% (NH4)2SO4. The column was eluted at 4 oC first with a 0.5 L linear 
gradient of (NH4)2SO4(20% to 15%) in buffer A, and then with 0.5 L buffer A containing 
15% (NH4)2SO4. The column fractions were analyzed by SDS-PAGE. The desired 
protein fractions were combined and concentrated at 4 °C using a 10K Amicon Ultra 
Centrifugal filter (Millipore). The concentrated protein fractions were loaded onto a 
Sephadex G-75 column and then the column was eluted with buffer A. The column 
fractions were analyzed by SDS-PAGE. The desired protein fractions were concentrated 
and stored at -80oC. Yield: 12mg protein/gm wet cell. 
For the second cloning method the IMPACT (Intein Mediated Purification with 
an affinity Chintin-binding Tag) system was employed. This system (vector pTXB1 
(NEB#N6707) with NdeI and SapI restriction sites) utilizes the inducible self-cleavage 
activity of protein splicing elements to cleave the affinity tag from recombinant protein. 
The base pairs for the two Nde I restriction sites were substituted using the following 
primers: GTTATGATGACATTTCGTATGTCCCTTTGG,CCAAAGGGACATACGA 
AATGTCATCATAAC;GAAGATGGGGCAAAAGCGTATGTACAATG,CATTGTAC
ATACGCTTTTGCC CCATCTTC.The original stop codon was replaced using the 
Primers ATAAATATGAACTGCTATGGAAGAGAAAAT,ATTTTCTCTTCCATAG 
CAGTTCATATTTAT. Finally, the oligonucleotide primers containing the NdeI 
(GTCTTAATACTGCTCATATGAAGTA TTTTATT) and SapI (CCAAT ATTTTC 
TGCTCTTC AGCAGTTCATATTT) restriction sites were used to clone the modified 
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gene into pTXB vector digested with the corresponding restriction enzymes. The 
recombinant vector was used to transformE.coli ER2566 (NEB# C2566) cells for 
culturing as previously described. The cell pellet was suspended in200 mL of column 
buffer (20 mM Tris-HCl pH 8.5, 500 mM NaCl, 1 mM EDTA).The cell lysate-derived 
supernatant was loaded onto a chitin bead (NEB#S6651) column(10 mL) at 4oC. The 
column was washed with 20 bed volumes of the column buffer before applying the on-
column cleavage buffer (50 mM DTT, 20 mM Tris-HCl pH 8.5, 500 mM NaCl, 1 mM 
EDTA). Following 24 h at 4oC the native protein was eluted from the column with 50 mL 
of column buffer. The eluant was concentrated and dialyzed at 4 oC against 3 changes of 
buffer A (pH 7.6; 50 mM Tris-HCl, 5 mM MgCl2, 1 mM DTT). Yield: 20mg protein/gm 
wet cell. 
 
3.2.3 Preparation of Wild-Type Recombinant BF1531 (ExPasY # Q64W45) 
All attempts to clone the B. fragilis (strain YCH46) BF1531 gene for over-
expression in E. coli using a genomic DNA/PCR-based strategy failed. Therefore, a 
codon-optimized gene was synthesized. The protein production group at Eli Lilley (under 
Steve Sauder and Steve Burley) synthesized 5 constructs: aa 2-377, 2-575, 17-377, 17-
575 and 216-377.These gene constructs were expressed in an E. coli Met auxotroph to 
produce the Seleno-Met protein products for crystal structure determination, which was 
carried out in Steve Almo’s laboratory. The gene constructs were also sent to our lab for 
kinetic analysis. The full length construct in the pET30 vector was used to transformE. 
coliBL21(DE3) codon+RIL cells. The confirmed colony was used to inoculate 10 mL of 
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LB medium containing 30 µg/mL karamycin and 20 µg/mL chloramphenicol at 37 oC. 
The 10 mL culture was then used to inoculate 6 L of fresh LB medium containing 30 
µg/ml karamycin and 20 µg/ml chloramphenicol. The culture was grown at 25 °C with 
shaking at 200 RPM. After ~6 h (O.D ~0.6 at 600nm), IPTG was added to a final 
concentration of 1 mM. The mixture was incubated at 20 °C with shaking at 200 RPM for 
14 h, before harvesting the cells by centrifugation at 6500 x g for 10 min. The 20 g of wet 
cells were suspended in 200 mL of lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole; pH 8.0). The cell suspension was passed through a French press at 1,200 PSIG 
and then centrifuged at 20000 x g at 4 °C for 45 min. The supernatant was loaded onto a 
Ni-NTA Agarose column (10 mL), which had been pre-equilibrated with the lysis buffer. 
The column was eluted with 150 mL of wash buffer (pH 8.0; 50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole) and then eluted with 400 mL elution buffer (pH 8.0; 50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole). The eluant wasanalyzed by SDS-PAGE 
and the desired fractions were combined and concentrated by using a Centricon 
(10kDa,Pall Filtron) at 4oC. Finally, the protein was dialyzed at 4 oC against three 
changes of 2.0L buffer A (pH 7.6; 50mM Tris, 5mM MgCl2, 1 mM DTT). The final 
concentration of protein was measured by using the Bradford method. Yield: 10mg  
protein/gm wet cell. 
 
3.2.4 Preparation of BF0824 Site Directed Mutants and Truncation Mutants 
Several gene constructs that encode BF0824 minus one or two of the three 
domains were prepared for the purpose of structure determination. Truc1 (1-330) was 
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prepared using two primers with NheI(GAGTCTTAATACTGCTAGCATGAAG 
TATTTTAT) and BamHI (GTTCCGTCTTTTTCGGATCCTCTTACGTGATGG) 
restriction sites; Truc 2 (331-529) was prepared using two primers with NheI 
(GGTGATTAATGCTAGCTTGGCAGGGGC) and BamH I (GGCGCAACTTGGATC 
CACATTCTCCAACT C ) restriction sites and Truc 3 (161-529) was prepared using two 
primers with NheI (GGCTTTTCGCAAAGCTAGCA CTTGTAAAACAAG) and BamH 
I (GGCGCAACTTGGATCCACATTCTCCAACTC) restriction sites. The PCR products 
were cloned into a pET 28a vector (adds an N-terminal His6tag). The protein preparation 
procedures used were the same as those used for the His6 tagged full length BF0824 
protein.  
Because the full length BF0824 was found to undergo cleavage at the central-C-
terminal linker during crystallization amino acid replacements were made in hopes of 
stabilizing the linker. The K350K351was replaced with E351V352 and K334K335 was 
replaced with 334A335L. Two pairs of oligonucleotide primers were used to make the 
quadruple–mutation, (CGGAAGA GGATGCACTAAAGACGGAAC AATATAAAGC, 
GCTTTATATTGTTCCGTCTTTAGTGCAATCCTCTTCCG;GCAGGACACAGGAAG
AAGTGAAATTTACAGATCTCGGTGC,GCACCGAGATCTGTAAATTTCACTTCTT
CCTGTGTCCTGC). The protein preparation procedures used were the same as those 
used for the His6 tagged full length BF0824 protein.  
Three key catalytic residues (Asp 178, Asp180 and Cys488) were replaced with 
Ala. The primers used for generation of the D178A, Asp180 and Cys488 mutanta are 
GTTTGGTTCTTGCTTTGGATAATACACTGTGGAG and CTCCACAGTGTATTA 
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TCCAAAGCAAGAACCAAAC;GTTTGGTTCTTGATTTGGCTAATACACTGTGGA
G and CTCCACAGTGTATTAGCCAAATCAACAACCAAAC;GATTCATTGTTGT 
TAAGCTCTAGGATCTTAGG and CCTAAGATCCTAGAGCTTAACAACAATG 
AATC, respectively. The protein preparation procedures used were the same as those 
used for the His6 tagged full length wild-type BF0824 protein.  
 
3.2.5 Preparation of the Apo and Holo Acyl Carrier Proteins BF0825 (ExPasY 
#Q64Y50) and BF0819 (ExPasY #Q64Y56) 
The BF0825 (Q64Y50) gene was cloned into the pET23a vectorusing the primers 
TAAATATGAACTCATATGGAAGAGAAAATATTGGAG (Nde I site) and CAAA 
ACGAACAACCTCCTCGAGTTTCCCCTGAAGTATC (Xho I site) and the 
methodology used for preparation of the BF0824-pET23a construct (for preparation of 
the C-terminal His6-tagged protein product). The same cell culture (except that 
amphicillin was used instead of kanamycin) and protein purification steps were followed. 
Yield: 8 mg protein/gm wet cell. ES-MS analysis identified the protein product as the apo 
BF0285. Theoretical mass: 9388 Da   vs observed mass 9415 Da. 
The BF0819 (Q64Y56) gene was cloned into the pET 14b vector using the 
primers TTTAAAATAATAATCATATGGAACTTAAAAC (Nde I site) and CAGG 
GGTTTGGATCCAAATATCAGACATC (Bamh I site). The N-terminal His6-tagged 
protein was prepared using the same methodology used in the preparation of the His6-
tagged BF0824. Yield: 5mg protein/gm wet cell. ES-MS analysis identified the protein 
product as the apo BF0285. Theoretical mass: 9842 Da   vs observed mass 9870 Da. 
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The holo-BF0825 was prepared as follows. To a 1 mL plastic tube 10 μL of apo-
BF0825 (8.53 mM in 50 mM Tris-HCl pH 7.6), 2.5 μL BF1558 (0.65 mM in50 mM Tris-
HCl  pH 7.6) and 70 μl CoA (20 mM) were  added. The resulting solution was incubated 
at 25 oC for 10 min after which 50 μL of 10 % formic acid was added. ES-MS analysis 
identified the protein product as the apo BF0285. Theoretical mass: 9727 Da   vs 
observed mass 9755 Da. 
The holo-BF0819 was prepared as follows. To a 1 mL plastic tube 30 μL of apo-
BF0819 (1.52 mM in 50 mM Tris-HCl pH 7.6), 1.5 μL BF1558 (0.65 mMin 50 mM Tris-
HCl pH 7.6) and 7 μl CoA (20 mM) were added. The resulting solution was incubated at 
25 oC for 10 min after which 50 μL of 10 % formic acid was added. ES-MS analysis 
identified the protein product as the apo BF0285. Theoretical mass: 10181 Da   vs 
observed mass 10210 Da. 
 
3.2.6 Preparation of the Phosphopantethienyl Transferase BF1558 (ExPasY # 
Q64W18) 
The BF1558 gene was cloned into the vector pET28a for expression in E. coli 
BL21 (DE3) cells using the primers CCTGATATCAGCTTTTCATATGGCTTTGTTA 
CGG) (NdeI  site) and TAATAGGATACGCTCTCGAGTTGTATTTTCTTCAT (XhoI 
site) in the PCR reactions. The purified PCR product was digested with restriction 
enzymes NdeI and XhoI and then the digested product was ligated to vector pET28a 
which had been digested with same enzymes. The ligation product was used to transform 
E. coli BL21 (DE3) competent cells (Stratagene). The confirmed colony of E.coli (BL21) 
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cells was used to inoculate 10mL of LB medium containing 30 µg/ml karamycin at 37oC. 
The 10mL culture was then used to inoculate 4L of fresh LB medium containing 30 
µg/ml karamycin and the culture was grown at 25 °C with shaking at 200 RPM. After 6 h 
(O.D ~0.6 at 600nm) IPTG was added to a final concentration of 1mM. The mixture was 
incubated at 20 °C and 200 RPM for 14 h, before harvesting the cells by centrifugation at 
6500 x g for 10min. The 15 g of wet cells were suspended in 150 mL of lysis buffer 
(50mM NaH2PO4, 300 mM NaCl, 10mM imidazole; pH 8.0). The cell suspension was 
passed through a French press at 1,200 PSIG and then centrifuged at 20000 x g at 4°C for 
45min. The supernatant was loaded onto a Ni-NTA Agarose column (10 ml), which had 
been pre-equilibrated with the lysis buffer. The column was eluted with 300 mL of wash 
buffer (pH 8.0; 50mM NaH2PO4, 300mM NaCl, 20mM imidazole) and then eluted with 
400mL of elution buffer (pH 8.0; 50mM NaH2PO4, 300mM NaCl, 250mM imidazole). 
The desired fractions were combined and concentrated at 4oC by using a Centricon (10 
kDa, Pall Filtron). The protein was dialyzed at 4oC against three changes of 2.5L buffer 
A (pH 7.6; 50mM Tris-HCl, 5mM MgCl2, 1mM DTT). The protein purity was verified 
by SDS-PAGE analysis. The concentration of protein was measured by using the 
Bradford method. Yield: 12mg protein/g wet cell. 
 
3.2.7 Preparation ofthe Putative 3-Oxyoacyl-ACP SynthaseBF0820 (ExPasY 
#Q64Y55)and Attempted Preparation of the Putative 3-Oxyoacyl-ACP Synthase 
BF0822 (ExPasY # Q64Y53). 
The BF0820 (Q64Y55) gene was cloned into the PET-28a vector using the 
primers GTTGTAAGAACAAAGGACATATGGCTTTTATAG (Nde I site) and ATCAA 
98 
 
AGAAAAAGGATCCTATATTTCCATAAAG (Bamh I site). The N-terminal His6-
tagged protein was prepared using the same methodology used in the preparation of the 
His6-tagged BF0824. Yield: 15 mg protein/g wet cell. 
The BF0822 (Q64Y53) gene was successfully cloned however it failed to express 
in E.coli  cell lines BL21(DE3), BL21 codon-RIL and NEB. Several attempts were tried 
to express this gene. The two primers with Nhe I (CTACAGGGGC 
TAGCTTGGTAATAGATGGAG) and HindIII (GAAATTTAAAATCAGGATCCATA 
ACTCAATATTC) restriction site were designed to amplify the gene by PCR. The gene 
product was inserted into different vectors to test expression. The pET28a vector was 
used for production of the N-terminal His6-tagged protein. The pET23a vector was used 
for production of the C-terminal His6-tagged and taggless protein. The chaperone plasmid 
set (Takara, Code 3340, pGro7) was used to aid the folding of the target protein.  The 
BF0822 gene was inserted into a pCold II DNA vector and co-expressed with the 
chaperones-GroEL and GroES. The  pETDuetvector (from Novagen) was utilized to 
express the BF0820 and BF0822 genes on the same vector. Finally the codon-optimized 
gene was synthesized at Eli Lilleyand inserted into an expression vector. None of the 
approaches resulted in BF0822 gene expression.  
 
3.2.7 Preparation of the Putative Serine O-Acetyl Transferase BF0818 (ExPasY # 
Q64Y57) 
The BF0818 (Q64Y57) gene was cloned into the pET23a vector using the primers 
ATGGAAATAATTAACATATGAAGAATATAGC (Nde I site) and TTTTCAATA 
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AATG TCTCGAGTTCCATTTTATTATT (Xho I site) and the methodology used for 
preparation of the BF0824-pET23a construct (for preparation of the C-terminal His6-
tagged protein product). The same cell culture and protein purification steps used in the 
preparation of the His6-tagged BF0824 were followed. Yield: 10 mg protein/g wet cell.  
 
3.2.8 Preparation of the Putative Malonyl-CoA: Acyl Carrier Protein Transacylase 
BF2258 (ExPasY # Q64U24). 
BF2258 (Q64U24) gene was cloned into the pET23a vector using the primers 
TTAAAAAACAAACATATGAAAGCATTTGTATTC (Nde I site) and GAGTGGTCT 
ATCA ATACTCGAGTGCTATTCC (Xho I site) and the methodology used for 
preparation of the BF0824-pET23a construct (for preparation of the C-terminal His6-
tagged protein product). The same cell culture and protein purification steps used in the  
preparation of the His6-tagged BF0824 were followed. Yield: 12 mg protein/g wet cell.  
 
3.2.9 BF0824 (ExPasY #Q64Y51) Molecular Mass Determination 
The theoretical subunit molecular mass of N-terminal His6-tagged recombinant 
BF0824 was calculated by using the amino acid composition, derived from the gene 
sequence, and the ExPASy Molecular Biology Server program Compute pI/MW. The 
subunit size of recombinant BT2127 was determined by SDS-PAGE analysis, which 
included the molecular weight standards from New England Biolabs Inc. The subunit 
mass was determined by MS-ES mass spectrometry. The native molecular was estimated 
by FPLC gel filtration column chromatography against protein standards (13.7-220 kDa 
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from GE Healthcare). The 1.6 cm x 60 cm Sephacryl S-200HR column (GE Healthcare) 
was eluted at 4 oC with bufferD (50 mM HEPES, 100 mM NaCl (pH 7.5)) at a flow rate 
of 1 mL/min. The BT2127 molecular weight was derived from the measured elution 
volume by extrapolation of the plot of the elution volume of the molecular weight 
standard versus log molecular weight. BT2127 native mass was also analyzed at the 
HHMI Biopolymer/Keck Foundation Biotechnology Resource Laboratory at Yale 
University by size exclusion chromatography coupled with on-line laser scattering, 
refractive index, and ultraviolet detection. 
 
3.2.10 BF1558 (ExPasY # Q64W18) Activity Assay  
BF0825. A reaction solution initially containing 1 mM apo-BF0825, 21 μM BF1558, 16 
mM CoA, 1 mM DTT, 5 mM MgCl2 and 50 mM Tris-HCl (pH 7.6) was incubated at 25 
oC for 10 min and then 50 μL of 10% formic acid were added to terminate the reaction. 
The holo-BF0825 was detected by ES-MS analysis (m/z at 9, 755 Da). 
BF0819. A reaction solution initially containing 1.2 mM apo-BF0819, 24.5 μM BF1558, 
3.5 mMCoA ,1 mM DTT, 5 mM MgCl2 and 50 mM Tris-HCl (pH 7.6) was incubated at 
25 oC for 10 min and then 50 μL of 10% formic acid were added to terminate the 
reaction. The holo-BF0819 was detected by ES-MS analysis (m/z at 10, 210 Da). 
 
3.2.11 Reaction of BF1531 (ExPasY # Q64W45) with 1,3-Diphosphoglycerate 
A reaction solution initially containing 300 μM C-terminal His6-tagged BF1531, 
1.8 mM ATP, 1.8 mM 3-phosphoglycerate, 20 units of phosphoglyceratekinase, 1 mM 
DTT, 50 mM MgCl2 and 50 mM Tris-HCl (pH 7.6) was incubated at 25 oC for 10 min 
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and then 50 μL of 10% formic acid were added to terminate the reaction. The glyceryl-
BF1531 was confirmed by ES-MS analysis (m/z at 67, 359 Da). 
 
3.2.12 Preparation of Glyceryl-BF0824 (ExPasY # Q64Y51) and Reaction with 
Holo-ACP BF0825 and Holo-ACP BF0819. 
To prepare glyceryl-BF0824 400 μL of N-terminal His6-tagged BF0824 (390 M 
in 50 mM Tris-HCl pH 7.6), 33 μL 3-phosphoglycerate (28 mM), 66 μL ATP (14 mM), 
30 μL MgCl2 (800 mM) and 5 μL 3-diphosphoglycerate-kinase (20 units) were combined 
and the resulting solution was incubated at 25oC for 30 min. The solution was clarified by  
centrifugation at 14000 rpm for two min. The supernatant was stored at -20oCwhile the 
product, glyceryl-BT0824 was confirmed by LC-MS. The frozen was reaction solution 
was thawed and a 1 mL aliquot containing ~0.29mM glyceryl-BF0824 was mixed with 
200 μL Holo-0825 (1.48mM). The resulting solution was incubated at 37 oC for 5 min. 
The reaction product was validated by ES-MS analysis.  
The transfer of the glyceryl moiety from glyceryl-BF0824 to the holo-BF0825 or 
holo-BF0819 was tested by incubating the reaction mixture comprised 22 M holo -
BF0825 or holo-BF0819 and 74 µM glyceryl-BF0824 in 50 mM Tris-HCl pH 7.6 at 25oC 
or 37 oC for 20 min. The reaction solutions were directly subjected to ES-MS analysis. 
 
3.2.13 Reaction of Glyceryl-BF0825 with BF0820 
Glyceryl-BF0825 (100 μL 0.24 mM in 50 mM Tris-HCl, pH 7.6) was incubated 
with the putative 3-oxoacyl-[acyl carrier protein] synthase BF0820 (39441Da, 7 μL, 1.0 
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mM in 50 mM Tris-HCl, pH 7.6)  at 37 oC for 30 min. The solution was clarified by 
centrifugation and then directly subjected to ES-MS analysis. The Glyceryl-BF0820 was 
observed (39530.6Da) with a slow rate. 
 
3.2.14 Reaction of Glyceryl-BF0825 with Coenzyme Aand BF0818 
Glyceryl-BF0825 (50 μL 0.24 mM in Tris pH 7.6 buffer) was incubated with the 
putative Serine-O-Acyl Transferase BF0818 (24268Da, 2 μL, 0.3 mM in Tris pH 7.6)  
and Coenzyme A (2μL, 4mM in Tris pH 7.6 buffer)at 25 oC for 30 min. The solution was 
frozen and then directly subjected to ES-MS analysis. No detectable glyceryl-CoA was 
found (m/z at 766 Da for CoA). 
 
3.2.15 Reaction of Holo-BF0825 with Various Acyl-CoAs Catalyzed by BF2258.  
The relative rates of BF2258 catalyzed acyl-transfer to the ACP holo-BF0825 
were measured by carrying out an HPLC-based fixed time assay. The initial reaction 
solutions contained 500 µM holo-BF0825, 500µM acyl-CoA, 50µM BF2258, 5 mM 
MgCl2, 1 mM DTT and 50 mM Tris-HCl (pH 7.6). The reaction solutions were incubated 
at 25 oC for 15 min before chromatographing them on a reversed-phased C18 column 
(100 x 4.6 mm; ThermoScientific ODS HYPERSIL) using a linear gradient of solvent A 
(100 mM Na3PO4 and 75 mM sodium acetate; pH 4.6) and solvent B (70% A in 
methanol) and a flow-rate at 1.5 ml/min. The acyl-BF0825 products were verified by ES-
MS analysis.  
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3.2.16 Structure Determination of Crystallization the C-terminal Domain BF1531 
Truncation Mutant (Residues 3-381). 
        This work was carried out in Steve Almo’s laboratory at Albert Einstein School of 
Medicine. PurifiedC-terminal His6-tagged Se-modified BF1531 (residues 3-381) was 
crystallized from 35% pentaerythritol propoxylate, 0.05 M HEPES, 0.2 M potassium 
chloride, pH 7.5, via the hanging drop vapor diffusion method, at 293.0 K. Diffraction 
data were collected at 100 K on NSLS beamline X4A using an ADSC QUANTUM 4 
CCD area detector, located in Brookheaven National Laboratory and processed using the 
DENZO [13] software suite. The His6-tagged Se-modified BF1531 crystallized in space 
group P21212 with unit cell dimensions a =75.74 Å, b = 126 Å and c = 41.62 Å. Data 
were collected to 1.71 Å resolution. Data collection, refinement, and final model statistics 
are reported in Table 3.1. Phases were determined by the SAD method using PHENIX 
[14] yielding a solution with one enzyme protomer in the asymmetric unit. Alternating 
rounds of manual rebuilding were performed using the molecular graphics program 
COOT[15]followed by minimization and simulated annealing in PHENIX.  
        The final model of the BF1531 partial structure, included residues 3-376 in the 
protomer, 275 water molecules, one tungstate ion, and one Mg2+ ion, was refined to 1.71 
Å resolution with a Rwork of 18.3% and Rfree of 20.9%. Analysis of the Ramachandran plot 
showed that 97.5% of residues fall in the most favored regions with 2.5% in the 
additionally allowed and generously allowed regions. Figures were produced using 
Molscript[16], and were rendered in POVRAY. 
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3.2.17 BF0824 Small Angle X-ray Diffraction (SAXS) Data Collection and 
Processing 
        This work was carried out by Dan Saltzberg (Karen Allen laboratory) in 
collaboration with the Hiro Tsuruta laboratory. SAXS data were collected at beam line 4-
2 at the Stanford Synchrotron Radiation Lightsource (Palo Alto, CA).  Concentrations of 
5, 10 and 20 mg/mL BF0824 in 50 mM Tris-HCl were each centrifuged at 14,000 g for 5 
min before placing on the sample holder block maintained at 10 °C.  Samples were 
exposed to radiation for 15 exposures, each 1 s in duration while passing through a 
capillary flow cell at a rate of 1μL/s and the scattering data collected on a MarCCD165 at 
a distance of 1.5mm from the sample flow cell.  Two buffer blanks were collected using 
the same procedure.  Each exposure was reduced by radially averaging each image to 
produce the scattering intensity as a function of the magnitude of the momentum transfer 
vector (q = 4π*sinθ/λ). Outlier exposures, possibly a result of bubbles in the beam path, 
were indicated computationally and then manually inspected.  Those exposures clearly 
different from the majority were discarded.   
         1D scattering profiles for each concentration of protein were constructed by 
subtracting ( 1 – volume fraction protein ) * 100% of the buffer scattering intensity from 
the averaged protein sample intensity.  A Guinier plot was constructed to look for signs 
of aggregation. At extremely low scattering angles, evidence of interparticle interactions 
were observed at higher concentrations.  Low-angle data that did not conform to the 
Guinier approximation was discarded.  The 1D scattering profiles at 20, 10, and 5 mg/mL 
FkbH were extrapolated to zero concentration using the PRIMUS data analysis package 
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of Svergun [17].  The radius of gyration was estimated using the Guinier approximation 
for points 9 through 19 ( 0.017< q < 0.026 )  and found to be 51.6 +/- 0.06 angstroms.  
The pairwise distance probability distribution (p(r))curve was constructed with GNOM 
[17]and found to reach zero at 185 Å.  The Rg as calculated from the p(r) curve is 51.3 Å.   
Ab-initio molecular envelopes for the full length BF0824 were calculated from the 
zero concentration extrapolation described above at a resolution range from 0.017 < q < 
0.311 (1/370 to 1/20 Angstroms).  The program DAMMIN [18]was used using default 
values for simulated annealing to create bead models fit to the extrapolated dataset.  Two 
models were created, one enforcing no symmetry (P1) and one enforcing a two-fold 
rotation axis (P2) because of the dimer assumed from the gel filtration solution data and 
the packing in the crystal structure of residues 3-376 of the ortholog BF1531.  Forty-six 
independent DAMMIN simulations were performed with each symmetry and the 
resulting bead models superimposed, averaged and filtered using the programs 
SUPCOMB, DAMAVER and DAMFILT [19-20].  The final bead models for both P1 
and P2 symmetry were converted to surface maps at 20Å resolution using pdb2vol from 
the SITUS software suite.   
        “Threading” homology models of the two N-terminal domains of BF0824 FkbH 
were based on the crystal structure of homologue BF1531 (PDB ID: 3NVB, XX% 
similarity) and constructed using MODELLER [21].  A set of homology models for the 
C-terminal transferase domain of FkbH was produced by the phyre2 protein fold 
recognition algorithm[22] using the final 169 residues of BF0824 (residues 360-529).  
The top 20 templates used in the modeling were all acetyl-transferases of the GNAT 
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superfamily.  The homology model based on the structure with the highest sequence 
identity, 22%, was selected (PDB 2OH1) allowing 90% of the residues to be modeled at 
>90% confidence, with the low confidence areas at the N- and C- termini of the modeled 
domain.   
        The homology model was fitted into the SAXS envelopes using COLORES from 
the SITUS software suite.  The top six fits were recorded. 
 
3.3 Results and Discussion 
3.3.1 BF0824 (ExPasY #Q64Y51) and BF1531 (ExPasY # Q64W45) X-ray Structure 
Analysis 
 BF0824 (529 amino acids) and BF1531 (575 amino acids) share 45 % sequence 
identity. An InterProScan (http://www.ebi.ac.uk/Tools/services/web_iprscan/) analysis of 
the two sequences predicts three domains: the N-terminal domain (residues 1-216 in 
BF1531) belongs to the GDSL hydrolase superfamily, the central domain (residues 220-
372 in BF1531) belongs to the HADSF type C0 and a C-terminal domain (residues 375-
575 I BF1531) belongs to the acyl-CoA N-acyl transferase family. The X-ray structure 
determinations of full length and truncated BF0824 and BF1531 constructs were pursued 
in the Karen Allen (BF0824) and Steve Almo (BF1531) laboratories. I carried out the 
BF0824 genetic engineering and protein preparations for the BF0824 X-ray structure 
determinations. I also provided full length BF0824 for the SAXS experiments.  
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BF0824. His6-tagged BF0824 was found having a mass of 63,685 Da 
compared to which had the theoretical mass of 63675 Da. The SDS-PAGE analysis gave 
an estimated subunit mass of 63 kDa.   The native mass measured by using molecular 
size gel filtration chromatography is ~116 kDa  consistent with the data  from the Keck 
Foundation Biotechnology Resource Laboratory ~125 kDa. These results indicate that 
protein BF0824 exist as a homodimer. The mass for the three truncated BF0824: Truc 
1(1-330), Truc 2 (331-529) and Truc 3 (161-529AA) were determined to confirm their 
structures: theoretical mass of Truc 1 is 40971 Da observed mass is 40971 Da; the 
theoretical mass of Truc 2 is 25052Da and the observed mass is 25184Da; the theoretical 
mass of Truc 3 is 44442 Da and the observed mass is 44482 Da.  
Full-length BF0824 was crystallized and an X-ray data set was collected. SDS-
PAGE analysis of the crystalline protein revealed that the protein had undergone 
cleavage and that only the truncated protein had crystallized. The C-terminal domain had 
been lost. Whereas the central domain could be resolved by molecular replacement using 
a HADSF homologue structure the N-terminal domain could not be resolved by 
molecular replacement. The truncation constructs Truc1 (1-330) Truc 2 (331-529) Truc 3 
(161-529) failed to crystallize. The linker mutant (334A335L/E351V352) designed to 
reduce the rate of C-terminal domain loss proved to undergo linker cleavage albeit at a 
reduced rate.  
BF01531. Five BF01531 constructs Truc1 (2-377), Truc2 (2-575), Truc3 (17-377), Truc4 
(17-575) and Truc5 (216-377). Only Truc1 and Truc3 crystallized. The structure 
determination was carried out on Truc2 which contains the N-terminal and central 
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domain.  The crystallization and refinement statistics are provided in Table 3.1. The 
structure was refined to 1.7 Å resolution (pdb code: 3NVB).  The structure includes one 
Mg2+ and one tungstate ion, which occupy the cofactor and phosphate binding sites, 
respectively, found in all HAD phosphotransferases.  
The structure is composed of two separate domains connected by one linker 
region (Figure 3.4). The N-terminal domain belongs to the SGNH hydrolase, or GDSL 
hydrolase superfamily based on DALI [23] search results, which has an unknown 
function in BF1531. The most similar structure to the N-terminal domain identified  
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Table 3.10. Crystallographic Data Collection and Refinement Statistics 
Data Collection Statistics  
Resolution (Å) 37.87-1.71(1.75-1.71) 
X-ray Source SYNCHROTRON 
Wavelength (Å) 0.97915 
Space group P21212 
Cell dimension (Å) a=75.74 b=126  c= 41.62 
Reflections Observed (unique) 42477 (xxx) 
Completeness (%) xxx (xxx) 
Rmergea (%) xxx (xxx) 
I/σ (I) xxx (xxx) 
Redundancy xxx (xxx) 
 
Refinement Statistics  
No. of protein residues/water atoms per asu 374/270 
No. of other ligands 2 
Number of reflections (work/free) 42477/2144 
Rwork/Rfree (%) 18.4/20.9 
Resolution (Å) 37.87-1.71  
Average B-factor (Å2) 22.1 
Protein  21.6 
Manganese /tungstate 22.1 
Water 27.7 
Root mean square deviation  
     Bond length (Å) 0.008 
     Bond angle (°) 1.140 
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a. Rmerge = ∑hkl∑i| Ihkl, i-<Ihkl> I | / ∑ hkl∑i | Ihkl, i |, where <Ihkl> is the mean intensity of the 
multiple Ihkl, i observations for symmetry-related reflections. Data for the highest 
resolution shell is in parenthesis by DALI is a lipase/acylhydrolase fromEnterococcus 
faecalis (PDB 1YZF) with rmsd 2.5 Å and 13 % sequence identity The C-terminal 
domain (central domain in full-length protein) is identified as C0 class of HAD members 
(Figure 1A) [24] which confers a phosphohydrolase activity. The HAD domain shares 
similar active-site residues with other HAD members. 
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The BF1531 HAD domain has the typical active-site residues seen in family 
members: two Asp residues (D226 and D228, the nucleophile and general acid/base 
catalyst, respectively) from motif 1, a Ser residue (S277) from motif 2, a Lys residue 
 
Figure 3.35. Ribbon diagram of the BF1531 partial structure consisting of a HAD domain 
(green) and GDSL hydrolase domain (blue). The Mg2+ cofactor is shown as a magenta 
sphere. 
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(K311) from motif 3 (which serve to position the transferring phosphoryl group and 
nucleophile) and one Asp residue (D334) from motif 4, which bind the Mg2+ cofactor. 
 
 
 
 
 
 
 
 
 
 
Figure 3.36. Zoom-in on the active site of the HAD domain. Red spheres are water 
molecules, the magenta sphere is Mg2+ and the black sphere is tungstate. 
In the HAD domain active site, there is one magnesium ion and one tugstate ion. 
The Mg2+ is coordinated by the side-chain of D226, backbone carbonyl group of D228, 
the side-chain of D334, two water molecules (one of which is positioned by the side 
chain of motif 1 D226 and the other by the side chain of motif 4 residue D335) and one 
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oxygen atom from the tungstate ion. The tungstate ion is 2.5 Å from the Asp nucleophile 
carboxylate. 
 
 
 
 
 
 
 
 
 
Figure 3.37. Structural overlay between MDP-1 (red) and BF1531 HAD domain (green) 
shown as a ribbon diagram. The active site residues, waters, and tungstate ligand from 
the BF1531 HAD domain are shown as ball and stick. 
           Based on Dali search results, MDP-1 is the most similar in structure to the BF1531 
HAD domain. The two structures share RMSD 1.87 Å and an identical active site. The 
two structures are superimposed in Figure 3.6 and their active sites are superimposed in 
Figure 3.7.  
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3.3.2 BF0824/BF1531 SAXS Analysis 
Because the structure determination of the full length BF0824 and BF1531 was 
unsuccessful SAXS was used to determine a structural envelope that we could use to 
generate a model of the native protein. The PHYRE webserver was used to construct a  
 
 
Figure 3.38. Active site overlay between MDP-1 (yellow) and BF1531 HAD domain 
(grey). The active site residues, Mg2+ cofactor (magenta sphere) and tungstate ligand 
from the BF1531 HAD domain and MDP1 domain are shown as ball and stick. 
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threading model of the C-terminal acyl transferase domain. The transferase domain was 
placed at a complementary interface with the HAD domain and positioned such that the 
catalytic cysteine was in close proximity (16Å) to the nucleophile Asp of the HAD 
domain (Figure 3.8).  
 
 
 
 
 
Figure 3.39. All-atom model of BF0824 monomer 
 
A model of the BF0824 dimer was constructed by applying the P2 symmetry axis 
from the 3NVB PDB file (see Figure 3.9) 
 
N-term 
 
HAD 
 
Transferase 
 
116 
 
 
 
Figure 3.40. Rough all-atom model of BF0824 dimer from homology model of C-
terminal (orange), HAD (blue) and acyl transferase (green) domains. The dimer is 160 Å 
long. 
 The overall shape of the rough all-atom dimer model has a consistent shape with 
the SAXS data, indicating that the oligomeric state of the protein is likely correct and that 
the transferase domains extend away from the central structure at either end of the dimer 
(Figure 3.10). 
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Figure 3.41. Ribbon models of BF0824 all-atom model with P2 SAXS envelope. 
 
.            The docked model indicates the N-terminal does not play a role in catalysis but 
rather it serves as a dimerization domain. As described below, the biological range of 
BF0824/BT1531 homologues was determined. A multiple sequence alignment of these 
homologues shows that many of these homologues are either missing the N-terminal 
domain or possess an N-terminal domain from a different protein fold family.  
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3.3.3 BF0824 (ExPasY #Q64Y51) and BF1531 (ExPasY #Q64W45) In vitro Function 
Determination 
The catalytic function of FKBH is to autoacylate the catalytic Cys residue of the 
C-terminal acyl transferase domain using 1,3-diphosphoglycerate and then remove the 
C(3)phosphate from the Cys-S-glyceryl-3-phosphate using the HAD domain catalytic 
residues. The final step is the transfer of the glyceryl moiety to an acceptor. First we 
showed using ES-MS to monitor the reaction that in the presence of 1,3-
diphosphoglycerate (generated in situ) BF0824 and BF1531 form the Cys-S-glyceryl 
adduct. The mass spectrum of N-terminal His6-tagged BF0824 before and after 
incubation (at a concentration of with 140 μM) with 3-phosphoglycerate (767 μM), ATP 
(924 μM), MgCl2(11 mM) and glycerate kinase (20 units) in Tris-HCl (50 mM, pH 7.6, 
25 oC) for 30 min, is shown in Figure 3.11. The mass spectrum of C-terminal His6-tagged 
BF1531 before and after incubation (at a concentration of with 300 μM) with 3-
phosphoglycerate (1.8 mM), ATP (1.8 mM), MgCl2(5 mM) and glycerate kinase (20 
units) in Tris-HCl (50 mM, pH 7.6, 25 oC) for 10 min, is shown in Figure 3.12.These 
results show that BF0824 and BF1531 are in fact functional FKBH enzymes. 
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Figure 3. 42. The mass spectrum of N-terminal His6-tagged BF0824 before (above) and 
after (below) incubation (at a concentration of with 140 μM) with 3-phosphoglycerate 
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(767 μM), ATP (924 μM), MgCl2 (11 mM) and glycerate kinase (20 units) in Tris-HCl 
(50 mM, pH 7.6, 25 oC) for 30 min. 
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Figure 3.43. The mass spectrum of C-terminal His6-tagged BF1531 before(above) and 
after (below) incubation (at a concentration of with 300 μM) with 3-phosphoglycerate 
(1.8 mM), ATP (1.8 mM), MgCl2 (5 mM) and glycerate kinase (20 units) in Tris-HCl (50 
mM, pH 7.6, 25 oC) for 10 min 
The next question to be addressed is what is the identity of the glyceryl unit 
acceptor. The likely candidate is the ACP, which is encoded by a gene located next to the 
FKBH gene (BF0825 in the case of BF0824 and BF1532 in the case of BF1532). For 
now only the transfer of the glyceryl unit from glyceryl-BF0824 to holo-BF0825 was 
tested. Recombinant BF0825 was isolated as the apo-ACP and the converted to the holo-
ACP by reaction with CoA catalyzed by recombinant phosphopantetheinyl transferase 
BF1558. 
           The ES-MS spectrum of holo-BF0825 before and after incubation (at a 
concentration of 22 μM) with glyceryl-BF0824 (71 μM)in 50 mM Tris-HCl (pH 7.6) at 
25 oC for 20 min shows that BF0825 is the acceptor. Notably, the recombinant ACP 
BF0819 (encoding gene is just upstream of that of the BF0824 gene) is a substrate for the 
recombinant phosphopantetheinyl transferase BF1558, however the holo-BF0819 is not a 
substrate for glyceryl-BF0824. The ES-MS spectrum of holo-BF0825 before and after 
incubation (at a concentration of 22μM) with glyceryl-BF0824 (37μM) in 50 mM Tris-
HCl (pH 7.6) at 25 oC and also at 37 oC for 20 min shows that holo-BF0825 is unchanged 
(Figure 3.13). Thus, the glyceryl-BF0824 discriminates between its ACP acceptor and an 
ACP that is encoded by the same capsular polysaccharide loci.  
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The conclusion drawn from these findings is that BF0824 catalyzes the 
glycerylation of the holo-ACP BF0825 using 1,3-diphosphoglycerate as the source of the 
glyceryl unit. The next step was to determine the identity of the acyl transferase that  
receives the glyceryl unit from glyceryl-BF0825. The putative acyl-transfereases encoded 
by the polysaccharide loci are: putative 3-oxyoacyl-ACP synthase BF0820 (a type III 
fatty acid synthase homolog), putative 3-oxyoacyl-ACP synthase BF0822 (a type III fatty 
acid synthase homolog), putative serine O-acetyl transferase BF0818 and  putative 
malony-CoA: ACP transacylase BF2258. Attempts to express the clone of BF0822 failed, 
however the other three acyl transferases were successfully prepared for activity testing.  
The reactions were carried out under the conditions detailed in Materials and Methods 
and the reaction solutions were subjected to ES-MS analysis. Disappointingly, no product 
was observed and presently the recipient of the BF0825 glyceryl unit remains unknown.  
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Figure 3.44. The ES-MS spectrum of holo-BF0825 before and after incubation (at a 
concentration of 22 μM) with glyceryl-BF0824 (71 μM) in 50 mM Tris-HCl (pH 7.6) at 
25 oC for 20mins. 
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3.3.4 BF0824 (ExPasY #Q64Y51) and BF1531 (ExPasY #Q64W45) Biological Range. 
To date reports of FKBH homologues have focused on FKBH domains that 
function within a polyketide synthase. BF0824 and BF1513 are not associated with a 
polyketide synthase and instead appear to contribute a glyceryl unit to a capsular 
polysaccharide. By tracking homologues via BLAST searches of the NCBI genome 
database the biological range of FKBH could be examined. Moreover, inspection of the 
gene context of FKBH genes in annotated genomes provides insight into possible FKBH 
functions.  
The FKBH  biological range search was limited to prokaryotes. None were found 
in Archea. Within the Bacteria FKBH is found primarily in Acintobacter and Bacillales. 
within Bacteroidetes/Chlorobi FKBH is found in Bacteroides fragilis (not all strains), 
Prevotella marshii, Parabacteroides distasonis, Bacteroides fluxus, Chitinophaga 
pinensis, Paludibacter propionicigenes, Bacteroides eggerthii and Prevotella ruminicola. 
Within Proteobacteria FKBH is present in select species of alpha, gamma, delta and 
epsilon division species.  
Inspection of FKBH gene contexts within the genomes of these bacteria provides 
some insight into the applications of FKBH function. FKBH is most commonly 
represented as a free-standing protein that is not linked to a polyketide synthase. The 
glyceryl moiety is apparently used in a variety of biosynthetic contexts that are yet to be 
discovered.  
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APPENDIX 
 
A.1 Published Collaborative Work 
 
A1.1 Divergence of biochemical function in the HAD superfamily: D-glycero-D-
manno-heptose-1,7-bisphosphate phosphatase (GmhB). 
Wang L, Huang H, Nguyen HH, Allen KN, Mariano PS, Dunaway-Mariano D. 
Department of Chemistry and Chemical Biology, University of New Mexico, 
Albuquerque, New Mexico 87131, USA. 
 
Abstract 
D-Glycero-D-manno-heptose-1,7-bisphosphate phosphatase (GmhB) is a member of the 
histidinol-phosphate phosphatase (HisB) subfamily of the haloalkanoic acid 
dehalogenase (HAD) enzyme superfamily. GmhB supports two divergent biochemical 
pathways in bacteria: the D-glycero-D-manno-heptose-1-alpha-GDP pathway (in S-layer 
glycoprotein biosynthesis) and the l-glycero-D-manno-heptose-1-beta-ADP pathway (in 
lipid A biosynthesis). Herein, we report the comparative analysis of substrate recognition 
in selected GmhB orthologs. The substrate specificity of the l-glycero-D-manno-heptose-
1-beta-ADP pathway GmhB from Escherichia coli K-12 was evaluated using hexose and 
heptose bisphosphates, histidinol phosphate, and common organophosphate metabolites. 
Only D-glycero-D-manno-heptose-1-beta,7-bisphosphate (k(cat)/K(m) = 7 x 106 M-1 s-1 
and D-glycero-D-manno-heptose-1-alpha,7-bisphosphate (k(cat)/K(m) = 7 x 104M-1 s-1 
displayed physiologically significant substrate activity. 31P NMR analysis demonstrated 
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that E. coli GmhB selectively removes the C(7) phosphate. Steady-state kinetic inhibition 
studies showed that D-glycero-D-manno-heptose-1-beta-phosphate (Kis = 60µM, and Kii 
= 150µM) and histidinol phosphate (Kis = 1 mM, and Kii = 6 mM), while not hydrolyzed, 
do in fact bind to E. coli GmhB, which leads to the conclusion that nonproductive 
binding contributes to substrate discrimination. High catalytic efficiency and a narrow 
substrate range are characteristic of a well-evolved metabolic enzyme, and as such, E. 
coli GmhB is set apart from most HAD phosphatases (which are typically inefficient and 
promiscuous). The specialization of the biochemical function of GmhB was examined by 
measuring the kinetic constants for hydrolysis of the alpha- and beta-anomers of D-
glycero-d-manno-heptose-1-beta,7-bisphosphate catalyzed by the GmhB orthologs of the 
l-glycero-D-manno-heptose-1-beta-ADP pathways operative in Bordetella bronchiseptica 
and Mesorhizobium loti and by the GmhB of the D-glycero-D-manno-heptose-1-alpha-
GDP pathway operative in Bacteroides thetaiotaomicron. The results show that although 
each of these representatives possesses physiologically significant catalytic activity 
toward both anomers, each displays substantial anomeric specificity. Like E. coli GmhB, 
B. bronchiseptica GmhB and M. loti GmhB prefer the beta-anomer, whereas B. 
thetaiotaomicron GmhB is selective for the alpha-anomer. By determining the anomeric 
configuration of the physiological substrate (D-glycero-D-manno-heptose-1,7-
bisphosphate) for each of the four GmhB orthologs, we discovered that the anomeric 
specificity of GmhB correlates with that of the pathway kinase. The conclusion drawn 
from this finding is that the evolution of the ancestor to GmhB in the HisB subfamily 
provided for specialization toward two distinct biochemical functions. 
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A.1.2 Structural determinants of substrate recognition in the HAD superfamily 
member D-glycero-D-manno-heptose-1,7-bisphosphate phosphatase (GmhB) . 
Nguyen HH, Wang L, Huang H, Peisach E, Dunaway-Mariano D, Allen KN. 
Department of Physiology and Biophysics, Boston University School of Medicine, 
Boston, Massachusetts 02118-2394, USA. 
 
Abstract 
The haloalkanoic acid dehalogenase (HAD) enzyme superfamily is the largest family of 
phosphohydrolases. In HAD members, the structural elements that provide the binding 
interactions that support substrate specificity are separated from those that orchestrate 
catalysis. For most HAD phosphatases, a cap domain functions in substrate recognition. 
However, for the HAD phosphatases that lack a cap domain, an alternate strategy for 
substrate selection must be operative. One such HAD phosphatase, GmhB of the HisB 
subfamily, was selected for structure-function analysis. Herein, the X-ray 
crystallographic structures of Escherichia coli GmhB in the apo form (1.6 Å resolution), 
in a complex with Mg2+ and orthophosphate (1.8 Å resolution), and in a complex with 
Mg2+ and D-glycero-D-manno-heptose-1-beta-7-bisphosphate (2.2 Å resolution) were 
determined, in addition to the structure of Bordetella bronchiseptica GmhB bound to 
Mg2+ and orthophosphate (1.7 Å resolution). The structures show that in place of a cap 
domain, the GmhB catalytic site is elaborated by three peptide inserts or loops that pack 
to form a concave, semicircular surface around the substrate leaving group. Structure-
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guided kinetic analysis of site-directed mutants was conducted in parallel with a 
bioinformatics study of sequence diversification within the HisB subfamily to identify 
loop residues that serve as substrate recognition elements and that distinguish GmhB 
from its subfamily counterpart, the histidinol-phosphate phosphatase domain of HisB. 
We show that GmhB and the histidinol-phosphate phosphatase domain use the same 
design of three substrate recognition loops inserted into the cap domain yet, through 
selective residue usage on the loops, have achieved unique substrate specificity and thus 
novel biochemical function. 
 
A.2 Manuscript of Collaborative Work Submitted for Publication 
 
A.2.1 Evolution of Substrate Specificity in Sialic Acid Phosphatases within Bacterial 
Species†, †† 
Kelly D. Daughtry, Liangbing Wang#, Hua Huang#, XXX, Steve C. Almo††, Debra 
Dunaway-Mariano#*, and Karen N. Allen§* 
Department of Physiology and Biophysics, Boston University School of Medicine, 
Boston, Massachusetts 02118-2394 
#Department of Chemistry and Chemical Biology, University of New Mexico, 
Albuquerque, NM 87131-0001 
††Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA 
§Department of Chemistry, Boston University, Boston, MA 02215- 2521 
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Running Title: Evolution of  Phosphatase Specificity 
Key Words: 2-keto-3-deoxyoctulosonic acid, KDO, 2-keto-3-deoxynononic acid, KDN, 
phosphohydolases, structural genomics, HAD enzyme superfamily, enzyme evolution  
††The coordinates of the E56A mutant, E56A/K67A double mutant, and 2-keto-3-
deoxynononic acid 9-phosphate phosphohydrolase complexed with 2-keto-3-
deoxynononic acid and metavanadate from B. thetaiotaomicron, 2-keto-3-
deoxyoctulosonic acid 8-phosphate phosphohydrolase from B. thetaiotaomicron, and 2-
keto-3-deoxy-D-manno-octulosonic acid 8-phosphate phosphohydrolase complexed with 
2-keto-3-deoxy-D-manno-octulosonic acid and metavanadate from H. influenzae have 
been deposited in the Protein Data Bank with accession codes XXX, XXX, XXX, XXX, 
and XXX.  
†This work was supported by NIH grant R01 GM61099 and U54 GM093342-01 (K.N.A. 
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Abbreviations  
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KDN, 2-keto-3-deoxynononic acid ; KDN9P, 2-keto-3-deoxynononic acid 9-phosphate; 
BT, Bacteroides thetaiotaomicron; 
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Abstract 
Defining substrate specificity in enzyme systems is crucial to understanding evolution 
and selection processes over time. Two paralogous enzymes (with 28% overall sequence 
identity) that work on substrates with similar structures, 2-keto-3-deoxy-D-manno-
octulosonate 8-phosphate (KDO8P) phosphatase  and 2-keto-3-deoxy-9-O-
phosphonononic acid phosphatase (KDN9P) phosphatase from Bacteriodes 
thetaiotaomicron, are both members of the C0 subfamily of the Haloalkanoate 
Dehalogenase Superfamily (HADSF). The two phosphotransferases have similar three-
dimensional structures, sugar phosphate substrates, and active site composition, with 
28% overall sequence identity). Previously, kinetic analyses show that B. 
thetaiotaomicron KDN9P phosphatase has a 60 fold greater specificity (kcat /Km) for 
KDN9P over KDO8P, while KDO8P phosphatase is 20 fold more efficient for KDO8P 
over KDN9P. In order to uncover the structural origins of substrate specificity the crystal 
structures of KDN9PP from B. thetaiotaomicron and KDO8PP from Haemophilus 
influenza were solved in the presence of the corresponding intermediate/transition state 
analog complex, KDN/vanadate or KDO/vanadate at 2.1 Å and 1.8Å resolution, 
respectively. Sequence analysis, examination of the ligand interactions, solvent 
accessibility, and comparison with the structure of the unliganded KDO8PP from B. 
thetaiotaomicron (1.8 Å resolution) shows that the previously identified specificity 
residues Glu 56 and Lys 67 in KDN9PP are replaced by Gly and Ala respectively in B. 
thetaiotaomicron KDO8P phosphatase. The role of these residues in delineating 
specificity was further demonstrated by mutational analysis and kinetics, with the Glu56 
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to Ala mutation in KDN9P phosphatase showing a switch in specificity from KDN9P to 
KDO8P. Moreover, the bioinformatic analysis of bacterial genomes lead to the 
identification of a subset of KDO8PP sequences with altered specificity determinants 
(Arg and Asp in place of Gly and Ala). Structural and kinetic analysis of hypothetical 
KDO8PP and KDN9PP enzymes confirm the identity of four KDO8PPs that can be 
recognized by these markers throughout gram-negative bacteria. Bioinformatic analysis 
of bacterial genomes indicates that the Bacteroides phylum contains KDO8PP enzymes 
with Gly/Ala specificity determinants, while the remainder of gram-negative bacteria 
(across all phyla) contains the Arg specificity determinant (similar to H. influenzae).  
Overall, structural and kinetic analysis in the presence of ligand was utilized to uncover 
specificity determinants which were not apparent from sequence analysis alone. 
Although the HADSF was initially named for 2-haloacid dehalogenase, the first 
well characterized family member [1], most extant members are phosphohydrolases. The 
conserved HADSF three-dimensional structsandwich comprised of repeating  units which 
adopt the typical Rossmannoid fold [2]. The four conserved motifs of the HADSF are 
juxtaposed in tertiary but not primary structure and contain catalytic residues and, in the 
phosphohydrolase members, residues that coordinate the Mg2+ (Figure A.1). Motif 1 
(DxD) comprises the nucleophilic Asp residue, and the Asp+2 residue contributes the 
backbone carbonyl for cofactor binding, and acts as general acid/base (Figure A.1). 
Motif 2 contains a Ser or Thr residue which coordinates the transferring phosphoryl 
group. Motif 3 contains a Lys/Arg residue which forms a salt bridge to both nucleophile 
and transferring phosphoryl group, positioning them with respect to one another. In Motif  
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4 Asp/Glu (and very rarely Asn/Gln) coordinate the magnesium cofactor. The HADSF 
can be classified by the location and topology of the inserted caps  [2], C0 caps have only 
a small inserted region between motifs 1 and 2, and C1 caps have a larger insert/domain 
in this region, whereas C2 caps have an insert/domain between motifs 2 and 3. The cap 
domain introduces a specificity loop into the active site in C1 and C2 HADSF members 
[3-4], while little is understood about the mechanism of specificity within C0 sub-family 
members. Thus C0 members are interesting to study to understand HADSF specificity 
elements.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure A.45: HADSF Structure, Figure generated by Pymol [53] 
 B. thetaiotaomicron is a gram negative symbiotic human gut bacterium, that has 
evolved to acquire and hydrolyze otherwise indigestible dietary polysaccharides [5].  
BT1677 is a 2-keto-3-deoxy-D-manno-octulosonate 8-phosphate phosphatase (KDO8PP) 
which produces KDO, a saccharide integral to lipid A and thus crucial for gram negative 
cell survival [6-8]. BT1713 was recently identified as a 2-keto-3-deoxy-9-O-
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phosphonononic acid phosphatase (KDN9PP) [9]. KDN is a sialic acid derivative 
commonly used in cell wall polysaccharides in higher level organisms [10-11].  
Eukaryotic synthesis of KDN is a two step process, entailing the condensation of 
mannose 6-phosphate and phosphoenolpyruvate to produce KDN9P, which is then 
dephosphorylated by KDN9PP to produce KDN [12]. In general, bacterial synthesis of 
KDN differs in that KDN is directly produced from the condensation of mannose and 
phosphoenolpyruvate [13]. Notably, in B. thetaiotaomocron KDN is synthesized via the 
eukaryotic two-step process (Figure A.2) [14]. The 8-carbon sugar KDO8P is formed 
from the condensation of D-arabinose 5-phosphate and phosphoenolpyruvate [15]. 
KDN9P is formed by the condensation of mannose 6-phosphate and 
phosphoenolpyruvate. Hydrolysis of the phosphate group is catalyzed in the next step by 
the corresponding phosphatase. The synthases preceding the phosphatases in the KDN 
and KDO pathways derive from different fold families (Figure A.2). Thus, biosynthesis 
of KDO and KDN are similar structurally yet are biosynthesized by distinct pathways.  
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Figure A.46: KDO and KDN biosynthesis. Schematic of KDO (left panel) and KDN 
(right panel) biosynthesis. Figure generated with ChemDraw 
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 The means of conferring specificity in the two phosphatases is not clear from 
primary sequence alignments since there is not a distinct specificity loop provided by the 
C0 cap, as there is in C1 or C2 cap members. An N-acetylneuraminic acid liganded  
structure of KDN9PP was recently published [9], but structural overlays of unliganded 
KDO8PP and liganded KDN9PP do not lead to the clear identification of specificity 
determinants. An E. coli KDO8PP c-terminal truncation mutant structure with ligand has 
also been determined to modest resolution [16], but a wild-type liganded structure is not 
available for comparison. While this work is informative, it does not assist in elucidating 
the basis of specificity. 
 The object of this work was to elucidate the structural means of KDO8PP and 
KDN9PP specificity in B. thetaiotaomicron, and determine the evolutionary importance 
in all gram-negative bacteria using bioinformatic techniques. 
 
Methods 
Unless otherwise stated all chemicals were obtained from Sigma-Aldrich and all 
primers, competent cells, ligases, polymerases and restriction enzymes from Invitrogen. 
 
Cloning and site-directed mutagenesis 
The gene encoding BT1713 was previously cloned [9].The gene encoding 
BT1677 was amplified from Bacteriodes thetaiotaomicron  VPI-5482 genomic DNA 
with primers 5’-CCG GCG GGG AGA ATT GGA GGC TAA TAT AA 3’ (forward) and 
5’-GCT GGC AGA CAG TCA GGC ATT GCA GGA AAT 3’ (reverse). After 
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amplification, the clone was modified to include restriction sites for Nde1 and BamH1 
using the primers 5’ GTAAAAGCATATGAGCACCATCAATTATGATTATCCCGC 
3’ (Nde1) and 5’TTATTAAAGGGATCCACAACTCACCAGCCGAAAGCATCTTCC 
GCC 3’ (BamH1) (bold letters indicate restriction sites). After amplification, the clone 
was digested with restriction enzymes Nde1 and BamH1. The fragment was cloned into a 
pET15b vector (Invitrogen) containing a thrombin protease site. 
BT1713 and BT1666 genes bearing site-directed mutations were prepared by a 
PCR-based strategy with commercial primers and the wild-type BT1713 or BT1677 
plasmid serving as a template. The gene sequence was confirmed by DNA sequencing.   
 
Expression and Purification 
Recombinant BT1713 wild-type and mutant was expressed and purified as 
previously described [9]. Recombinant BT1677 was purified from Escherichia coli BL-
21(DE3) cells transformed with the pET15b vector harboring the BT1677 sequence. 
Cells were grown in LB media at 37 °C until A600 = 1.0 when IPTG was added to a final 
concentration of 1 mM. Cells were harvested by centrifugation after 4 h. Cell pellets were 
resuspended in 20 mM Hepes pH 7.5 and 100 mM NaCl and were lysed by sonication. 
Cell debris was removed by centrifugation for 45 min. The soluble fraction was filtered 
using a 0.22 µm sterile filter and applied to a TALON Metal Affinity Resin (Clontech) 
gravity column (5 mL) equilibrated in 20 mM Hepes pH 7.5, 100 mM NaCl and 10mM 
imidazole. BT1677 was eluted using a step gradient of imidazole (30 mM, 100 mM, 250 
mM, and 500 mM). Fractions containing BT1677 were analyzed by SDS-PAGE, pooled, 
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and dialyzed against 2L of 20 mM Hepes pH 7.5, 100 mM NaCl 10 mM imidazole, and 1 
mM DTT. The dialyzed protein was cleaved using Tagzyme DAPase (Qiagen) for 2 
hours at 37 °C with 225 rpm shaking. The cleavage mixture was applied to the TALON 
Metal Affinity Resin (Clontech) gravity column (5mL) pre-equilibrated in 20 mM Hepes 
pH 7.5, 100 mM NaCl and 10 mM imidazole. The flow-through was analyzed by SDS-
PAGE, pooled and dialyzed against 2L of 20 mM Hepes buffer, pH 7.5, 50 mM NaCl, 
and 10 mM MgCl2. Purified protein was concentrated to 30 mg/mL using Amicon Ultra 
Concentrators. Typical yields were 3.75 mg / g cell paste of enzyme that was > 90% pure 
as assessed by SDS/PAGE. 
All BT1713 mutants were isolated and purified to homogeneity (as judged by 
SDS-PAGE analysis) from transformed and induced E. coli cells using the same protocol 
used for wild-type BT1713. 
 
Crystallization, Data Collection and Structure Solution BT1677 (BT-KDO8PP) 
 Crystals of BT1677 (BT-KDO8PP) were obtained by the vapor diffusion method 
using hanging drop geometry. Drops were equilibrated against reservoir solution 
containing 30% polyethylene glycol (PEG) MME 550, 40 mM MgCl2, 100 mM Hepes, 
pH 7.5 at 18 °C. The hanging drops contained equal volumes (1 µl each) of the reservoir 
solution and a 30 mg/mL protein solution in 20 mM Hepes buffer, pH 7.5, 50 mM NaCl, 
and 10 mM MgCl2. Small crystals (0.1mm x 0.1mm x 0.05mm) appeared within 2 days. 
The crystals belonged to the space group P212121 with cell dimensions a=37.517 Å b= 
91.349 Å c=170.115 Å.  There were four molecules in the asymmetric unit and the 
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solvent comprised 35% of the unit cell. Surface solvent was removed using Paratone, and 
the resulting crystals were flash-cooled in liquid nitrogen. Data was collected at 100 K 
using a single wavelength at the X12C beamline of the National Synchrotron Light 
Source (Brookhaven National Laboratory, Upton, NY). For data collection, beamline 
X12C was equipped with a Brandeis 2 x 2 CCD detector. Data were collected to 1.8 Å 
resolution and processed with the program DENZO and SCALEPACK (Table A.1).  
 
Table A.11 Data collection and refinement statistics for BT-KDO8PP, BT-KDN9PP 
liganded with Mg2+, VO3- and KDN and HI-KDO8PP liganded with KDO and VO3-. 
Values in parentheses are for the highest resolution shell, NA indicates not applicable 
Data Collection BT-KDO8PP 
BT-KDN9PP/ 
KDN/VO3- 
HIKDO8PP/ 
KDO/VO3- 
Space group   P212121   P21212         I4   
Cell dimension (Å)  
 a = 37.52  
 b = 91.35   
c = 170.12  
 a=81.30  b=106.32  
c=74.15  
 a = b = 79.85  
c = 52.15   
Molecules / ASU 4 4 1 
Wavelength (Å)  1 1.54 1.54 
Resolution (Å)  
85.1 - 1.8 
(1.86 – 1.8) 
28.5 - 2.1 
 (2.2 – 2.1) 
29.5 - 1.8 
(1.89 - 1.8) 
Observed reflections   822,448 220,160 120,635 
Unique reflections   55,354 38,011 14,537 
143 
 
Completeness (%)  91.1 (79.7)   95.5 (99.0)  95.6 (91.4)  
Rmerge (%)  6.1 (43.2)  7.6 (48.3)  5.73 (38.13)  
<I/>  19.6 (2.79)  6.29 (2.5)  13.68 (2.40)  
Redundancy  5.3 (4.8) 5.4 (2.73) 7.9 (5.7)  
Twin Law     -k,-h,-l  
Twin Fraction    0.33 
Refinement        
R / Rfree  17 / 22.1  19.67 / 26.45  14.52 / 17.60  
Average Temperature Factor  (Å2)       
Protein /Water 23.47 / 29.0 26.4 / 26.0 18.3 / 26.0 
Mg / Ligand 16.9 / NA             30.4 / 47.1 16.0 / 21.6 
Rms deviation from ideal    
Bonds  0.013 0.008 0.0286 
Angles  1.376 1.115 2.352 
 
 The structure of unliganded wild-type BT-KDO8PP was determined to 1.8 Å 
resolution with phases determined by the molecular replacement method with the 
program Phaser in the CCP4 suite [17-18]. The search model was the protomer of BT-
KDN9PP (BT_1713), leading to a clear solution for four protomers (forming the 
expected tetramer). The structure was refined using the program CNS [19] using data 
between 50 and 1.8 Å, for which F ≥ 2σ(F).  An energy minimization molecular 
dynamics cycle was followed by a simulated annealing molecular dynamics cycle at 5000 
K which was followed by alternating cycles of positional and individual temperature 
factor refinement. The resulting model was manually inspected and modified with the 
program COOT [20].  In the final stages of the refinement, water molecules were added 
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to the model using an electron-density acceptance criteria of d ≥ 3σ(d) in the Fo-Fc 
difference electron-density map 
 
 BT1713 liganded with KDN/VO3- 
 Crystals of BT1713 (BT-KDN9PP) were obtained by vapor diffusion in hanging 
drops. Drops were equilibrated against reservoir solution containing 19% PEG 3350 and 
100 mM magnesium formate at room temperature. The hanging drops contained equal 
volumes (1µl each) of the reservoir solution and a 29 mg/mL protein solution in 10 mM 
Hepes buffer, pH 7.5 and 10 mM MgCl2. Small crystals (0.15 mm x 0.15 mm x 0.01 mm) 
appeared in 1 day. Crystals were soaked in 50 L of 50 mM KDN, 20 mM sodium 
vanadate, 22% PEG 3350 and 100 mM magnesium formate for one week before data 
collection. Surface solvent was removed by dragging the crystal through paratone then 
flash-cooling in liquid nitrogen. The crystals belonged to the space group P21212 with 
cell dimensions a=81.296 Å b=106.324 Å c=74.147 Å. Data was collected at a single 
wavelength on the Bruker Microstar-H running at 2.7 kW with Helios multi-layer optics 
and a Platinum 135 CCD detector at Bruker AXS, Madison, Wisconsin, USA. Data were 
collected to 2.1 Å, reduced using SAINT and scaled using SADABS from 
the PROTEUM2 software suite (Table A.1). 
 The structure of liganded BT-KDN9PP was determined to 2.1 Å resolution by the 
molecular replacement method with the program MOLREP in the CCP4 suite. The search 
model was the protomer of KDN9PP, leading to a clear solution for four protomers (the 
expected tetramer). Successive rounds of model refinement were performed with the 
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program PHENIX [21] with data between 50 and 2.1 Å, for which F ≥ 2σ(F) with 
alternating cycles of positional and individual temperature factor refinement. The 
resulting model was inspected and modified with the program COOT. In the final stages 
of refinement, water molecules were added to the model with electron-density acceptance 
criteria of d ≥ 3σ(d) in the Fo–Fc difference electron-density map. Ligand molecules 
(KDN and VO3-) were added when the Rfree was below 30%. A composite omit map with 
coefficients 2Fo-Fc was calculated using the program CNS. 
 
BT1713 Glu56Ala and Glu56Ala Lys67Ala 
Crystals of BT1713 Glu56Ala mutant were obtained by vapor diffusion using 
hanging drop geometry. Drops were equilibrated against reservoir solution containing 
100 Mm Bis-Tris buffer, pH 6.2, 200 mM MgCl2, and 23% PEG 3350. Drops contained 
equal volumes (1µl each) of seed stock solution suspended in mother liquor and 20 
mg/mL protein in 50 mM Hepes buffer, pH 7.5 and 5 mM MgCl2. Seed stock was 
prepared by adding one crystal to 500 µL of mother liquor and crushing using Seed Bead 
from Hampton Research. Crystals appeared within one day (0.170 x 0.075 x 0.03 mm) 
belonging to the space group P2221. A single crystal was dragged through paratone to 
remove surface solvent for cryo-protection, and placed directly in the liquid nitrogen 
stream. Data was collected at a single wavelength (1.54 Å) on a Bruker MICROSTAR 
micro-focus rotating anode with Helios optics and Platinum 135 CCD detector, using a 
four circle kappa goniometer, at Boston University. Data was collected to 2.28 Å 
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resolution, reduced using SAINT and scaled using SADABS from the PROTEUM2 
software suite [24] (Table A.1). 
The structure of BT1713 mutants, E56A and E56A/K67A double mutant, were 
determined to 2.28 and 2.05 Å resolution respectfully by the molecular replacement 
method with the program MolRep in the CCP4 suite. The search model was the protomer 
of BT1713. KDN9PP-E56A/K67A is twinned (twin fraction = 0.035, twin law l, -k, h). 
Twin refinement was included in the rounds of refinement, resulting in improved maps 
than without twin refinement for KDN9PP-E56A/K67A. Otherwise, the refinements of 
KDN9PP-E56A were the same. Phenix refine was used to perform iterative cycles of 
atomic positional refinement, atomic displacement parameter refinement and real space 
atomic position refinement. Each round of Phenix was followed by manual inspection in 
COOT. Waters were added to the model with electron-density acceptance criteria of d ≥  
3σ(d) in the Fo–Fc difference electron-density map.  
 
 HI1679 (HI-KDO8PP) 
 Crystals of HI1679 (HI-KDO8PP) were obtained by vapor diffusion in hanging 
drops. Drops were equilibrated against reservoir solution containing 21% PEG 3550, 100 
mM Tris, pH 8.5 at 17 °C. The hanging drops contained equal volumes (1 µl each) of the 
reservoir solution and an 11 mg/mL protein solution in 50 mM Hepes buffer, pH 7.6, 5 
mM MgCl2 and 1 mM DTT. Small crystals (0.15 mm x 0.1 mm x 0.05 mm) appeared in 
within 1 day. Crystals were soaked in 50 μL of 100 mM Tris pH 8.5, 30% PEG 3350, 
20mM vanadate, and 20 mM KDO for 3 days at room temperature before data collection.  
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Surface solvent was removed by dragging the crystal through Paratone then flash-cooling 
in liquid nitrogen. The crystals belonged to the space group I4 with cell dimensions a= 
79.846 Å b= 79.846 Å c= 52.151 Å.  There was one molecule in the asymmetric unit and 
the solvent comprised 46% of the unit cell. Data was collected at a single wavelength 
(1.54 Å) on a Bruker MICROSTAR micro-focus rotating anode with Helios optics and 
Platinum 135 CCD detector, using a four circle kappa goniometer, at Boston University 
Department of Chemistry. Data was collected to 1.8 Å resolution, reduced using SAINT 
and scaled using SADABS from the PROTEUM2 software suite [24] (Table A.1). 
 The structure of ligand-bound HI-KDO8PP was determined at a 1.8 Å resolution by 
the molecular replacement method with the program MolRep in the CCP4 suite. The 
search model was the protomer of HI1679 (PDB ID: 1K1E with 7 C-terminal residues 
manually removed) [22], leading to a clear solution for the protomer. The presence 
of twinning was confirmed by examination of the cumulative intensity distribution, with 
a twinning fraction of 0.33 and twin law –k, -h, -l. The structure was refined using the 
program REFMAC [23] with the data between 29.46 and 1.8 Å, for which F ≥ 2σ(F). 
Restrained refinement with hemihedral twin refinement was performed. The resulting 
model was inspected and modified with the program COOT.  In the final stages of 
refinement, water molecules were added to the model with electron-density acceptance 
criteria of δ≥3σ(δ) in the Fo–Fc difference electron-density map. Vanadate and 2-keto-3-
deoxy-octulosonic acid (KDO) were added to the model in the final round of refinement. 
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Determination of Steady State Kinetic Constants 
BT1713 Activity  
 Reaction mixtures (1 mL) at 25 oC and initially containing  BT1713 (0.04µM for 
KDN9P; 1.0µM for KDO8P), varying concentrations of KDN9P (50µM-560µM) or 
KDO8P (100µM-1500µM), 10 U of NeuNAc aldolase[9], 10 U of lactate dehydrogenase, 
2 mM MgCl2, and 0.2 mM NADH in 50 mM K+HEPES (pH 7.0) were monitored at 340 
m (∆ε = 6200M –1 cm –1). Initial velocity data were fitted to equation 1 using the 
computer program KinetAsyst I in order to define the steady state kinetic constants.   
    V0=Vmax[S]/([S] + Km ) (Equation 1) 
where V0 is the initial velocity, Vmax the maximum velocity, [S] the substrate 
concentration, and Km the Michaelis-Menten constant for the substrate. The kcat value was 
calculated from Vmax and [E] according to the equation kcat=Vmax/[E], where [E] is the 
protein subunit concentration in the assay reaction 
 
Result and Analysis: 
Bioinformatic Analysis 
 The HI-KDO8PP amino-acid sequence was used to search for additional KDN9PP 
or KDO8PP sequences using BLAST [24] within each phylum of bacteria. Sequences 
were separated using the specificity sequence identifier: KDO8PP T/SxGxxxxxxxRxxA, 
KDO8PP T/SxRxxxxxxxRxxD/E/T/S/Q/N, KDN9PP T/SxExxxx xxxRxxK, where T/S 
indicates motif 2 of the HADSF. With each sequence identified, the bacterial genome 
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was then solely searched for additional C0 HAD family members using the initially 
identified C0. Additional sequences were classified based on the above specificity 
sequence identifiers. 
 
Variability Analysis 
Protein variability was computed with multiple sequence alignments of KDN9PP, 
KDO8PP (with Gly, KDO8PP-Gly) and KDO8PP (with Arg, KDO8PP-Arg) using the 
Protein Variability Server [25]. Variability is calculated using the Shannon entropy 
equation [26], with a score of 0 indicating absolute conservation across all sequences and 
4.322 indicating that all 20 natural amino acids are found at that position(a variability 
score ≤ 2 is considered conserved). A random selection of sequences from each group 
was chosen as input and results mapped onto the corresponding three-dimensional 
structures of BT-KDN9PP, BT-KDO8PP, and HI-KDO8PP. Electrostatic potential 
surfaces of BT-KDO8PP, BT-KDN9PP and HI-KDO8PP were calculated using GRASP 
[30]. KDO8P was manually docked into BT-KDO8PP structure using the phosphate 
binding site and overlays with HI-KDO8PP/KDO/VO3- as a guide. The structure was then 
minimized  using an energy minimization molecular dynamics cycle (200 steps) in the 
program CNS [18]. 
 
Structural Comparison of BT-KDN9PP and BT-KDO8PP 
The structure of unliganded B. thetaiotaomicron KDO8PP with Mg2+-bound was 
solved and refined to a resolution of 1.8 Å (Table A.1) for comparison with BT-
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KDN9PP, which has previously been solved (PDB ID 3E8M, [9]). BT-KDO8PP and BT-
KDN9PP have 28% primary sequence identity and an overall RMSD of 1.6 Å for the 
protomer (Figure A.3). Both enzymes were crystallized as tetramers in the asymmetric 
unit, with the active site at the interface of two subunits, consistent with other KDO8PPs 
[15, 22]. Thus, one subunit acts as the HAD core or ‘catalytic’ domain, containing the 
HAD conserved motifs, and the other subunit acts as a ‘cap’ domain, and is expected to 
contribute residues to ligand the substrate leaving group. When comparing unliganded 
structures of KDN9PP with KDO8PP, there exists a very similar protomer structure and 
active-site makeup. Notable differences are seen in the C-terminus with the C-terminus of 
BT-KDN9PP being alpha helical and extended away from the core domain, while the C-
terminus of BT-KDO8PP does not have clear electron density associated with it; possibly 
this temporal or spatial disorder indicates flexibility in this region. Two other KDO8PP 
structures have previously been solved from E. coli (PDB ID 2R8E [15]) and H. 
influenza (PDB ID 1K1E, [22]), both containing extended C-terminal tails which are 
juxtaposed to the active site of the adjacent monomer, indicating a possible role in  
functionality of the C-terminus of KDO8PPs in specificity, exclusion of bulk solvent or 
catalytic positioning of the substrate [15]. Indeed, a truncation mutant of the last 
seve167) yields a 15-fold reduction in kcat compared to wild-type BT-KDO8PP (Table 
A.2) with a 7 fold reduction in Km. Similar results are seen for E. coli KDO8PP [15]. 
This highlights the importance of the C-terminus to substrate turnover in KDO8PP 
enzymes. 
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Table A.12: BT-KDN9PP and BT-KDO8PP wild-type steady-state kinetics. Steady-state 
kinetic constants for BT-KDN9PP and BT-KDO8PP catalyzed hydrolysis of KDN9P or 
KDO8P in 50 mM K+HEPES containing 2 mM MgCl2 (pH 7.0, 25oC). 
Enzyme Substrate kcat (s
-1) Km (mM) kcat/Km  ( M-1s-1) 
BT-KDO8PP 
KDN9P 0.061 ± 0.005 0.89 ± 0.19 69 
KDO8P 1.5 ± 0.3 0.10 ± 0.04 1.5 x 104 
A167 
truncation KDO8P 0.10 ± 0.1 0.76 ± 0.01 1.3 x 10
2 
BT-KDN9PP 
KDN9P 1.2 ± 0.1 0.105 ± 0.09 1.1 x 104 
KDO8P 0.092 ± 0.003 0.43 ± 0.07 2 x 102 
E56A 
KDN9P 0.026 ± 0.002  0.41 ± 0.01  6 x 101  
KDO8P 0.109 ± 0.02 0.207 ± 0.09 5 x 102 
E56A / K67A 
KDN9P 0.004 ± 0.0008 0.99 ± 0.03 4.1 
KDO8P 0.062 ± 0.002 0.196 ± 0.009 3.1 x 102 
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Figure A.47: Overlay of BT-KDN9PP and BT-KDO8PP.  The RMSD of Cα of the 
monomers is 1.6 Å. BT-KDN9PP is shown in blue, BT-KDO8PP green (Mg2+ depicted 
as magenta sphere).  figures generated using MOLSCRIPT [54] 
 
Kinetic Comparison of BT-KDN9PP and BT-KDO8PP 
 With the similarities noted between these two enzymes, one could assume each 
enzyme would be able to readily dephosphorylate the sugar phosphate substrate of the 
other. Each enzyme shows high catalytic efficiency toward its physiological substrate 
with the kcat/Km = 1.2 x 104 M-1 s-1 for BT- KDN9PP against KDN9P, and kcat/Km = 1.5 x 
104 M-1 s-1 for BT-KDO8PP against KDO8P (Table A.2, [9]). Steady-state kinetics of the 
two enzymes with the swapped substrate gives a large decrease in kcat/KM (KDO8PP has 
a 22 fold decrease in kcat/Km against KDN9P versus KDO8P, and KDN9PP has a 60 fold 
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decrease in kcat/KM against KDO8P versus KDN9P) (Table A.2). Clearly the enzymes are 
able to differentiate KDO8P and KDN9P via hydrogen-bonding, electrostatic, or steric 
interactions with the substrate.  
 
Structural Analysis of BT-KDN9PP with KDN and VO3- 
Analysis of the ligand bound structure clarifies specificity determinants by 
highlighting primary structure differences between BT-KDN9PP and BT-KDO8PP. The 
most obvious difference is found in two BT-KDN9PP ligand binding residues. Glu56 of 
the core subunit and Lys67* of the adjacent (cap) subunit in BT-KDN9PP occur as Gly63 
and Ala74* respectively in BT-KDO8PP. Met20 in KDN9PP is Val in KDO8PP. These 
three differences open up a pocket in BT-KDO8PP for ligand binding. Also, Asn106 in 
KDN9PP is Pro113 in KDO8PP. These changes, which potentially could affect the 
ability of KDO8PP to discriminate against KDN9P were thus tested by site-directed 
mutagenesis. 
 
Structure Determination and Kinetics of E56A and E56A/K67A BT-KDN9PP  
 The X-ray crystallographic structure of E56A and E56A/K67A BT-KDN9PP 
mutants were solved (Table A.3) to demonstrate that the mutations do not affect overall 
stability of the enzyme. Both structures are similar to wild-type BT-KDN9PP, with 
RMSD values of 0.23 Å, and 0.0 Å for E56A and E56A/K67A, respectively (Figure 
A.4). We can conclude that changes seen in activity (kcat and Km) are solely due to the 
replacement of a residue rather than global structural changes.  
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Figure A.48: BT-KDN9PPmutant structures. Rainbow colored ribbon diagram of BT-
KEN9PP Glu56Ala (right panel) and BT-KDN9PP Glu56Ala / Lys67Ala (left panel). 
Magnesium is shown as magenta spheres.  
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Table A.13: BT-KDN9PP mutant data collection and refinement statistics. Data 
collection and refinement statistics for BT-KDN9PP Glu56Ala and Glu56Ala / 
Lys67Ala. Values in parentheses are for the highest resolution shell. 
Data Collection BT-KDN9PP-Glu56Ala BT-KDN9PP-Glu56Ala-Lys67Ala 
Space group   P2221 P21 
Cell dimension (Å)   a=88.94  b=94.12  c=161.50 a=72.37 b=116.77 c=75.18 
Molecules / ASU 8 8 
Wavelength (Å)  1.54 1.54 
Resolution (Å)  2.28 2.05 
Observed 
reflections   388,814 832,804 
Unique reflections   62,511 76,062 
Completeness (%)  99.9 (100) 97.4 (92.7) 
Rmerge (%)  8.78 ( 46.48) 13.08 (47.69) 
<I/σ>  11.6 (2.2) 14.12 (3.73) 
Redundancy  6.21 10.66 
Twin Law  None l, -k, h 
Twin Fraction  0.0 0.067 
Refinement      
R / Rfree  19.54 / 24.93 21.27 / 25.29 
Average B Factor  
(Å2)  25.76 19.05 
Rms deviation from ideal   
     Bonds  0.007 0.006 
     Angles  1.015 0.941 
 
 
Steady-state kinetics were previously reported for BT-KDN9PP-E56A mutant 
against the substrate KDN9P [9]. The BT-KDN9PP-K67A protein is unstable and could 
not be assayed. The BT-KDN9PP-E56A is a stable mutant, with kcat/Km = 6 x 101 M-1 s-1 
against KDN9P as substrate (Table A.2) showing a 200 fold decrease compared to wild-
type. When KDO8P is supplied as substrate, kcat/Km = 5 x 102 M-1s-1 (2 fold increase 
compared to wild-type). With this single mutation, the specificity of BT-KDN9PP has 
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shifted to favor KDO8P over KDN9P (ratio of KDO8P/KDN9P kcat/Km is 8 fold, Table 
A.2).  Double mutants of E56A and K67A were assayed to test for further enhancement 
of the specificity switch between the two sugars. The E56A/K67A mutant of KDN9PP is 
80 fold more specific for KDO8P over KDN9P (kcat /Km of 3.1 x 102 vs. 4.1 M-1s-1, 
respectively, Table A.2). The change in specificity is due to a large loss of binding 
affinity of KDN9P as reflected by Km, due to the absence of critical ligand binding 
residues (Glu56 and Lys67).  
 
BT-KDO8PP and BT-KDN9PP Analysis 
 Together the X-ray crystallographic and mutational kinetic data highlight the 
importance of two critical residues within each active site. In KDN9PP, Glu56 and Lys67 
provide key ligand stabilizing interactions to position the substrate KDN9P for catalysis 
(Figure A.5). When these residues are mutated to Ala, the selectivity of the KDN9PP 
changes to prefer KDO8P as substrate. This correlates with the presence of Gly and Ala 
at the homologous positions in KDO8PP, indicating their importance in substrate 
specificity.  The production of KDN is uncommon in bacteria, and it is normally found in 
eukaryotic organisms [27], with the exception of a few bacteria such as S. fredii and K. 
ozaenae [28-29]. The pathway utilized in these bacterium has not been studied.  It is thus 
interesting that B. thetaiotaomicron has acquired the ability to produce KDN, probably 
through gene duplication. It is tempting to speculate that environmental pressures played 
a role in this evolution. B. thetaomicron is a human gut symbiont, the most abundant 
found in human feces [5, 30]. Because Lipid A, of which KDO is an integral part, is a 
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potent stimulator of the human innate immune response [31], B. thetaiotaomicron  must 
circumvent immunity in order to survive in the gut. It is known in other bacterial species 
(eg. H. influenzae, Salmonella O48) that sialyated bacterial cells do not up regulate the 
innate immune response [32-34]. The use of KDN to sialate the B. thetaiotaomicron cell 
surface and mimic human cells would prevent eliciting the innate immune response to 
Lipid A.   
158 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.49: Structure of KDN9PP in complex with KDN and VO3-. 2Fo-Fc composite 
omit electron density map contoured at 1.0 sigma (dark gray cages, left panel) shown for 
KDN and VO3-,(yellow), and  Mg2+  is depicted as magenta sphere, residue Asp10 shown 
in gray. Hydrogen bonds to KDN (ball and stick, yellow) are shown (dashed line, right 
panel). The catalytic domain (gray residues) and ‘cap domain’ (brown residues with *) 
are shown, otherwise colored as in left panel. 
 
Bioinformatic Analysis 
 To elucidate the evolutionary relationship between KDO8PP and KDN9PP 
enzymes, bioinformatic techniques were employed to analyze available bacterial genome  
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sequences in NCBI. 6 displays a representative sample of the sequences collected and 
analyzed, separated by specificity marker. Sequences were separated using the specificity 
markers for BT-KDO8PP, and BT-KDN9PP determined herein (vide supra). Out of a 
total of 4,303 bacterial genome sequences available, a random sample of 687 sequences 
was analyzed for KDO8PP and KDN9PP by phylum. It is important to note that over 
2,000 genomes are found in the proteobacteria phylum alone and thus was sub-divided 
into classes. All bacteria labeled as non-classified were excluded from analysis. 
 All species in the Bacteroides phylum contain a KDO8PP gene with Gly and Ala at 
the two specificity residue positions. Only a subset of Bacteroides species (11 out of 77 
analyzed) also contain a KDN9PP gene, confirmed by the presence or absence of KDN9P 
synthase, the preceding enzyme in the KDN pathway [12, 14], which is found adjacent to 
the KDN9PP gene. KDN9PP orthologues were identified in a subset of the Bacteroides 
phylum, and in the Chlorobi phylum (Table A.4). The Chlorobi phylum contains 
KDO8PP enzymes with Arg at the first specificity position and consists of green sulfur 
photoautotrophic bacteria which are considered most similar to Bacteroides [35], and the 
need for KDN production is not clear. All other gram-negative bacteria do not contain a 
gene for KDN9PP, as assessed by BLAST searches of each bacterial genome for which a 
KDO8PP gene was identified.  
. 
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Table A.14: Bioinformatic Summary. All phyla of bacteria are listed with number of 
genome sequences analyzed, percent of sequences in phyla analyzed, number of C0 
Phylum Genomes 
 
Percent 
 
C0 Specificity 
 
Enzyme 
Actinobacteria 25 6.8 1 E KDN9PP 
Aquificae 9 75 1 R KDO8PP 
Bacteroides 77 54 1 or 2 G KDO8PP E KDN9PP 
Chlorobi 12 86 2 R KDO8PP E KDN9PP 
Chlamydiae 6 13 1 R KDO8PP 
Cyanobacteria 16 12 1 G / S KDO8PP 
Deferibacteres 2 100 1 R KDO8PP 
Elusomicrobia 2 40 1 R / G KDO8PP 
Fibrobacteres 3 75 2 R KDO8PP E KDN9PP 
Firmicutes 17 1.5 1 R KDO8PP 
Fusobacteria 20 65 1 K KDO8PP 
Gemmatimonadetes 1 100 1 R KDO8PP 
Alphaproteobacteria  5 1.1 1 E KDN9PP 
Betaproteobacteria 98 32 1 R KDO8PP 
Gammaproteobactera 288 26 1 R KDO8PP 
Delta/Epsilon 
 
88 56 1 R KDO8PP 
Zetaproteobacteria 1 100 1 R KDO8PP 
Nitrospirae 2 100 1 R KDO8PP 
Planctomycetes 5 83 1 R KDO8PP 
Spirochaetes 4 1.3 1 N / S KDO8PP 
Synergistetes 6 100 1 R KDO8PP 
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gi|29347087|ref|NP_810590.1|        
MRTVNIKDGYAIQLAVKKGLHIAIITGGRTEAVRIRFAALGVK--DLYMG 83 
gi|265765968|ref|ZP_06094009.1      
MRTVNVKDGYAIQLAVKKGLRIAIITGGRSDVVRKRFIGLGVS--DLYFG 83 
gi|150005032|ref|YP_001299776.      
MRTVNIKDGYALQLAVKCGLHVAIITGGNTEAVRKRYEGLGIK--DVYLA 81 
gi|237713692|ref|ZP_04544173.1      
MRTVNIKDGYAIQLAVKKGLHIAIITGGRTEAVRIRFEGLGVK--DLYMG 83 
gi|224540513|ref|ZP_03681052.1      
MRTVNIKDGYALHLACKQGLLLGIITGGRSEAVRKRFMALGIPSEDIYMA 85 
gi|262340978|ref|YP_003283833.      
VRQMFAKDGYAMQLAKKKGYNLCIITRGSDLMVFRRLRGLNIR--YIYQG 79 
gi|167763293|ref|ZP_02435420.1      
LRTVNIKDGYALHLAARHEIPLAIITGGRTEAVRKRFRALGILPENIYMG 85 
gi|288928245|ref|ZP_06422092.1      
LRTVNIKDGYAIQFAQKVGLRICIITGGDTKAVRKRFEGLGVE--DIYMK 81 
gi|218130320|ref|ZP_03459124.1      
LRTVNIKDGYALHLAAKHEIPLAIITGGRTEAVRRRFLALGIPAENIYMG 85 
gi|198276869|ref|ZP_03209400.1      
MRSVNIKDGYALQLAVKCGLHVAIITGGKTEAVRKRYEGLGIK--DVYLG 81 
 
gi|29347123|ref|NP_810626.1|        
WKKFNTSDSAGIFWAHNKGIPVGILTGEKTEIVRRRAEKLKVDY--LFQG 76 
gi|294970963|gb|EFG46856.1|         
SVRVHRGDGMGVSRLVKAEFPFLILSKERNPVVTRRAEKLRVE---VAQG 84 
gi|254403203|ref|ZP_05018149.1      
FVSVHRGDGLGIAALRDSGLKMLILSTEQNPVVAARARKLKIP---VLHG 86 
gi|72160415|ref|YP_288072.1|        
TVVVNRGDGMGVSLLLKAGIRVCILSTEVNSVVRARARKLGVP---VMHG 85 
gi|239979820|ref|ZP_04702344.1      
RVSVHRGDGLGIAALRDAGIPLLILSTEQNPVVTARARKLRIP---VLHG 83 
gi|29829917|ref|NP_824551.1|        
FVSVHRGDGLGIAALRKSGLTMLILSTEQNPVVAARARKLKIP---VLHG 84 
gi|271964804|ref|YP_003339000.      
MVAVSRSDGMGIALLRRSGVKLMIMSTEHNPVVAARARKLGVP---VLQG 83 
gi|256778605|ref|ZP_05517068.1      
LVAVHRGDGLGIAALRRAELALLILSTEKNPVVAARGRKLQVP---VLHG 84 
gi|254377988|ref|ZP_04993443.1      
LVSVHRGDGLGIAALRRSGLPLLILSTEQNPVVAARARKLRVP---VLHG 84 
gi|78189040|ref|YP_379378.1|        
LKRYSIRDGMGVERLRNAGIETCIMTGERSPNVQKRAEKLCMKW--LYLG 88 
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gi|16273566|ref|NP_439821.1|        
IKSFHVRDGLGIKMLMDADIQVAVLSGRDSPILRRRIADLGIK--LFFLG 80 
gi|149190591|ref|ZP_01868860.1      
LKTFHTRDGYGIKALMSAGVEVAIITGRRSQIVENRMTALGIS--LIYQG 95 
gi|260857325|ref|YP_003231216.      
LKAFNVRDGYGIRCVLTSDIEVAIITGRKAKLVEDRCATLGIT--HLYQG 98 
gi|170765508|ref|ZP_02900319.1      
LKAFNVRDGYGIRCALTSDIEVAIITGRKAKLVEDRCATLGIT--HLYQG 98 
gi|54310339|ref|YP_131359.1|        
LKTFHTRDGYGIKSLMNAGIEIAIITGRQSAIVENRMTALGIK--HIYQG 95 
gi|24114487|ref|NP_708997.1|        
LKAFNVRDGYGIRCALTSDIEVAIITGRKAKLVEDRCATLGIT--HLYQG 98 
gi|168231927|ref|ZP_02656985.1      
LKAFNVRDGYGIRCALTSNIEVAIITGRKAKLVEDRCATLGIV--HLYQG 98 
gi|15803738|ref|NP_289772.1|        
LKAFNVRDGYGIRCALTSDIEVAIITGRKAKLVEDRCATLGIT--HLYQG 98 
gi|218691488|ref|YP_002399700.      
LKAFNVRDGYGIRCALTSDIEVAIITGRKAKLVEDRCATLGIT--HLYQG 98 
gi|262273848|ref|ZP_06051661.1      
LKAFHTRDGYGVKSLMNAGVEIAIITGRKSAIVERRMAALGIQ--HIYQG 95 
 
Figure A.50: Sample alignment of KDO8PP and KDN9PP sequences from bacteria. 
HAD motif two is colored green, specificity residues are highlighted in blue (KDO8PP-
Gly), pink (KDN9PP, Glu), and purple (KDO8PP-Arg). 
 
Within the Gram-positive genomes, bacteria in the Actinobacteria phylum were 
found to possess KDN9PP genes, all with Glu at the first specificity position, and Lys at 
the second specificity position. The absolute conservation of the two specificity residues 
in KDN9PPs is consistent with its importance in ligand binding, as seen in the BT-
KDN9PP/VO3/KDN structure. All KDN9PPs identified in the Actinobacteria phylum are 
found as fusion proteins to a CMP transferase domain, that catalyzes the transfer of KDN 
to CMP [36]. The Actinobacteria phylum consists mainly of Streptomyces (the largest 
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genus, 21 genomes out of 25 identified in our bioinformatic analysis), which utilize 
anionic cell-wall polymers containing KDN [37-40]. As expected, no other bacterial 
species contained the additional KDN9PP gene, with few exceptions (see below). The 
absence of KDN9PP and other KDN synthesis genes correlates well with the rare 
appearance of KDN in bacteria.  
 Surprisingly, further genome searching indicated an alternative KDO8PP present in 
all other gram-negative bacteria, with Arg present at the first specificity residue and a 
variety of residues (Asp, Glu, Thr, Ser, etc) at the second specificity position. Thus, the 
enzyme observed over these bacteria is dissimilar to the B. thetaiotaomicron KDO8PP 
enzyme under study here.  
The presence of a KDO8PP bearing Arg at this position indicates that the 
Bacteroides phylum divergently evolved with respect to KDO8PP from all other gram-
negative bacteria. The divergent evolution possibly occurred through selective pressure 
to retain KDO8P phosphatase activity, while still allowing for variation of substrate 
binding residues to limit activity against other sugars present in the Bacteroides 
metabolome such as KDN9P. 
 
Exceptions to the Rule 
The class of Betaproteobacteria within the Proteobacteria phylum consists of 
aerobic or facultative anaerobic bacteria. In general, the bacterial species contain one C0 
phosphatase, which is annotated as a KDO8PP with Arg at the first specificity position. A 
subset of the Burkholderia species contains two C0 phosphatases, both with sequences 
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consistent with assignment as KDO8PPs, the first enzyme bearing Arg at the first 
specificity position,  and the second enzyme bearing Gly at the first specificity position. 
It appears that the Burkholderia species have evolved to contain two KDO8PP enzymes, 
which we cannot explain in terms of physiological function. Burkholderia are known to 
have a very potent LPS causing an upregulation of the innate immune response [41]. 
 The Francisella species in the Gammaproteobacteria contain a single C0 
phosphatase with Lys at the first specificity position. We propose that they are KDO8PPs 
because the Francisella species are shown to have the typical gram-negative Lipid A 
moiety [42]. The Fusobacteria phylum also contains KDO8PPs with Lys at this position. 
Fusobacteria are most similar to Bacteroides species, with a typical Lipid A moiety, but 
are noted to possess an exceptionally virulent LPS [43-44]. We propose that these 
Francisella and Fusobacteria enzymes identified are KDO8PPs, as the specificity residue 
was conservatively replaces from Arg to Lys , and no KDN9P synthase genes were 
identified within these genomes. The Acidobacteria class of Fibrobacteres phylum 
contains both KDO8PP (with Arg) and KDN9PP (with Glu). Acidobacteria are a highly 
acidic soil bacterium, and have only 4 total genome sequences available, so it is unclear 
the role the KDO or KDN plays in cell survival or defense.  
 
Additional KDO8PP and KDN9PP Kinetic Analysis 
We chose to functionally characterize KDO8PP enzymes with alternate residues 
present at the first specificity residue (these were additionally targeted for functional 
characterization by the Enzyme Function Initiative, http://www.enzymefunction.org). 
165 
 
The structures of E. coli, and H. influenzae KDO8PPs have previously been reported [15, 
22] as well as the kinetics constants for the E. coli enzyme against KDO8P and are used 
for comparison.  L. pneumophila, P. syringae and V. cholera are found in the 
gammaproteobacteria class of proteobacteria, the largest phylum of bacteria. L. 
pneumophila subsp. pneumophila str. Philadelphia 1 KDO8PP contains an Ala at the 
first specificity position, Gln at the second specificity position, and is one of the 
exceptions to the rule we have observed. Other L. pneumophilia strains contain an Arg at 
the first specificity position.  
 The kcat and Km of each enzyme confirms its assignment as a KDO8PP orthologue. 
L. pneumophila subsp. pneumophila str. Philadelphia 1 KDO8PP (LP-KDO8PP) is 
specific for KDO8P as substrate with kcat / Km = 1.7 x 103 M-1s-1 (compared to kcat / Km = 
1.8 x 101 M-1s-1 for KDN9P), with a similar activity to BT-KDO8PP (Table A.5). E. coli, 
P. syringae and V. cholera KDO8PPs all contain an Arg at the first specificity position 
and a variety of residues at the second specificity position (Thr, Ser. Ala 
respectively).The kinetics show that each enzyme is specific for KDO8P (Table A.5), 
with kcat / Km ranging from 103 to 105 M-1s-1 and selectivity over KDN9P of 100 to 4,500 
fold. Steady-state kinetics also confirm that H. influenzae KDO8PP (HI-KDO8PP) is a 
KDO8PP with a kcat/Km = 4.8 x 103 M-1 s-1 towards KDO8P (Table A.5) and contains 
specificity residues Arg and Asp. HI-KDO8PP with KDN9P provided as substrate yields 
a kcat/Km = 1.3 M-1 s-1, thus HI-KDO8PP is 370 fold more specific for KDO8P over 
KDN9P. This is a significant difference from the BT-KDO8PP (22 fold more specific for 
KDO8P over KDN9P) and indicates a significant role of Arg in the specificity of HI-
166 
 
KDO8PP.  The variability of the second specificity position in KDO8PPs indicates it 
plays a minor role in enzyme specificity.  
 
Table A.15: Steady-state kinetics to assign KDO8PP and KDN9PP enzymes. Steady-
state kinetic constants for enzyme catalyzed hydrolysis of KDN9P or KDO8P in 50 mM 
K+HEPES containing 2 mM MgCl2 (pH 7.0, 25oC). 
Phylum /   
   
Substra
 
kcat 
 
 
Km 
 
 
kcat/Km   
  
ratio Spec
  
 
PDB 
 
Actinobacteria /  
 S  itilli  /  
 
KDO8P 9.4 ± 
 
1.2 ± 
 
7.7 x 102 1.6 Glu / 
L  
3MMZ 
KDN9P 20 ± 
 
1.7± 
 
1.2 x 103 
Gammaproteobac
t i  / 
     
KDO8P 1300 ± 
 
1.7 ± 
 
7.7 x 105 4530 Arg 
/ Th  
2R8E 
KDN9P 7.7 ± 
 
4.6 ± 
 
1.7 x 102 
Gammaproteobac
t i  / 
    
 
KDO8P 78 ± 4 1.6 ± 
 
4.8 x 103 370 Arg 
/ 
 
1K1E 
KDN9P 2.1 ± 
 
16 ± 5 1.3 x 101 
Gammaproteobac
t i  /  
   
 
KDO8P 8 ± 0.4 0.5 ± 
 
1.7 x 103 100 Ala / 
Gl  
3N1U 
KDN9P 1.8 ± 
 
10 ± 1 1.8 x 101 
Gammaproteobac
t i  /  
   
 
KDO8P 60 ± 
 
0.5 ±0.
 
1.2 x 104 670 Arg 
/ S  
3MN1 
KDN9P 1.7 ± 
 
9.6 ± 
 
1.8 x 101 
Gammaproteobac
teria /  
V. cholerae / 
Q9KP52 
KDO8P 8.9 ± 
 
0.19 
 
4.7 x 103 
200 
Arg 
/  
Ala 
3N07 
KDN9P 
2.5 ± 
0.1 
11 ± 1 2.3 x 101 
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 An enzyme from S. avermitillis mis-annotated as KDO8P was found to possess the 
signature determinants for KDN9PP. Kinetic characterization demonstrates the SA-
KDN9PP is specific for KDN9P with a kcat / Km = 1.2 x103 M-1s-1. Notably, SA-KDN9PP 
occurs as a fusion protein with CMP transferase. Overall, then, the identity of KDN9PP 
enzymes can be based on Glu and Lys markers, and KDO8PP enzymes based on Gly and 
Ala or Arg and Asp/Ser/Ala/Gln/Thr markers. 
 
Additional Structural Data  
To correlate the bioinformatic and kinetic data, with structural information of 
KDO8PP and KDN9PP enzymes were compared (PDB ID 2R8E (E. coli, EC-KDO8PP), 
1K1E (H. influenzae, HI-KDO8PP), 3MN1 (P. syringae, PS-KDO8PP), 3N1U (L. 
pneumophila, LP-KDO8PP), 3N07 (V. cholera, VC-KDO8PP), 3MMZ (S. avermittillis, 
SA-KDN9PP).  
  Structural overlays of all available KDO8PP and KDN9PP enzymes show the 
three-dimensional location of the putative specificity residues in the active site is 
retained, (Figure A.7). Additionally the location always maps in primary structure with 
the first specificity residue positioned two residues after HADSF motif two (Ser/Thr), 
and the second specificity residue positioned 11 amino acids after the first. Overall, 
specificity residues in KDO8PP and KDN9PP enzymes throughout bacteria are 
conserved in primary and tertiary structure.  
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Figure A.51: Overlay of all KDO8PP and KDN9PP specificity residues. Side chains of 
motif one Asp and both specificity residues (indicated in parentheses) shown for EC-
KDO8PP (Arg78, Thr89, cyan), HI-KDO8PP (Arg60, Asp71, yellow), PS-KDO8PP 
(Arg69, Ser80, orange), LP-KDO8PP (Ala71, Gln82, forest green), VC-KDO8PP 
(Arg75, Ala86, brown), SA-KDN9PP (Glu64, Lys75,blue), BT-KDO8PP (Gly63, Ala74, 
green), BT-KDN9PP (Glu56, Lys67, gray with oxygen colored red and nitrogen colored 
blue) active overlayed. KDN (gray), VO3- (slate), Mg2+ (magenta sphere), and ribbon 
diagram of BT-KDN9PP shown for reference. Figure generated using PyMol 
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Structural Analysis of HI-KDO8PP with KDO and VO3- 
 The functional importance of Arg at the first specificity position is highlighted by 
the structure of the complex of HI-KDO8PP with KDO and VO3- as a transition state 
mimic, which was solved to 1.8 Å (Figure A.8). Two conformations of KDO were found 
in the crystal structure, each modeled with 50% occupancy (Figure A.8). The second 
conformer is not indicative of KDO8P binding, as the terminal OH forms a hydrogen 
bond to oxygen of VO3-, and was thus not included in analysis. Structural analysis shows 
three charge-charge interactions and two hydrogen bonds to the leaving-group sugar. 
Arg60 makes a mono-dentate salt bridge to an oxygen of the substrate carboxyl (2.8 Å, 
Figure A.8) revealing the basis of the functional importance of this residue in the binding 
of substrate. The second specificity residue, Asp71, does not interact with ligand, which 
correlates with the variability of that residue found in our bioinformatic data. The other 
important ligand-protein interactions include a bi-dentate salt bridge from Arg 68 to the 
carboxyl group of KDO (2.8 and 2.9 Å), and a hydrogen bond between the carbonyl of 
Val38 and Met178 to O2 (2.5 Å) and O4 (3.2Å), respectively. Also, a water molecule 
forms a bridging hydrogen bond to O7 of KDO (3 Å) and Asp108 (2.8 Å) of HI-
KDO8PP. The C6-C8 carbon chain of KDO is packed neatly against the side chain 
methylene carbons of Arg60. The C-terminus of HI-KDO8PP (from the ‘cap’ subunit) is 
found adjacent to the active site, effectively blocking solvent from the binding pocket 
(the final residue, Gln180 could not be modeled into density). The backbone oxygen of 
Met178 forms a hydrogen bond with O3 of KDO. This structure, combined with C-
terminal deletion mutant kinetics for BT-KDO8PP and the E. coli KDO8PP (vide infra 
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and [18]) demonstrates that the C-terminus of KDO8PP plays a role in positioning ligand, 
allowing effective catalysis. Previously, the only ligand bound KDO8PP structure 
available was with a C-terminal truncation [15]. 
 
 
 
Figure A.52: Structure of HI-KDO8PP in complex with KDO and VO3-(yellow) is 
shown and Asp14, Val15 and Asp16 (motif one, gray, left panel). Hydrogen bonds 
(dashed line) between KDO the catalytic domain (gray residues) and ‘cap domain’ 
(brown residues with *) are shown. Magnesium is represented as a magenta sphere and 
vanadium is represented as a slate blue sphere. Figures generated using MOLSCRIPT 
and POVS CRIPT [54-55]. 
Both structure and kinetics of KDO8PP from H. influenzae, E. coli and B. 
thetaiotaomicron demonstrates the function of the C-terminus in binding substrate and 
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providing solvent exclusion. In contrast, the C-terminal tail of BT-KDN9PP does not 
stabilize substrate; structural analysis shows it is positioned far from the active site. The 
C-terminal tail of KDN9PPs and KDO8PPs are functionally disparate and represent a key 
difference not observable via sequence alignment alone.  
 The other contribution to shape of the binding pocket is the specificity determinant 
residues. HI-KDO8PP has Arg60 (Asp71, the second specificity marker does not interact 
with substrate) and BT-KDN9PP has Glu56 and Lys67, which directly form hydrogen 
bonds to the substrate. BT-KDO8PP has Gly63 and Ala74 at these positions, significantly 
altering the shape of the active site compared to HI-KDO8PP and BT-KDN9PP. With 
respect to the size and shape of the binding cleft, HI-KDO8PP is more similar to BT-
KDN9PP than BT-KDO8PP. This provides explanation as to why HI-KDN9PP can 
accommodate KDN9P as a substrate (Table A.5).   
Our data indicate that KDO8PP has evolved to retain functionality while altering 
substrate binding. This is confirmed by our kinetic and structural analysis. KDO8PP 
either provides Arg as a direct ligand for KDO8P, or Gly to provide an altered binding 
pocket that is catalytically efficient toward KDO8P. 
 
Variability Analysis 
 To identify any other possible conserved specificity residues, the sequence entropy 
of each set of KDN9PP and KDO8PP enzyme sequences was determined. A  
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multiple sequence alignment of all KDN9PP sequences (44 available sequences from 
Actinobacteria, Bacteroides and Chlorobi phyla) was utilized to calculate entropy which 
was mapped our structure of BT-. For KDO8PP with the Gly marker (KDO8PP-Gly), 
sequences from Bacteroides (47) and Cyanobacteria (11) were aligned, with results 
mapped onto the BT-KDO8PP structure. For KDO8PP with the Arg marker (KDO8PP-
Arg), selected sequences from all other phyla were aligned  with results mapped onto the 
HI-KDO8PP structure. 
 Variability analysis confirms the identity of KDN9PP specificity residues, as 
expected, and identifies Ser 37 (BT-KDN9PP numbering) as absolutely conserved 
(Figure A.9). Ser37 does not contribute to ligand binding in the structure presented 
above (4.2 Å from KDN), it may affect the polarity of the active site. 
  
 
 
 
 
 
 
 
 
Figure A.53: Variability of KDO8PP-Gly, KDO8PP-Arg and KDN9PP. Ribbon diagram 
surrounding the active site of each structure: KDO8PP-Gly variability mapped onto BT-
KDO8PP (left panel, KDO (yellow sticks) is docked), KDO8PP-Arg variability mapped 
onto HI-KDO8PP (middle panel), and KDN9PP variability mapped onto BT-KDN9PP 
(right panel). HAD motifs and specificity residues are shown as sticks. 
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 The variability analysis of KDO8PP-Gly shows that Arg38 (BT-KDO8PP 
numbering) is conserved throughout Bacteroides and is conservatively replaced in the 
Cyanobacteria (6 / 12 Arg, 5 / 12 Lys).  Likewise, in KDO8PP-Arg the orthologous 
position is absolutely conserved as Lys throughout all phyla. The functionality of this 
Lys/Arg residue is to position the acid/base Asp residue motif one). In KDO8PP-Arg 
proteins, Lys is excluded from solvent by the specificity residue Arg, in comparison to 
KDO8PP-Gly proteins, Arg/Lys is exposed to solvent due to the presence of Gly at the 
specificity position. This can be seen by comparing electrostatic surfaces of BT-KDO8PP 
with HI-KDO8PP calculated by GRASP [25] (Figure A.10). The insertion of a positive 
charge into the KDO8P binding site provides a potential ligand for the KDO8P 
carboxylate. Another mechanism could be to alter the electrostatic environment of the 
active site to favor negatively charged ligand. Docking models of KDO8P into BT-
KDO8PP show that it is plausible to suggest KDO8P can form a weak charge charge 
interaction with Arg38 and Arg71 (Figure A.10, 4 Å and 4.4 Å respectively). Arg38 is 
present behind KDO8P carboxyl, and Arg71 is found to the left of Arg37 in Figure A.8. 
cannot visibly be docked into the same position. We hypothesize that Arg/Lys 38 is 
contributing to ligand binding or altering the electrostatic environment of the active site 
to make it more favorable for KDO8P binding, which has a negative charge due to the 
carboxylate. This mechanism feasibly allows for selectivity of KDO8P over KDN9P. 
Thus KDO8PP-Gly enzymes have possibly evolved a secondary mechanism for ligand 
binding, alternative to KDN9PP and KDO8PP-Arg. 
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Figure A.54: Electrostatic potential of BT-KDN9PP, BT-KDO8PP and HI-KDO8PP 
active site. Electrostatic surface potential generated using GRASP [30]. BT-KDO8PP 
surface is shown with KDO8P docked (yellow sticks, left panel), HI-KDO8PP surface is 
shown with KDO for positioning reference (middle panel), and BT-KDN9PP surface 
shown with KDN (right panel). 
The active site design does not eliminate KDN9P phosphatase activity in BT-
KDO8PP, as confirmed by kinetics (Table A.2). This can be explained by the presence of 
Arg71 in BT-KDO8PP, which corresponds to Arg 64 in BT-KDN9PP, and Arg 68 in HI-
KDO8PP, both of which form a bi-dentate salt bridge to ligand (Figure A.5, Figure A.8). 
Variability analysis shows that this residue is conserved in all three enzymes (KDN9PP – 
0, KDO8PP-Gly – 0.112, KDO8PP-Arg – 0.094) and Arg is always found in the same 
position in primary structure, eight residues downstream from the first specificity residue. 
The presence of Arg at this position allows for KDN9P to weakly bind to BT-KDO8PP in 
the absence of the specificity residues Glu and Lys. 
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Phylogenetic Correlation  
 Recent phylogenetic proteome analysis provides a bacterial tree of life for 
comparison with our findings [43]. The Bacteroides phylum is shown as a divergence on 
the path to gram-negative bacteria, namely the proteobacteria phylum. Our data correlate 
well with this tree of life, indicating that at some point in time a divergence occurred, 
where the Bacteroides phylum evolved separately from other gram-negative bacteria, 
possibly due to co-habitation with humans. Our data indicate that bacteria which are 
symbiotic with humans contain both KDO8PP and KDN9PP genes (e.g. Bacteroides and 
Chlorobi), while pathogenic bacteria tend to not have a KDN9PP gene, nor the 
corresponding synthase. Although, some bacteria like H. influenzae have evolved a 
secondary mechanism for obtaining KDN and its derivatives by importing sialic acid 
from the extracellular environment [44], it appears that the chosen mechanism in 
Bacteroides is to mimic human cells by acquiring the ability to produce sialic acids used 
to decorate the cell wall in humans.  
 
Evolutionary Divergence and Duplication 
Enzyme Specificity 
 A literature search illustrates the complexity in identifying a single residue which 
induces substrate selectivity seen here, as very few examples can be found. One example 
is tyrosine ammonia-lyase (TAL) of the aromatic lyase family. TAL is selective for L-
Tyr over L-Phe by 150 – 300 fold depending on the enzyme analyzed [45] and contains a 
His residue adjacent to the active site.  Sequence alignments confirm that His is present 
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in the same position in other TALs, while phenylalanine ammonia-lyases contain Phe at 
the same position. Mutation of His89 to Phe in TAL modifies the substrate selectivity to 
Phe over Tyr (15,000 fold) [45]. A similar example is the alteration of dyhydroflavonol 
4-reductase specificity in Gerbera by changing a single amino acid (Asn134Leu) [46]. 
This results in the switch of specificity to solely utilize dihydrokaempferol  as substrate, 
excluding dihydroquercetin and dihydromyricetin, which only differ in the addition of 
one or two hydroxyls, respectively, present on the ring structure [46]. The lack of 
examples in the literature highlights the difficulty in uncovering the mechanisms of 
substrate selectivity. The work described herein represents a structure-function-
bioinformatic approach which is feasible for teasing out subtleties in enzyme specificity. 
The correlation of structural, kinetic and bioinformatic data confirms the identity 
of two KDO8P phosphatases within bacterial species. The vast majority of bacteria 
contain a KDO8PP enzyme with an Arg residue at the identified specificity position. The 
HI-KDO8PP liganded structure highlights the importance of Arg in positioning KDO8P 
for catalysis. Yet, some KDO8PPs (i.e. B. thetaiotaomicron and L. pneumophila subsp. 
pneumophila str. Philadelphia 1) are specific for KDO8P, but replaced Arg with Gly or 
Ala. This exemplifies the variability and adaptability of enzymes. The loss of a large 
charged residue changes the shape of the KDO8P binding pocket which allows KDO8P 
binding, while reducing the ability of the enzyme to take in alternative substrates. This is 
critical for bacteria like B. thetaiotaomicron which must produce KDO for normal 
growth, and KDN to mimic human cells to prevent the innate immune response. 
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